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Abstract	  
 
Mechanisms	  that	  regulate	  gene	  expression	  are	  fundamental	  to	  many	  complex	  
biological	  processes	  and	  disease	  states.	  	  Genome-­‐wide	  approaches	  that	  combine	  
chromatin-­‐immunoprecipitation	  (ChIP)	  and	  next-­‐generation	  sequencing	  have	  
greatly	  advanced	  our	  understanding	  of	  chromatin	  structure	  and	  the	  role	  that	  
histone	  modification	  plays	  in	  transcriptional	  regulation.	  	  In	  particular,	  these	  
advances	  revealed	  important	  associations	  between	  functional,	  non-­‐coding	  DNAs	  and	  
specific	  histone	  modifications,	  which	  have	  been	  used	  technically	  to	  identify	  
numerous	  distal	  regulatory	  elements	  and	  furthered	  our	  knowledge	  of	  
transcriptional	  regulation	  and	  cell-­‐specific	  gene	  regulation.	  	  Fshr	  is	  a	  gene	  expressed	  
only	  in	  testicular	  Sertoli	  cells	  and	  ovarian	  granulosa	  cells	  and	  its	  expression	  is	  
critical	  for	  proper	  gonad	  function	  and	  fertility.	  	  Importantly,	  underlying	  its	  exquisite	  
cell-­‐specificity	  is	  a	  transcriptional	  mechanism	  limited	  to	  only	  two	  cell	  types,	  which	  
previous	  studies	  revealed	  was	  dependent	  on	  distal	  regulatory	  elements.	  	  To	  help	  
identify	  these	  elements,	  we	  used	  ChIP,	  combined	  with	  next-­‐generation	  sequencing,	  
to	  globally	  map	  Histone	  3	  Lysine	  4	  tri-­‐methylation	  (H3K4me3)	  in	  Sertoli	  and	  myoid	  
cells.	  	  H3K4me3	  is	  a	  post-­‐translational	  histone	  modification	  known	  to	  associate	  with	  
distal	  regulatory	  elements	  and	  promoter	  regions	  of	  actively	  transcribed	  genes.	  	  
Analysis	  of	  H3K4me3	  enrichment	  profiles	  identified	  a	  distal	  site	  3’	  to	  Fshr	  that	  was	  
specific	  to	  Sertoli	  cells.	  	  Transient	  transfection	  analysis	  indicated	  the	  region	  
represses	  Fshr	  promoter	  activity	  and	  in	  vitro	  binding	  analysis	  revealed	  that	  GATA-­‐4	  
and	  an	  unknown	  protein	  bound	  to	  the	  region,	  implicating	  them	  in	  cell-­‐specific	  
regulation	  of	  Fshr.	  	  These	  studies	  provide	  evidence	  that	  Fshr	  is	  regulated	  by	  a	  distal	  
	   iv	  
regulatory	  element	  and	  have	  provided	  insight	  into	  the	  nature	  of	  these	  regulatory	  
proteins.	  	  This	  work	  provides	  a	  database	  mapping	  H3K4me3	  enrichment	  within	  
Sertoli	  and	  peritubular	  myoid	  cells	  that	  can	  be	  used	  to	  identify	  new	  regulatory	  
regions.	  	  Overall,	  these	  studies	  have	  furthered	  our	  knowledge	  of	  cell-­‐specific	  gene	  
regulation	  in	  Sertoli	  cells	  and	  provided	  new	  data	  that	  will	  lead	  to	  a	  better	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The	  Gonadotropin	  Hormones	  
Luteinizing	  hormone	  (LH)	  and	  follicle-­‐stimulating	  hormone	  (FSH),	  are	  
integral	  parts	  of	  the	  neural	  and	  endocrine	  interchange	  between	  the	  hypothalamus,	  
pituitary,	  and	  gonads	  that	  controls	  steroid	  hormone	  synthesis	  and	  gamete	  
production	  (reviewed	  in	  (Young	  1995;	  Achermann	  and	  Jameson	  1999;	  Plant	  2008)).	  	  	  
At	  the	  top	  of	  the	  network	  is	  gonadotropin	  releasing	  hormone	  (GnRH),	  which,	  once	  
released	  from	  the	  hypothalamus,	  binds	  receptors	  on	  pituitary	  gonadotrophs	  and	  
induces	  the	  synthesis	  and	  secretion	  of	  LH	  and	  the	  FSH.	  Once	  in	  circulation,	  LH	  and	  
FSH	  finalize	  the	  communication	  by	  binding	  their	  receptors	  and	  transmitting	  signals	  
to	  the	  gonads.	  	  These	  signals	  are	  at	  the	  hub	  of	  the	  regulatory	  network,	  relaying	  
neuronal	  signals	  from	  the	  hypothalamus	  to	  the	  gonads	  and	  inducing	  feedback	  
signals	  returned	  to	  the	  hypothalamus	  and	  pituitary.	  	  The	  receptors	  for	  FSH	  and	  LH,	  
FSHR	  and	  LHR,	  reside	  on	  the	  surface	  of	  somatic	  cells	  in	  the	  gonads	  and	  are	  members	  
of	  the	  Rhodopsin	  receptor	  family	  of	  G-­‐protein	  coupled	  receptors,	  but	  unlike	  the	  
other	  members,	  LHR	  and	  FSHR	  have	  extended	  NH2-­‐terminal	  extracellular	  domains	  
with	  numerous	  leucine-­‐rich	  repeats	  that	  assist	  ligand	  specificity	  (Braun,	  Schofield	  et	  
al.	  1991;	  Dias,	  Cohen	  et	  al.	  2002;	  Vassart,	  Pardo	  et	  al.	  2004;	  Bogerd	  ;	  Lagerstrom	  and	  
Schioth).	  FSH	  binding	  elicits	  several	  diverse	  signaling	  events,	  but	  the	  most	  
characterized	  is	  that	  initiated	  by	  adenylyl	  cyclase,	  followed	  by	  induction	  of	  cAMP,	  
PKA	  activation,	  and	  protein	  phosphorylation	  (Heindel,	  Rothenberg	  et	  al.	  1975;	  
Dorrington	  and	  Armstrong).	  	  FSH	  binding	  is	  also	  associated	  with	  an	  increase	  in	  
intercellular	  calcium,	  activation	  of	  mitogen	  activated	  protein	  kinase	  (MAPK),	  and	  
	   3	  
stimulation	  of	  inositol	  triphosphate	  (IP3)	  (Flores,	  Veldhuis	  et	  al.	  1990;	  Tena-­‐
Sempere,	  Manna	  et	  al.	  1999;	  Seger,	  Hanoch	  et	  al.	  2001).	  	  
Because	  the	  receptor	  is	  required	  for	  signal	  transduction,	  the	  original	  message	  
relayed	  by	  FSH	  is	  delivered	  only	  to	  cells	  expressing	  FSHR	  and	  influenced	  by	  receptor	  
levels.	  	  Thus,	  FSHR	  expression	  determines	  both	  the	  targets	  and	  extent	  of	  FSH	  action,	  
ultimately	  directing	  hormone	  response	  to	  granulosa	  cells	  in	  the	  ovary	  and	  Sertoli	  
cells	  in	  the	  testis	  (Heindel,	  Rothenberg	  et	  al.	  1975).	  In	  the	  ovarian	  granulosa	  cells,	  
temporal	  changes	  in	  FSH	  signaling	  regulate	  a	  number	  of	  transcriptional,	  metabolic,	  
and	  hormonal	  activities	  that	  are	  important	  for	  the	  proliferation	  and	  differentiation	  
events	  required	  for	  follicular	  growth	  and	  oocyte	  maturation	  (Abou-­‐Issa	  and	  
Reichert	  1977;	  Peluso	  and	  Steger	  1978;	  Grasso	  and	  Reichert	  1990;	  Dunkel,	  Tilly	  et	  
al.	  1994;	  Rannikki,	  Zhang	  et	  al.	  1995;	  Sairam,	  Jiang	  et	  al.	  1996;	  Kumar,	  Wang	  et	  al.	  
1997;	  Simoni,	  Gromoll	  et	  al.	  1997;	  Simoni,	  Gromoll	  et	  al.	  1997;	  Huhtaniemi	  and	  
Themmen	  2005).	  	  In	  testicular	  Sertoli	  cells,	  the	  actions	  of	  FSH	  change	  with	  testis	  
development	  [reviewed	  in	  (Kishi,	  Minegishi	  et	  al.	  1998;	  Meachem,	  Ruwanpura	  et	  al.	  
2005)].	  	  Initially,	  during	  the	  perinatal	  period,	  FSH	  induces	  Sertoli	  cell	  proliferation	  
and	  establishes	  the	  final	  Sertoli	  cell	  number	  that	  will	  ultimately	  determine	  
spermatogenic	  output,	  while	  later	  in	  development	  FSH	  stimulates	  Sertoli	  cell	  
transcriptional	  and	  metabolic	  activities,	  which	  contribute	  to	  the	  hormonal	  and	  
nutritional	  environment	  necessary	  for	  germ	  cell	  survival	  and	  development	  (Orth,	  
Higginbotham	  et	  al.	  1984;	  Russell	  and	  Griswold	  1993;	  Spiteri-­‐Grech,	  Weinbauer	  et	  
al.	  1993;	  Boitani,	  Stefanini	  et	  al.	  1995;	  Meachem,	  McLachlan	  et	  al.	  1996;	  Shetty,	  
Marathe	  et	  al.	  1996;	  Singh	  and	  Handelsman	  1996;	  Ruwanpura,	  McLachlan	  et	  al.	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2008).	  	  In	  both	  males	  and	  females,	  FSH	  induces	  hormonal	  signals	  that	  return	  to	  the	  
pituitary	  and	  hypothalamus,	  as	  part	  of	  the	  feedback	  mechanism	  upholding	  the	  
endocrine	  balance	  in	  the	  reproductive	  axis	  (Benson,	  Sorrentino	  et	  al.	  1969;	  
Moguilevsky,	  Libertun	  et	  al.	  1970;	  Yen	  and	  Tsai	  1971;	  Shahmanesh,	  Sedigh	  et	  al.	  
1980;	  Schwartz	  1982;	  McNeilly,	  Souza	  et	  al.	  2002).	  
	  
FSHR	  Expression	  	  	  
Expression	  of	  FSHR,	  both	  protein	  and	  mRNA,	  is	  remarkably	  limited	  with	  
respect	  to	  its	  cellular	  profile,	  with	  Sertoli	  and	  granulosa	  cells	  by	  far	  the	  predominant	  
expressing	  cell	  types	  (Ketelslegers	  and	  Catt	  1974;	  Orth	  and	  Christensen	  1977;	  
Heckert	  and	  Griswold	  1991;	  Dankbar,	  Brinkworth	  et	  al.	  1995).	  	  FSHR/Fshr	  
(Human/mouse	  gene)	  transcripts	  are	  first	  observed	  in	  embryonic	  gonads,	  around	  
embryonic	  day	  14.5	  in	  males	  and	  20.5	  in	  females	  (Dankbar,	  Brinkworth	  et	  al.	  1995;	  
Rannikki,	  Zhang	  et	  al.	  1995).	  	  These	  initial	  transcripts	  are	  incomplete	  and	  represent	  
only	  the	  extracellular	  portion	  of	  the	  receptor,	  with	  full-­‐length	  mRNA	  expressed	  
several	  days	  later	  (Richards,	  Ireland	  et	  al.	  1976;	  Sokka	  and	  Huhtaniemi	  1990;	  
Rannikki,	  Zhang	  et	  al.	  1995).	  In	  the	  rodent	  ovary,	  Fshr	  expression	  coincides	  with	  
primary	  follicle	  formation	  and	  follicular	  development	  through	  the	  pre-­‐antral	  stage,	  
with	  initial	  full-­‐length	  transcripts	  and	  hormone	  binding	  observed	  shortly	  after	  birth	  
(around	  postnatal	  day	  3)	  and	  continuing	  to	  increase	  through	  day	  21	  (Sokka	  and	  
Huhtaniemi	  1990;	  Dunkel,	  Tilly	  et	  al.	  1994;	  O'Shaughnessy,	  Marsh	  et	  al.	  1994;	  
Rannikki,	  Zhang	  et	  al.	  1995;	  Drummond,	  Dyson	  et	  al.	  1996).	  In	  the	  testis,	  full-­‐length	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FSHR	  mRNA	  initiates	  during	  fetal	  development	  (around	  embryonic	  day	  16.5	  in	  the	  
rat)	  and	  expression	  is	  maintained	  throughout	  development	  and	  in	  the	  adult	  testis,	  
(Steinberger,	  Thanki	  et	  al.	  1974;	  Nimrod,	  Erickson	  et	  al.	  1976;	  Sprengel,	  Braun	  et	  al.	  
1990;	  Camp,	  Rahal	  et	  al.	  1991;	  Heckert	  and	  Griswold	  ;	  Oshaughnessy,	  Marsh	  et	  al.	  
1994;	  Dankbar,	  Brinkworth	  et	  al.	  1995;	  Rannikki,	  Zhang	  et	  al.	  1995).	  Once	  the	  
spermatogenic	  cycle	  is	  initiated,	  FSHR	  levels	  change	  with	  the	  cycle,	  with	  levels	  
highest	  at	  stages	  X-­‐II	  and	  lowest	  at	  VI-­‐VII	  (Heckert	  and	  Griswold	  ;	  Kliesch,	  Penttila	  et	  
al.	  1992;	  Heckert	  and	  Griswold	  ;	  Rannikko,	  Penttila	  et	  al.	  1996).	  	  	  Several	  signals	  that	  
regulate	  ovarian	  and	  testicular	  physiology	  also	  influence	  FSHR	  expression.	  	  In	  the	  
ovary,	  FSHR	  is	  regulated	  by	  a	  combination	  of	  transcriptional	  and	  posttranscriptional	  
mechanisms	  induced	  by	  FSH	  and	  activin,	  and	  indirectly	  by	  follistatin	  through	  its	  
influence	  on	  activin	  (Knecht,	  Ranta	  et	  al.	  1983;	  Woodruff,	  D'Agostino	  et	  al.	  1988;	  
Sanford	  and	  Batten	  ;	  Nakatani,	  Shimasaki	  et	  al.	  1991;	  Themmen,	  Blok	  et	  al.	  1991;	  
Nakamura,	  Minegishi	  et	  al.	  1993;	  Sites,	  Patterson	  et	  al.	  1994;	  Minegishi,	  Tano	  et	  al.	  
1995;	  Tano,	  Minegishi	  et	  al.	  1995;	  Tano,	  Minegishi	  et	  al.	  1997).	  In	  the	  testis,	  FSHR	  is	  
primarily	  regulated	  by	  its	  ligand,	  which	  decreases	  its	  expression	  through	  several	  
mechanisms,	  including	  membrane	  receptor	  internalization,	  mRNA	  stability,	  and	  
transcriptional	  regulation	  (Jahnsen,	  Gordeladze	  et	  al.	  1980;	  Fletcher	  and	  Reichert	  
1984;	  Shimizu,	  Tsutsui	  et	  al.	  1987;	  Themmen,	  Blok	  et	  al.	  1991;	  Monaco,	  Foulkes	  et	  
al.	  1995;	  Viswanathan,	  Wood	  et	  al.	  2009).	  	  	  
While	  FSHR	  expression	  is	  largely	  considered	  gonad-­‐specific,	  there	  are	  several	  
reports	  of	  its	  presence	  outside	  the	  ovary	  and	  testis;	  in	  particular,	  uterus,	  prostate,	  
bone,	  and	  the	  ovarian	  surface	  epithelia	  (Zheng,	  Magid	  et	  al.	  1996;	  Ben-­‐Josef,	  Yang	  et	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al.	  1999;	  Mariani,	  Salvatori	  et	  al.	  2006;	  Sun,	  Peng	  et	  al.	  2006).	  	  In	  prostate	  and	  
ovarian	  epithelial	  cells,	  FSH	  signaling	  is	  implicated	  in	  cell	  proliferation	  and	  tumor	  
invasiveness	  in	  precancerous	  and	  malignant	  cells	  (Ben-­‐Josef,	  Yang	  et	  al.	  1999;	  Choi,	  
Choi	  et	  al.	  2004;	  Ji,	  Liu	  et	  al.	  2004;	  Zhang,	  Chen	  et	  al.	  2009).	  	  In	  bone,	  there	  is	  strong	  
evidence	  linking	  FSH	  and	  FSHR	  to	  hypogonadal	  bone	  loss	  in	  women	  but	  there	  is	  still	  
uncertainty	  as	  to	  the	  site	  of	  FSH	  action	  (Sun,	  Peng	  et	  al.	  2006;	  Prior	  2007;	  Zaidi,	  
Blair	  et	  al.	  2007;	  Zaidi,	  Zhu	  et	  al.	  2007;	  Ritter,	  Thuering	  et	  al.	  2008;	  Cannon,	  Cortez-­‐
Cooper	  et	  al.	  2009;	  Zaidi,	  Blair	  et	  al.	  2009;	  Robinson,	  Tourkova	  et	  al.	  2010;	  Sun,	  
Zhang	  et	  al.	  2010).	  	  Consequently,	  it	  has	  been	  difficult	  to	  assess	  from	  the	  literature	  
the	  degree	  to	  which	  normally	  differentiated	  cells,	  other	  than	  Sertoli	  and	  granulosa	  
cells,	  actively	  transcribe	  FSHR/Fshr.	  	  However,	  this	  specificity	  can	  be	  more	  
accurately	  appreciated	  by	  evaluating	  high-­‐throughput	  expression	  data	  available	  
through	  the	  public	  domain.	  	  As	  an	  example,	  data	  generated	  as	  part	  of	  the	  mouse	  
transcriptome	  project,	  derived	  by	  massively	  parallel	  signature	  sequencing	  of	  over	  
30	  tissues,	  showed	  Fshr	  mRNA	  present	  in	  the	  ovary	  at	  much	  higher	  levels	  than	  in	  
the	  testis	  (Figure	  1-­‐1,	  from	  GEO	  Record	  GDS868).	  However,	  the	  expression	  
signatures	  were	  from	  adult	  tissues	  and	  therefore	  the	  testis	  profile	  reflects	  a	  pool	  of	  
expressing	  Sertoli	  cells	  that	  is	  significantly	  diluted	  by	  an	  extended	  germ	  cell	  
population,	  while	  not	  such	  dilution	  effect	  occurs	  in	  the	  ovary.	  	  Thus,	  on	  the	  cellular	  
level,	  expression	  is	  expected	  to	  be	  more	  equitable.	  	  What	  is	  most	  striking	  in	  these	  
findings	  is	  that,	  with	  this	  highly	  sensitive	  method,	  no	  other	  tissues	  showed	  
detectable	  FSHR/Fshr	  expression.	  	  	  What	  is	  the	  mechanism	  that	  is	  responsible	  for	  
this	  remarkable	  cell-­‐specificity?	  	  Currently,	  it	  is	  unknown	  but,	  as	  reviewed	  below,	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the	  evidence	  indicates	  that	  FSHR	  expression	  is	  directed	  by	  factors	  that	  control	  its	  
transcription	  through	  elements	  located	  at	  significant	  distance	  from	  the	  gene	  itself.	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FSHR/Fshr	  Transcription	  	  
Transcription	  of	  FSHR/Fshr	  contributes	  to	  receptor	  levels	  and	  directs	  its	  cell-­‐
specificity,	  indicating	  components	  of	  the	  underlying	  mechanisms	  are	  important	  for	  
both	  FSH	  responsiveness	  and	  target	  cell	  identity.	  Our	  current	  understanding	  of	  
FSHR/Fshr	  transcription	  is	  derived	  largely	  from	  studies	  on	  the	  rat,	  murine,	  ovine,	  
and	  human	  FSHR/Fshr	  genes,	  which	  focused	  on	  characterization	  of	  the	  5’	  flanking	  
region.	  	  The	  resulting	  data	  provided	  significant	  insight,	  revealing	  both	  similarities	  
and	  differences	  between	  promoters	  of	  the	  four	  species.	  	  Since	  most	  promoter	  
characteristics	  were	  detailed	  in	  a	  previous	  review,	  the	  discussion	  here	  will	  be	  
limited	  to	  its	  prominent	  features	  (Heckert	  2005).	  	  
The	  accumulated	  information	  represents	  primarily	  transient	  transfection	  
and	  DNA/protein	  binding	  results	  from	  Sertoli	  and	  granulosa	  cells	  that	  identified	  
regulatory	  elements	  and	  their	  associated	  binding	  proteins	  within	  promoters	  
represented	  by	  various	  species	  and	  lengths	  and	  revealed	  both	  similarities	  and	  
differences	  in	  promoter	  function	  (Huhtaniemi,	  Eskola	  et	  al.	  1992;	  Gromoll,	  Dankbar	  
et	  al.	  1994;	  Goetz,	  Lloyd	  et	  al.	  1996;	  Heckert,	  Daggett	  et	  al.	  1998;	  Heckert,	  Sawadogo	  
et	  al.	  2000;	  Heckert	  2001;	  Kim	  and	  Griswold	  2001;	  Xing	  and	  Sairam	  2001;	  Xing,	  
Danilovich	  et	  al.	  2002;	  Xing	  and	  Sairam	  2002;	  Xing	  and	  Sairam	  2002).	  Promoter	  
sequence	  comparisons	  between	  several	  species	  showed	  significant	  conservation	  of	  
approximately	  1000bp	  5’	  to	  the	  translational	  start,	  a	  reference	  point	  used	  to	  avoid	  
uncertainty	  in	  transcriptional	  start	  sites	  for	  some	  species	  (Huhtaniemi,	  Eskola	  et	  al.	  
1992;	  Gromoll,	  Dankbar	  et	  al.	  1994;	  Sairam	  and	  Subbarayan	  1997;	  Tena-­‐Sempere,	  
Manna	  et	  al.	  1999;	  Xing	  and	  Sairam	  2001;	  Heckert	  and	  Griswold	  2002;	  Heckert	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2005).	  While	  variations	  in	  methodology	  and	  promoter	  context	  make	  it	  hard	  to	  
assess	  relevance	  to	  regulatory	  sequences	  identified	  in	  a	  single	  species	  or	  study,	  
results	  representing	  the	  rat,	  sheep,	  and	  human	  promoters	  identified	  a	  common	  E	  
box	  element	  (Goetz,	  Lloyd	  et	  al.	  1996;	  Heckert,	  Daggett	  et	  al.	  1998;	  Findlay	  and	  
Drummond	  1999;	  Xing	  and	  Sairam	  2001;	  Xing,	  Danilovich	  et	  al.	  2002;	  Putowski,	  
Schillings	  et	  al.	  2004).	  	  Located	  just	  5’	  to	  the	  transcriptional	  start	  sites,	  the	  element	  
contributes	  significantly	  to	  promoter	  activity	  and	  provides	  a	  common	  mechanistic	  
theme	  that	  features	  the	  E	  box	  and	  its	  cognate	  binding	  factors	  upstream	  stimulatory	  
factor	  1	  (USF1)	  and	  2	  (USF2)	  (Figure	  1-­‐2).	  	  The	  USF	  proteins	  are	  members	  of	  the	  
helix-­‐loop-­‐helix	  family	  and	  form	  both	  homo-­‐	  and	  heterodimers	  (Shieh,	  Sparkes	  et	  al.	  
1993;	  Viollet,	  Lefrancois-­‐Martinez	  et	  al.	  1996;	  Rodriguez,	  Girones	  et	  al.	  2003).	  	  
There	  is	  considerable	  evidence,	  both	  in	  vitro	  and	  in	  vivo,	  documenting	  the	  
importance	  of	  the	  E	  box	  and	  the	  USF	  proteins	  for	  Fshr	  promoter	  activity	  (Goetz,	  
Lloyd	  et	  al.	  1996;	  Heckert,	  Daggett	  et	  al.	  1998;	  Findlay	  and	  Drummond	  1999;	  
Heckert,	  Sawadogo	  et	  al.	  2000;	  Griswold	  and	  Kim	  2001;	  Heckert	  2001).	  	  Studies	  on	  
USF1	  and	  USF2	  also	  showed	  differential	  effects	  on	  Fshr	  expression	  in	  testis	  and	  
ovary	  and,	  in	  Sertoli	  cells,	  FSH	  modulates	  their	  activity	  via	  the	  inhibitory	  protein	  ID2	  
(Deoxyribonucleic	  Acid	  Binding/Differentiation-­‐2),	  which	  likely	  explains	  the	  
corresponding	  change	  in	  Fshr	  mRNA	  levels	  (Hermann,	  Hornbaker	  et	  al.	  2008;	  
Viswanathan,	  Wood	  et	  al.	  2009).	  Other	  proteins	  noted	  for	  regulating	  the	  Fshr	  
promoter	  include	  steroidogenic	  factor-­‐1	  (SF-­‐1),	  SMAD3,	  E2F,	  GATA-­‐1,	  and	  ETS,	  
several	  of	  which	  bind	  sequences	  that,	  when	  mutated,	  reduce	  promoter	  activity	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(Heckert	  2001;	  Kim	  and	  Griswold	  2001;	  Levallet,	  Koskimies	  et	  al.	  2001;	  Gong	  and	  
McGee	  2009;	  Brune,	  Adams	  et	  al.	  2010).	  	  	  	  
Despite	  numerous	  studies	  on	  the	  promoter,	  no	  mechanism	  evolved	  that	  
could	  explain	  its	  cell	  specificity.	  	  This	  deficiency	  in	  promoter	  specificity	  was	  also	  
demonstrated	  by	  studies	  that	  evaluated	  16	  distinct	  transgenic	  mouse	  lines	  for	  cell-­‐
specific	  expression	  of	  reporters	  directed	  by	  either	  5.0kbp	  or	  143bp	  (8	  lines	  each)	  of	  
rat	  Fshr	  promoter	  sequence,	  none	  of	  which	  showed	  Sertoli	  or	  granulosa	  cell	  specific	  
expression	  (Heckert,	  Sawadogo	  et	  al.	  2000).	  Similar	  finding	  were	  reported	  for	  
1.5kbp	  of	  the	  human	  promoter	  (Nordhoff,	  Gromoll	  et	  al.	  2003).	  	  	  	  The	  recognition	  
that	  sequences	  beyond	  the	  5.0kbp	  promoter	  were	  required	  for	  expression,	  together	  
with	  emerging	  data	  on	  regulatory	  elements	  that	  act	  from	  distal	  positions,	  led	  to	  
studies	  using	  yeast	  artificial	  chromosomes	  (YACs)	  as	  transgenes,	  in	  order	  to	  define	  
the	  region	  required	  for	  FSHR	  specificity.	  	  While	  YAC	  transgenic	  data	  is	  limited	  to	  a	  
single	  mouse	  line,	  which	  harbors	  the	  entire	  rat	  Fshr	  gene	  plus	  sequences	  that	  span	  
>50kbp	  5’	  and	  >30kbp	  3’,	  its	  failed	  detection	  in	  Sertoli	  and	  granulosa	  cells	  supports	  
Fshr	  distal	  regulation	  and	  suggests	  important	  sequences	  extend	  well	  beyond	  the	  
gene	  (Hermann,	  Hornbaker	  et	  al.	  2007).	  	  	   	  
With	  the	  evidence	  that	  proper	  expression	  of	  FSHR/Fshr	  requires	  
contributions	  from	  regulatory	  elements	  located	  outside	  the	  promoter	  region,	  most	  
likely	  at	  significant	  distances,	  the	  challenge	  became	  identifying	  these	  sites	  within	  a	  
vast	  amount	  of	  potential	  sequence.	  	  Initially,	  with	  only	  a	  small	  amount	  of	  available	  
sequence,	  this	  was	  tackled	  using	  conventional	  DNase	  I	  hypersensitivity	  mapping	  to	  
identify	  regions	  of	  accessible	  chromatin	  and	  thus	  potential	  sites	  of	  regulatory	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importance	  (Hermann	  and	  Heckert	  2005).	  	  This	  revealed	  four	  hypersensitive	  sites	  
located	  within	  a	  45	  kb	  region	  surrounding	  the	  first	  exon,	  three	  of	  which	  showed	  
significant	  sequence	  conservation,	  which	  is	  also	  a	  predictive	  feature	  of	  important	  
regulatory	  elements	  (Hermann	  and	  Heckert	  2005).	  	  One	  of	  these,	  DHS#3,	  was	  
located	  approximately	  4kb	  downstream	  and	  showed	  much	  greater	  sensitivity	  to	  
DNase	  I	  in	  non-­‐expressing	  cells	  (myoid)	  than	  expressing	  cells	  (Sertoli),	  suggesting	  
an	  association	  with	  gene	  silencing	  (Figure	  V-­‐2).	  Further	  functional	  characterization,	  
using	  transient	  transfections	  and	  in	  vitro	  and	  in	  vivo	  binding	  assays,	  revealed	  
important	  elements	  that	  attenuated	  gene	  expression	  and	  their	  cognate	  binding	  
proteins,	  OCT1,	  GATA4,	  and	  GATA1.	  	  The	  studies	  also	  implicated	  OCT1	  in	  selective	  
binding	  to	  this	  element	  in	  order	  to	  maintain	  its	  silent	  state	  in	  non-­‐expressing	  cells	  
(Hermann	  and	  Heckert	  2005).	  	  While	  the	  approach	  proved	  to	  be	  a	  valid	  means	  to	  
identify	  important	  regulatory	  elements,	  it	  was	  evident	  that	  scanning	  extensive	  
regions	  of	  the	  genome	  without	  better	  knowledge	  of	  its	  DNA	  content	  or	  genomic	  
landscape	  was	  impractical.	  	  	  This	  has	  since	  been	  remedied	  by	  the	  infusion	  of	  
genomics	  data	  that	  brought,	  not	  only	  new	  sequence	  information,	  but	  also	  a	  wealth	  of	  
insight	  on	  the	  FSHR/Fshr	  gene	  and	  it	  residing	  landscape.	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The	  FSHR	  Gene	  
The	  initial	  characterization	  of	  the	  FHSR	  gene	  in	  1992	  revealed	  a	  pronounced	  
structural	  similarity	  to	  the	  LHR	  gene	  that	  suggested	  the	  two	  evolved	  through	  
duplication	  of	  a	  common	  ancestral	  gene	  (Heckert,	  Daley	  et	  al.	  1992).	  Similarities	  
between	  FSHR/Fshr	  and	  LHR/Lhr	  and	  the	  genes	  for	  other	  G-­‐protein	  coupled	  
receptors	  (GPCR)	  also	  suggested	  the	  predecessor	  for	  FSHR/Fshr	  and	  LHR/Lhr	  was	  
formed	  by	  combining	  a	  common	  GPCR	  ancestral	  gene,	  encoding	  the	  characteristic	  
transmembrane	  and	  intracellular	  domains,	  with	  multiple	  repeated	  exons	  derived	  
from	  tandem	  duplications	  of	  a	  module	  for	  a	  leucine-­‐rich	  motif,	  a	  featured	  attribute	  
of	  the	  extracellular	  domain	  of	  glycoprotein	  hormone	  receptors	  (Heckert,	  Daley	  et	  al.	  
1992).	  	  Formation	  of	  the	  gonadotropin	  receptor	  genes	  through	  tandem	  duplication	  
of	  an	  ancestral	  gene	  was	  further	  substantiated	  by	  recent	  genomics	  data	  that	  show	  
they	  are	  arranged	  in	  tandem	  on	  chromosomes	  from	  nearly	  all	  annotated	  Tetrapoda	  
genomes	  (Heckert,	  Daley	  et	  al.	  1992;	  Montgomery,	  Tate	  et	  al.	  1995;	  Chauvigne,	  
Tingaud-­‐Sequeira	  et	  al.	  2010).	  	  While	  the	  two	  ancestral	  descendants,	  FSHR/Fshr	  and	  
LHR/Lhr,	  differ	  by	  one	  exon	  (10	  for	  FSHR/Fshr	  and	  11	  for	  LHR/Lhr),	  the	  coding	  
scheme	  is	  largely	  the	  same,	  with	  the	  carboxy-­‐terminal,	  transmembrane-­‐intracellular	  
domain	  encoded	  by	  the	  last	  exon	  and	  the	  amino-­‐terminal,	  extracellular	  domain	  by	  
all	  preceding	  exons	  (Koo,	  Ji	  et	  al.	  1991;	  Tsai-­‐Morris,	  Buczko	  et	  al.	  1991;	  Heckert,	  
Daley	  et	  al.	  1992).	  	  Exons	  that	  partition	  the	  receptors’	  extracellular	  domains	  also	  
share	  a	  repeated	  structure	  that	  delineates	  seven	  of	  the	  leucine-­‐rich	  motifs	  into	  
exons	  2-­‐8	  and	  two	  into	  exon	  9	  (Figure	  1-­‐3).	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However,	  despite	  knowing	  the	  structure	  of	  FSHR/Fshr	  for	  nearly	  two	  
decades,	  it	  wasn’t	  until	  the	  various	  genome-­‐sequencing	  projects	  greatly	  expanded	  
the	  available	  sequence	  data	  that	  there	  was	  accurate	  knowledge	  of	  its	  size	  or	  
chromosome	  habitat.	  Now,	  FSHR/Fshr	  chromosome	  locations	  and	  annotated	  
sequences	  are	  reported	  for	  more	  than	  40	  vertebrate	  species	  through	  the	  University	  
of	  California,	  Santa	  Cruz	  Genome	  Browser	  (http://genome.ucsc.edu/)	  and	  similar	  
web	  sites.	  	  In	  human,	  rat,	  and	  mouse	  FSHR/Fshr	  are	  located	  on	  chromosomes	  2,	  6	  
and	  17,	  respectively,	  and	  spans	  roughly	  200kb,	  a	  size	  much	  larger	  than	  originally	  
predicted	  (Heckert,	  Daley	  et	  al.	  1992;	  Huhtaniemi,	  Eskola	  et	  al.	  1992;	  Rousseau-­‐
Merck,	  Atger	  et	  al.	  1993;	  Gromoll,	  Ried	  et	  al.	  1994;	  Rhead,	  Karolchik	  et	  al.	  2010)	  
(Figure	  1-­‐3).	  	  	  This	  wealth	  of	  sequence	  information	  also	  disclosed	  several	  defining	  
features	  of	  FSHR/Fshr	  and	  its	  surrounding	  neighborhood	  that	  indicates	  its	  
associated	  regulatory	  environment	  is	  strongly	  influenced	  by	  evolutionary	  constraint	  
that	  retains	  regulatory	  sequences	  directing	  distally-­‐located	  genes	  (Hermann	  and	  
Heckert	  2005;	  Hermann,	  Hornbaker	  et	  al.	  2007).	  	  This	  includes	  the	  tandem	  
placement	  of	  FSHR/Fshr	  between	  NRXN1/Nrxn1,	  it	  closest	  5’	  neighbor,	  and	  LHR/Lhr,	  
its	  closest	  3’	  neighbor,	  to	  form	  a	  highly	  conserved	  syntenic	  block,	  which	  was	  
identified	  by	  several	  studies	  to	  indicate	  evolutionary	  constraints	  intended	  to	  
preserve	  the	  alignment	  between	  noncoding	  sequences	  and	  their	  target	  genes	  
(Hermann	  and	  Heckert	  2005;	  Engstrom,	  Ho	  Sui	  et	  al.	  2007;	  Kikuta,	  Laplante	  et	  al.	  
2007;	  Akalin,	  Fredman	  et	  al.	  2009).	  	  	  
Another	  notable	  feature	  is	  the	  large	  intergenic	  distances	  between	  FSHR/Fshr	  
and	  its	  adjoining	  neighbors,	  which	  span	  more	  than	  750kbp	  on	  its	  5‘	  side	  and	  200kbp	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on	  its	  3‘	  side	  (Hermann	  and	  Heckert	  2005).	  	  The	  uninhabited	  region	  between	  
NRXN1/Nrxn1	  and	  FSHR/Fshr	  is	  characteristic	  of	  a	  gene	  desert,	  or	  long	  genomic	  
stretch	  devoid	  of	  protein-­‐coding	  sequences	  or	  other	  obvious	  biological	  functions.	  	  
Such	  regions,	  when	  located	  within	  a	  conserved	  syntenic	  block,	  are	  associated	  with	  
areas	  of	  enhanced	  sequence	  conservation,	  suggesting	  the	  content	  was	  under	  
evolutionary	  pressure	  to	  retain	  functional	  and	  contextual	  information	  of	  resident	  
elements	  (Venter,	  Adams	  et	  al.	  2001;	  Ovcharenko,	  Loots	  et	  al.	  2005;	  Akalin,	  
Fredman	  et	  al.	  2009).	  	  While	  evidence	  shows	  not	  all	  gene	  deserts	  have	  measurable	  
activity,	  numerous	  risk	  loci	  and	  regulatory	  elements	  are	  documented	  within	  these	  
regions,	  confirming	  their	  importance	  to	  the	  genome	  (Lodder,	  Eussen	  et	  al.	  2009;	  Xu,	  
Tsumagari	  et	  al.	  2009;	  Kiltie	  2010).	  	  Comparative	  sequence	  analysis	  has	  been	  
consistently	  used	  in	  genome-­‐wide	  studies	  to	  evaluate	  evolutionary	  constraint	  as	  a	  
means	  to	  understanding	  genome	  structure,	  biological	  function,	  and	  evolution	  
(Waterston,	  Lindblad-­‐Toh	  et	  al.	  2002).	  The	  initial	  whole-­‐genome	  sequence	  
comparisons	  between	  mouse	  and	  human	  provided	  considerable	  insight	  and	  
estimated	  5%	  of	  the	  human	  genome	  was	  conserved	  over	  70-­‐100	  million	  years	  
(Lander,	  Linton	  et	  al.	  2001;	  Venter,	  Adams	  et	  al.	  2001;	  Dermitzakis,	  Reymond	  et	  al.	  
2002;	  Mural,	  Adams	  et	  al.	  2002;	  Waterston,	  Lindblad-­‐Toh	  et	  al.	  2002;	  Pennacchio	  
2003).	  What	  was	  remarkable	  in	  this	  finding	  was	  that	  only	  1/3	  of	  the	  conserved	  
sequences	  was	  located	  in	  coding	  regions.	  	  Thus,	  the	  genome’s	  non-­‐coding	  sector	  
represents	  the	  largest	  portion	  under	  evolutionary	  selection,	  which	  suggested	  there	  
is	  considerable	  functional	  information	  within	  conserved	  non-­‐coding	  sequences,	  aka	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evolutionary	  conserved	  regions	  (ECRs)	  (Waterston,	  Lindblad-­‐Toh	  et	  al.	  2002;	  
Dermitzakis,	  Reymond	  et	  al.	  2005).	  
Expansion	  of	  genome	  sequence	  data	  and	  specie	  representation	  added	  
significantly	  to	  the	  power	  of	  cross-­‐species	  sequence	  comparison	  and	  the	  genomic	  
landscape	  and	  sites	  of	  potential	  biological	  functions,	  which	  led	  to	  identification	  of	  
many	  non-­‐coding	  sequences	  involved	  in	  gene	  regulation,	  including	  enhancers,	  
insulators,	  silencers	  and	  matrix	  attachment	  regions	  (Glazko,	  Koonin	  et	  al.	  2003;	  
Koonin	  2003;	  Nobrega,	  Ovcharenko	  et	  al.	  2003;	  de	  la	  Calle-­‐Mustienes,	  Feijoo	  et	  al.	  
2005;	  Woolfe,	  Goodson	  et	  al.	  2005;	  Pennacchio,	  Ahituv	  et	  al.	  2006;	  Prabhakar,	  
Poulin	  et	  al.	  2006;	  Visel,	  Prabhakar	  et	  al.	  2008).	  	  	  A	  connection	  between	  sequence	  
conservation	  and	  regulatory	  sequences	  was	  nicely	  illustrated	  in	  a	  recent	  study	  that	  
used	  chromatin	  immunoprecipitation	  (ChIP)	  and	  massively	  parallel	  sequencing	  to	  
map	  DNA	  sites	  linked	  to	  p300,	  a	  co-­‐regulator	  for	  many	  transcription	  factors	  (Visel,	  
Blow	  et	  al.	  2009).	  Results	  from	  mouse	  embryonic	  tissues	  (forebrain,	  midbrain	  and	  
limb)	  showed	  p300	  highly	  enriched	  at	  sites	  containing	  conserved	  non-­‐coding	  
sequence	  and,	  of	  those	  evaluated,	  nearly	  all	  were	  functional.	  	  The	  study	  also	  
demonstrated	  that	  most	  p300-­‐associated	  sites/enhancers	  were	  located	  at	  least	  
10kbp	  from	  a	  potential	  target	  gene,	  which	  suggests	  distal	  elements	  are	  commonly	  
involved	  in	  transcriptional	  control.	  	  Direct	  evidence	  for	  long-­‐distance	  gene	  
regulation	  is	  found	  in	  numerous	  studies	  that	  demonstrate	  transcriptional	  effects	  
from	  distant	  sequences	  on	  specific	  target	  genes,	  such	  as	  those	  for	  β-­‐globin,	  IFγ,	  
SOX9,	  GATA3,	  FGF4,	  IL-­‐10,	  and	  CD69	  (Martinez-­‐Jimenez,	  Gomez-­‐Lechon	  et	  al.	  2005;	  
Bejerano,	  Lowe	  et	  al.	  2006;	  Schoenborn,	  Dorschner	  et	  al.	  2007;	  Vazquez,	  Laguna	  et	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al.	  2009).	  The	  significance	  of	  non-­‐coding	  regulatory	  sequences	  to	  human	  disorders	  
has	  also	  gained	  recognition	  with	  reports	  linking	  them	  to	  diseases	  and	  
developmental	  disorders,	  as	  noted	  in	  cases	  of	  x-­‐linked	  deafness,	  preaxial	  polydactyl,	  
campomelic	  dysplasia,	  sex	  reversal,	  postaxial	  polydactyly	  (de	  Kok,	  Merkx	  et	  al.	  
1995;	  Bishop,	  Whitworth	  et	  al.	  2000;	  Jamieson,	  Perveen	  et	  al.	  2002;	  Epstein	  2009;	  
Lodder,	  Eussen	  et	  al.	  2009).	  	  In	  the	  case	  of	  preaxial	  polydacyl,	  the	  reported	  mutation	  
was	  located	  within	  a	  regulatory	  element	  approximately	  1Mbp	  from	  its	  target	  gene	  
that	  emphasizes	  not	  only	  the	  remarkable	  linear	  distance	  in	  which	  the	  
transcriptional	  signal	  passes	  but	  also	  the	  importance	  of	  nuclear	  architecture	  in	  
positioning	  regions	  that	  collaborate	  in	  the	  transcriptional	  signal	  (reviewed	  in	  
(Schneider	  and	  Grosschedl	  2007)).	  	  	  	  	  
	  
	   	  




Figure	  1-­‐3.	  Organization	  of	  FSHR/Fshr	  and	  its	  genomic	  environment.	  	  Top,	  
structural	  FSHR/Fshr	  and	  LHCGR/Lhcgr,	  depicting	  the	  exon	  distribution	  of	  the	  
receptor’s	  protein	  domains.	  	  Middle,	  position	  of	  the	  NRXN1;FSHR;LH/CGR	  syntenic	  
region	  on	  human	  chromosome	  2	  (red	  box	  indicated	  by	  arrow).	  	  Bottom,	  syntenic	  
region	  of	  NRXN1/Nrxn1,	  FSHR/Fshr,	  and	  LHCGR/Lhcgr	  from	  human,	  rat,	  mouse,	  and	  
chicken,	  with	  sizes	  indicated	  for	  the	  genes	  and	  intervening	  regions.	  Exons	  (top)	  and	  
genes	  (bottom)	  are	  indicated	  by	  rectangles,	  intervening	  regions	  by	  lines,	  and	  
transcriptional	  direction	  by	  arrows.	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The	  Search	  for	  New	  Regulatory	  Elements	  
Identification	  of	  regulatory	  regions	  is	  clearly	  facilitated	  by	  predictions	  based	  
on	  sequence	  conservation.	  	  However,	  the	  evidence	  is	  also	  clear	  that	  sequence	  
conservation	  does	  not	  detect	  all	  regulatory	  elements	  nor	  provide	  any	  assurance	  that	  
the	  predicted	  sites	  are	  functional,	  and	  thus,	  most	  effective	  when	  used	  in	  conjunction	  
with	  other	  corroborating	  techniques,	  particularly	  ones	  that	  can	  assess	  chromatin	  
changes	  linked	  to	  transcriptional	  activity	  (Nobrega,	  Ovcharenko	  et	  al.	  2003;	  
Dermitzakis,	  Reymond	  et	  al.	  2005;	  Rizzolio,	  Bione	  et	  al.	  2008;	  D'Haene,	  Attanasio	  et	  
al.	  2009;	  Liska,	  Snajdr	  et	  al.	  2009;	  Vazquez,	  Laguna	  et	  al.	  2009;	  Visel,	  Zhu	  et	  al.	  
2010).	  	  In	  studies	  to	  identify	  regulatory	  sequences	  that	  direct	  FSHR/Fshr	  
transcription,	  results	  from	  transgenic	  and	  promoter	  studies	  shifted	  the	  
experimental	  focus	  away	  from	  the	  promoter	  to	  the	  region	  encompassing	  all	  of	  
FSHR/Fshr	  and	  its	  adjoining	  intergenic	  regions,	  which	  required	  a	  new	  set	  of	  tools	  
and	  resources	  that	  fortunately	  evolved	  from	  the	  collection	  of	  genome	  sequences	  and	  
efforts	  to	  understand	  their	  content.	  	  Initial	  reports	  on	  the	  FSHR/Fshr	  conservation	  
profile	  compared	  human	  and	  rat	  sequences	  by	  direct	  pairwise	  comparison	  and	  
analysis	  of	  precompiled	  LAGAN	  alignments	  through	  the	  web-­‐based	  VISTA	  genome	  
browser	  (Hermann	  and	  Heckert	  2005).	  	  This	  revealed	  over	  150	  conserved	  sites,	  
which,	  when	  matched	  together	  with	  DNase	  I	  hypersensitivity	  data,	  was	  instrumental	  
in	  the	  identification	  of	  an	  important	  silencing	  region	  in	  the	  first	  intron	  (discussed	  
above).	  	  However,	  it	  was	  also	  evident	  that	  greater	  constraints	  were	  required	  to	  
improve	  functional	  prediction	  and	  therefore,	  once	  more	  distant	  genomes	  (e.g.	  
chicken)	  were	  available	  and	  included	  in	  computations,	  evolutionary	  conserved	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regions	  (ECRs)	  with	  greater	  predictive	  power	  could	  be	  distinguished	  and	  seven	  of	  
the	  most	  conserved	  were	  selected	  for	  functional	  testing	  by	  transient	  transfection	  
(Hermann,	  Hornbaker	  et	  al.	  2007).	  With	  continuous	  enhancements	  in	  genome	  data	  
and	  resources	  that	  improve	  regulatory	  element	  prediction,	  the	  number	  of	  selected	  
sites	  has	  grown	  to	  more	  than	  twenty,	  which	  includes	  the	  original	  seven	  ECRs.	  	  	  
These	  sequences	  were	  identified	  using	  the	  human	  genome	  and	  the	  UCSC	  Genome	  
Browser	  (http://genome.ucsc.edu/)	  to	  reveal	  highly	  conserved	  (vertebrate	  
consensus	  and	  net	  alignment	  with	  chicken	  as	  the	  target),	  non-­‐coding	  sequences	  with	  
a	  significant	  regulatory	  potential	  score	  (7X	  regulatory	  potential;	  (Waterston,	  
Lindblad-­‐Toh	  et	  al.	  2002;	  Consortium	  2004;	  Gibbs,	  Weinstock	  et	  al.	  2004;	  Havlak,	  
Chen	  et	  al.	  2004;	  Kolbe,	  Taylor	  et	  al.	  2004;	  King,	  Taylor	  et	  al.	  2007)).	  	  Figure	  1-­‐4	  
provides	  an	  example	  of	  the	  FSHR	  locus	  spanning	  from	  LHCGR	  to	  NRXN1	  that	  was	  
modified	  from	  the	  UCSC	  Genome	  Browser	  results	  to	  show	  the	  top	  predicted	  sites	  
(marked	  ECRs)	  for	  FSHR/Fshr	  regulatory	  sequences	  and	  the	  key	  features	  used	  in	  
their	  selection.	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Summary	  
The	  evidence	  to	  date	  shows	  that	  sequences	  directing	  FSHR/Fshr	  expression	  
lie	  far	  from	  the	  start	  of	  transcription	  in	  a	  regulatory	  environment	  without	  defined	  
boundaries,	  which	  complicates	  their	  detection	  using	  standard	  molecular	  
approaches.	  While	  computational	  genomics	  has	  helped	  narrow	  the	  search,	  
limitations	  due	  to	  false	  positives	  and	  undetected	  sequences	  caution	  its	  use	  without	  
additional	  methods	  to	  substantiate	  the	  data	  (Giresi,	  Kim	  et	  al.	  2007).	  	  Fortunately,	  
many	  technologies	  have	  adapted	  to	  the	  influx	  of	  sequence	  data	  by	  developing	  high-­‐
throughput	  and	  genome-­‐wide	  strategies.	  Two	  such	  strategies	  offer	  considerable	  
promise	  for	  regulatory	  element	  identification	  and	  that	  the	  FSHR/Fshr	  
transcriptional	  mechanism	  is	  within	  reach.	  	  Both	  strategies	  reveal	  chromatin	  
signatures	  featured	  in	  regulatory	  sequences;	  one	  identifies	  sequences	  bound	  to	  
modified	  histones	  linked	  to	  transcriptional	  activity	  by	  chromatin	  
immunoprecipitation,	  the	  other	  identifies	  open	  regions	  of	  chromatin,	  similar	  to	  
DNase	  I	  hypersensitivity,	  by	  formaldehyde	  associated	  identification	  of	  regulatory	  
elements	  (Wu,	  Smith	  et	  al.	  2006;	  McGaughey,	  Stine	  et	  al.	  2009).	  	  Implementation	  of	  
such	  strategies	  together	  with	  comparative	  genomics	  will	  significantly	  enhance	  the	  
probability	  of	  relevant	  sequence	  identification	  and	  the	  mechanistic	  understanding	  
of	  the	  regulatory	  landscape.	  	  When	  used	  with	  high-­‐throughput	  strategies,	  i.e.	  high-­‐
density	  tiling	  arrays	  and	  next	  generation	  sequencing,	  to	  canvass	  the	  genome	  
without	  the	  bias	  of	  conservation,	  additional	  insight	  is	  likely	  on	  mechanisms	  that	  
employ	  non-­‐conserved	  regulatory	  elements	  and	  possible	  contributions	  to	  species-­‐
specific	  regulatory	  features	  (Roh,	  Wei	  et	  al.	  2007;	  Chen,	  Lin	  et	  al.	  2008).	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Abstract	  
To	  advance	  our	  understanding	  of	  genome	  function	  and	  gene	  regulation	  in	  
Sertoli	  cells,	  we	  employed	  Chromatin	  Immunoprecipitation	  combined	  with	  next-­‐
generation	  sequencing	  (ChIP-­‐Seq)	  to	  globally	  map	  the	  histone	  landscape	  in	  Sertoli	  
and	  myoid	  cells	  of	  the	  day	  15	  Sprague	  Dawley	  rat.	  	  Three	  histone	  modifications	  were	  
selected	  for	  analysis	  based	  on	  their	  ability	  to	  identify	  active	  genomic	  regions,	  active	  
enhancer/promoter	  regions	  and	  repressed	  genomic	  regions	  	  -­‐	  Histone	  4	  Lysine	  
acetylation	  (K5,	  8,	  12	  and	  16),	  Histone	  3	  Lysine	  4	  tri-­‐methylation	  and	  Histone	  3	  
Lysine	  27	  tri-­‐methylation	  (respectively).	  	  Raw	  ChIP-­‐Seq	  sequence	  tags	  were	  
processed	  and	  aligned	  to	  the	  rattus	  norvegicus	  genome	  (assembly:	  rn5	  March	  2012)	  
using	  the	  Burrows-­‐Wheeler	  Aligner.	  	  Datasets	  contain	  alignment	  profiles	  of	  the	  
processed	  sequence	  tags	  generated	  by	  Illumina	  Sequencing	  and	  can	  be	  viewed	  using	  
the	  UCSC	  Genome	  Browser.	  	  Overall,	  45-­‐80%	  of	  the	  sequence	  tags	  aligned	  to	  the	  
genome	  except	  for	  the	  SC-­‐H4ac	  and	  SC-­‐HeK27me3	  samples,	  which	  aligned	  poorly	  
and	  were	  not	  used	  for	  further	  analysis.	  	  We	  have	  generated	  two	  reference	  databases	  
that	  map	  the	  H3K4me3	  profile	  across	  the	  rattus	  norvigicus	  genome	  in	  P15	  Sertoli	  
and	  myoid	  cells	  using	  two	  genome	  assemblies	  –	  a	  masked	  and	  unmasked	  genome.	  	  
These	  databases	  can	  be	  used	  for	  peak	  finding	  analysis,	  identificaiton	  of	  regulatory	  
regions	  and	  can	  be	  manually	  evaluated	  to	  identify	  H3K4me3	  enrichment	  at	  specific	  
gene	  loci.	  	  Use	  of	  these	  databases	  will	  further	  our	  understanding	  of	  the	  regulatory	  
landscape	  in	  Sertoli	  cells	  and	  provide	  new	  insite	  into	  the	  transcriptional	  regulation	  
within	  these	  cells.	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Introduction	  
The	  objective	  of	  this	  project	  is	  to	  elucidate	  transcriptional	  mechanisms	  
relevant	  to	  Sertoli	  cell	  function	  by	  identifying	  new	  cis-­‐regulatory	  elements.	  	  To	  
obtain	  this	  objective,	  two	  testicular	  cell	  types	  will	  be	  included	  in	  our	  genome-­‐wide	  
analysis	  of	  histone	  modifications	  –	  Sertoli	  and	  peritubular	  myoid	  cells.	  	  These	  two	  
cell	  types	  differ	  in	  their	  physiologic	  function	  and	  will	  provide	  a	  contrasting	  view	  of	  
the	  histone	  landscape	  at	  different	  loci	  within	  the	  genome.	  	  Comparison	  of	  the	  
histone	  landscape	  between	  these	  cell	  types	  will	  lead	  to	  the	  characterization	  of	  both	  
common	  and	  cell-­‐type	  specific	  regulatory	  regions	  and	  thus	  further	  our	  
understanding	  of	  transcriptional	  regulation	  in	  these	  two	  cell	  types.	  	  
At	  P15,	  Sertoli	  cells	  are	  undergoing	  several	  physiologic	  changes.	  	  First,	  the	  
Sertoli	  cells	  have	  ceased	  mitotic	  activity	  (Steinberger	  and	  Steinberger	  1971;	  Russell,	  
de	  Franca	  et	  al.	  1995),	  and	  are	  entering	  their	  final	  stages	  of	  differentiation.	  	  	  Thus,	  
the	  final	  number	  of	  Sertoli	  cells	  that	  will	  populate	  the	  adult	  testis	  is	  determined	  
(Steinberger	  and	  Steinberger	  1971).	  	  Aside	  from	  diminished	  mitotic	  activity,	  the	  
Sertoli	  cells	  are	  also	  forming	  cell-­‐to-­‐cell	  junctions	  with	  each	  other,	  which	  leads	  to	  
the	  formation	  of	  the	  blood-­‐testis	  barrier.	  	  These	  intracellular	  junctions	  also	  act	  to	  
compartmentalize	  developing	  germ	  cells	  throughout	  each	  stage	  of	  maturation,	  
ensuring	  the	  proper	  niche	  for	  development	  (Ryser,	  Glauser	  et	  al.	  2011).	  	  	  
The	  peritubular	  myoid	  cells	  form	  a	  single	  layer	  of	  cells	  that	  lye	  just	  outside	  
the	  basal	  lamina	  of	  the	  seminiferous	  tubules	  in	  rodents	  (Bressler	  and	  Ross	  1973).	  	  
These	  cells	  are	  similar	  to	  smooth	  muscle	  cells	  and	  are	  believed	  to	  play	  an	  important	  
role	  in	  the	  rhythmic	  contraction	  of	  the	  tubules	  (Leeson	  and	  Forman	  1981).	  	  During	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testis	  formation,	  the	  Sertoli	  cells	  and	  peritubular	  myoid	  cells	  work	  in	  concert	  with	  
each	  other	  to	  establish	  the	  basil	  lamina,	  which	  is	  the	  main	  physical	  structure	  
forming	  the	  tubule	  (Tung,	  Skinner	  et	  al.	  1984).	  	  Aside	  from	  a	  structural	  and	  physical	  
role	  in	  testis	  function,	  myoid	  cells	  interact	  with	  Sertoli	  cells	  in	  a	  paracrine	  manor	  to	  
regulate	  Sertoli	  cell	  function	  (Raychoudhury,	  Thompson	  et	  al.	  1993;	  Verhoeven,	  
Hoeben	  et	  al.	  2000).	  	  	  Identifying	  new	  cis-­‐regulatory	  elements	  within	  these	  two	  cell	  
types	  will	  further	  our	  understanding	  of	  testis	  development,	  cell-­‐specific	  gene	  
regulation,	  and	  contribute	  to	  our	  overall	  understanding	  of	  gene	  regulation	  within	  
the	  testis.	  	  
Chromatin	  Immunoprecipitation	  (ChIP)	  provides	  a	  powerful	  tool	  that	  gives	  
researchers	  the	  ability	  to	  understand	  protein/DNA	  association	  in	  vivo	  on	  a	  genome	  
wide	  scale.	  	  ChIP	  is	  a	  powerful	  technique	  used	  to	  identify	  proteins	  bound	  to	  DNA	  in	  
vivo	  and	  has	  provided	  enormous	  insight	  into	  chromatin	  structure.	  	  For	  ChIP	  
analysis,	  nuclear	  proteins	  are	  cross-­‐linked	  to	  DNA	  and	  immunoprecipitated	  using	  an	  
antibody	  of	  interest.	  	  The	  resulting	  immunoprecipitated	  DNA	  pool	  can	  be	  analyzed	  
by	  PCR	  to	  identify	  specific	  targeted	  regions	  or	  analyzed	  with	  next-­‐generation	  
sequencing	  to	  provide	  a	  genome-­‐wide	  view.	  	  	  
The	  current	  study	  focused	  on	  identifying	  enrichment	  patterns	  of	  three	  well-­‐
studied	  histone	  modifications	  in	  Sertoli	  and	  myoid	  cells.	  	  We	  selected	  Histone	  4	  
Lysine	  5,	  8,	  12	  and	  16	  acetylation	  (H4ac),	  Histone	  3	  Lysine	  4	  tri-­‐methylation	  
(H3K4me3)	  and	  Histone	  3	  Lysine	  27	  tri-­‐methylation	  (H3K27me3)	  to	  identify	  
euchromatic	  regions,	  active	  promoters	  and	  cis-­‐regulatory	  elements	  and	  repressed	  
regions	  (respectively).	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The	  antibody	  selected	  for	  identification	  of	  H4ac	  recognizes	  chromatin	  
regions	  with	  at	  least	  one,	  and	  possibly	  more,	  modification/s	  to	  Lysine	  5,	  8,	  12	  and	  
16.	  	  This	  mark	  was	  selected	  for	  its	  known	  association	  with	  active	  genes	  (Roh,	  Ngau	  
et	  al.	  2004;	  McCann,	  Muro	  et	  al.	  2007;	  Ramsey,	  Knijnenburg	  et	  al.	  2010).	  	  	  Previous	  
studies	  have	  shown	  that	  histone	  acetylation	  is	  associated	  with	  larger	  chromatin	  
regions	  that	  contain	  actively	  transcribed	  genes	  (reviewed	  in	  (Calestagne-­‐Morelli	  and	  
Ausio	  2006)).	  	  Within	  these	  genes,	  acetylation	  is	  often	  found	  within	  the	  core	  
promoter	  and	  gene,	  and	  we	  would	  like	  to	  determine	  if	  H4ac	  is	  correlated	  with	  
actively	  transcribed	  promoters	  and	  genes	  within	  our	  cell	  populations.	  	  
Histone	  3	  Lysine	  4	  tri-­‐methylation	  is	  a	  mark	  often	  associated	  with	  
transcriptionally	  active	  promoter	  regions	  and	  enhancer	  regions	  (Bernstein,	  Kamal	  
et	  al.	  2005;	  Kim,	  Barrera	  et	  al.	  2005;	  Heintzman,	  Hon	  et	  al.	  2009).	  	  	  We	  selected	  this	  
histone	  mark	  for	  two	  reasons:	  	  1)	  To	  determine	  if	  this	  mark	  can	  be	  associated	  with	  
active	  promoters	  in	  Sertoli/Spermatogonia	  cells,	  and	  2)	  to	  determine	  if	  this	  mark	  
can	  identify	  enhancer	  regions	  within	  our	  cell	  populations	  (discussed	  further	  in	  
Chapter	  3).	  	  As	  genome	  wide	  studies	  have	  identified	  peaks	  of	  H3K4me3	  surrounding	  
transcriptional	  start	  sites	  of	  active	  genes	  in	  multiple	  cell	  types	  (Schmid	  and	  Bucher	  
2007;	  Heintzman,	  Hon	  et	  al.	  2009),	  we	  believe	  this	  mark	  will	  also	  be	  associated	  with	  
active	  promoters	  within	  testis	  cell	  populations.	  	  	  
Histone	  3	  Lysine	  27	  tri-­‐methylation	  is	  a	  mark	  associated	  with	  
transcriptionally	  silent	  regions	  (Young,	  Willson	  et	  al.	  2011).	  	  The	  current	  
understanding	  of	  this	  methylation	  mark	  indicates	  that	  a	  broad	  region	  of	  H3K27me3	  
is	  often	  found	  at	  genes	  that	  are	  actively	  silenced	  (Pauler,	  Sloane	  et	  al.	  2009).	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Recently,	  H3K27me3	  was	  identified	  within	  the	  promoter	  regions	  of	  transcriptionally	  
active	  genes	  in	  association	  with	  H3K4me3	  (Dahl,	  Reiner	  et	  al.	  2010;	  McEwen	  and	  
Ferguson-­‐Smith	  2010).	  	  It	  is	  believed	  that	  this	  active,	  yet	  repressive	  chromatin	  state	  
acts	  to	  poise	  genes	  for	  activation.	  	  It	  is	  most	  commonly	  associated	  with	  the	  promoter	  
region	  of	  genes	  that	  encode	  transcription	  factors	  that	  are	  critical	  for	  development	  
(Bernstein,	  Mikkelsen	  et	  al.	  2006;	  Young,	  Willson	  et	  al.	  2011).	  	  For	  our	  study,	  this	  
mark	  will	  serve	  to	  identify	  silenced	  regions	  and	  in	  conjunction	  with	  H3K4me3	  
identify	  poised	  genes.	  
	   The	  Sertoli	  and	  myoid	  cell	  enrichment	  profiles	  generated	  using	  these	  
modifications	  display	  all	  of	  the	  sequence	  tags	  that	  aligned	  to	  the	  Rattus	  norvegicus	  
(rn5,	  March	  2012)	  genome	  in	  two	  formats,	  Masked	  and	  Unmasked.	  	  The	  sequence	  
tags	  were	  aligned	  to	  a	  complete	  genome	  (Unmasked)	  and	  a	  genome	  that	  did	  not	  
contain	  repeats	  (Masked).	  	  The	  resulting	  databases	  are	  searchable	  by	  chromosome	  
location	  or	  gene	  name	  and	  can	  be	  used	  for	  peak	  finding	  analysis	  (see	  Chapter	  3).	  	  All	  
but	  two	  of	  our	  ChIP-­‐Seq	  samples	  generated	  good	  quality	  genome-­‐wide	  maps	  
identifying	  cell-­‐specific	  enrichment	  of	  each	  histone	  modification	  tested.	  	  The	  Sertoli	  
cell	  samples	  for	  H4ac	  and	  H3K27me3	  did	  not	  align	  well	  to	  the	  reference	  genome	  and	  
will	  need	  re-­‐sequenced	  before	  further	  analysis	  can	  be	  performed.	  	  We	  did	  obtain	  
good-­‐quality	  alignments	  for	  both	  Sertoli	  and	  myoid	  cell	  H3K4me3	  and	  myoid	  cell	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Materials	  and	  Methods	  
Animal	  Use.	  	  All	  experiments	  using	  animals	  were	  approved	  by	  the	  Institutional	  
Animal	  Care	  and	  Use	  Committee	  of	  the	  University	  of	  Kansas	  Medical	  Center	  
(Protocol	  2009-­‐1850),	  and	  performed	  in	  accordance	  with	  the	  National	  Institutes	  of	  
Health	  Guide	  for	  the	  Care	  and	  Use	  of	  Laboratory	  Animals.	  
	  
Sertoli	  Cell	  and	  Myoid	  Cell	  Preparations.	  	  Sertoli	  and	  myoid	  cells	  were	  prepared	  
as	  previously	  described	  with	  slight	  modification	  (Steinberger,	  Heindel	  et	  al.	  1975;	  
Karl	  and	  Griswold	  1990).	  	  Briefly,	  tubules	  were	  isolated	  from	  P15	  Sprague	  Dawley	  
rats.	  	  	  Tubules	  were	  processed	  through	  a	  series	  of	  digestions	  releasing	  the	  myoid	  
cells	  which,	  following	  centrifugation,	  remain	  in	  the	  supernatant	  while	  Sertoli	  cells	  
and	  germ	  cells	  are	  collected	  in	  the	  pellet.	  	  During	  the	  isolation,	  myoid	  cells	  were	  
removed	  from	  the	  tubules	  prior	  to	  complete	  digestion	  and	  subsequent	  release	  of	  the	  
Sertoli	  and	  germ	  cells.	  	  The	  majority	  of	  germ	  cells	  remaining	  in	  the	  culture	  after	  
digestion	  are	  spermatogonia	  as	  more	  advanced	  stages	  of	  germ	  cells	  are	  removed	  
during	  tubule	  digestion.	  	  Sertoli	  cells	  were	  used	  fresh	  for	  ChIP	  assays	  and	  thus	  
contain	  a	  subpopulation	  of	  spermatogonia.	  	  Myoid	  cells	  were	  cultured	  in	  Ham’s	  F12	  
(Cellgro,	  Corning,	  NY	  -­‐#10-­‐080-­‐CV),	  10%	  FBS,	  1.5mM	  HEPES	  (Sigma-­‐Aldrich,	  St.	  
Louis,	  MO	  -­‐	  H0887)	  and	  1%	  Pen-­‐Strep	  (Sigma-­‐Aldrich,	  St.	  Louis,	  MO	  -­‐	  P0781).	  All	  
cell	  culture	  was	  at	  37°C	  in	  5%	  CO2.	  	  Sertoli	  cells	  were	  either	  used	  directly	  
(Chromatin	  Immunoprecipitation)	  or	  cultured	  for	  two	  days	  and	  shocked	  with	  10	  
mM	  Tris	  pH	  7.4	  for	  2-­‐4	  minutes	  to	  remove	  germ	  cells.	  	  Myoid	  cells	  were	  cultured	  
and	  passaged	  two	  times	  before	  use.	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Chromatin	  Preparations.	  	  Chromatin	  was	  prepared	  as	  previously	  described	  (Hiroi,	  
Christenson	  et	  al.	  2004).	  	  Prior	  to	  cross	  linking,	  Sertoli	  and	  myoid	  cells	  were	  counted	  
to	  establish	  cell	  numbers	  for	  digestion.	  	  To	  cross-­‐link	  chromatin,	  primary	  rat	  Sertoli	  
and	  myoid	  cells	  were	  and	  incubated	  in	  30	  mL	  cell	  media	  containing	  1%	  
Formaldehyde	  for	  10	  minutes	  at	  room	  temperature.	  	  Cross-­‐linking	  was	  stopped	  by	  
the	  addition	  of	  125mM.	  	  Cells	  were	  pelleted	  and	  washed	  two	  times	  in	  10	  mL	  ice-­‐cold	  
PBS	  containing	  freshly	  prepared	  Protease	  Inhibitors	  (Roche,	  South	  San	  Francisco,	  
CA-­‐#,	  South	  San	  Francisco).	  	  Cell	  pellets	  were	  washed	  three	  times	  in	  20	  mL	  ice-­‐cold	  
MC	  lysis	  buffer	  (10mM	  Tris-­‐HCl	  pH	  7.5,	  10mM	  NaCl,	  3mM	  MgCl2,	  0.5%	  NP-­‐40)	  and	  
incubated	  on	  ice	  for	  10	  minutes	  during	  the	  third	  wash.	  	  After	  the	  final	  wash	  was	  
complete	  the	  cell	  pellets	  were	  vortexed	  (setting	  3)	  for	  three	  minutes.	  	  The	  cells	  were	  
pelleted,	  the	  supernatant	  removed	  and	  the	  pellet	  frozen	  by	  immersion	  in	  liquid	  
nitrogen.	  	  The	  pellets	  were	  then	  thawed	  in	  an	  ice-­‐water	  bath.	  	  Cells	  were	  
resuspended	  to	  4	  x	  107	  cells/mL	  in	  MNase	  buffer	  (10mM	  Tris-­‐HCl	  pH	  7.5,	  10mM	  
NaCl,	  3mM	  MgCl2,	  1mM	  CaCl2,	  4%	  NP-­‐40)	  and	  disrupted	  using	  10	  strokes	  with	  a	  
Type	  B	  pestle	  in	  an	  ice-­‐cold	  Dounce	  homogenizer	  to	  release	  chromatin.	  	  Chromatin	  
suspensions	  were	  then	  diluted	  with	  cold	  MNase	  buffer	  to	  a	  final	  concentration	  of	  2	  x	  
107	  cells/mL.	  	  Micrococcal	  nuclease	  (New	  England	  BioLabs	  M0247S)	  was	  added	  
(120U	  per	  2	  x	  106	  cells)	  and	  extracts	  were	  incubated	  for	  30	  minutes	  at	  37°C.	  	  
Nuclease	  digestion	  was	  stopped	  by	  the	  addition	  of	  (final	  concentration):	  	  6mM	  
EGTA,	  1x	  protease	  inhibitors	  (Roche,	  South	  San	  Francisco,	  CA),	  10%	  SDS	  and	  
200mM	  NaCl.	  	  Samples	  were	  aliquoted	  to	  1	  x	  107	  cells	  (~500	  µl)	  and	  stored	  at	  -­‐80°C.	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Chromatin	  Immunoprecipitation.	  	  Rat	  Sertoli	  and	  myoid	  chromatin	  was	  used	  for	  
ChIP	  at	  an	  equivalent	  of	  1	  x	  107	  cells	  per	  immunoprecipitation	  sample.	  	  	  Chromatin	  
samples	  were	  thawed	  on	  ice	  and	  pre-­‐cleared	  by	  the	  addition	  of	  75	  µl	  of	  a	  50%	  slurry	  
of	  pre-­‐blocked	  protein	  A-­‐agarose	  beads	  (Millipore	  16-­‐157)	  for	  one	  hour	  at	  4°C	  with	  
rotation.	  	  Agarose	  beads	  were	  then	  pelleted	  by	  centrifugation	  for	  one	  minute	  at	  
3900	  x	  g	  at	  4°C	  and	  the	  supernatants	  transferred	  to	  new	  tubes.	  	  Five	  micrograms	  of	  
primary	  antibody	  was	  added	  to	  the	  supernatants	  and	  the	  samples	  incubated	  at	  4°C	  
for	  18	  hours.	  	  The	  primary	  antibodies	  used	  were:	  	  Anti-­‐acetyl-­‐Histone	  H4	  (Lys5,	  8,	  
12,	  16)	  (Millipore	  06-­‐866);	  Anti-­‐trimethyl-­‐Histone	  H3	  (Lys4)	  (Millipore	  07-­‐473);	  
Anti-­‐trimethyl-­‐Histone	  H3	  (Lys27)	  (Millipore	  07-­‐449),	  IgG	  (Santa	  Cruz	  SC-­‐2027).	  	  
100	  µl	  of	  protein	  A-­‐agarose	  slurry	  was	  added	  to	  each	  sample	  and	  incubated	  for	  one	  
hour	  at	  4°C	  with	  rotation.	  	  Chromatin	  and	  agarose	  beads	  were	  then	  transferred	  to	  
Spin-­‐X	  tubes	  (Corning,	  Tewksbury	  MA-­‐#8160)	  for	  washing.	  	  Each	  wash	  (600	  µl)	  was	  
preformed	  for	  five	  minutes	  at	  RT	  on	  a	  rotator,	  followed	  by	  a	  one-­‐minute	  spin	  at	  300	  
x	  g.	  	  Wash	  conditions	  were	  as	  follows:	  1	  x	  Low	  Salt	  Wash	  (20mM	  Tris	  pH	  8.1,	  
150mM	  NaCl,	  2mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%	  SDS,	  protease	  inhibitors),	  1	  x	  High	  
Salt	  Wash	  (20mM	  Tris	  pH	  8.1,	  500mM	  NaCl,	  2mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%	  
SDS,	  protease	  inhibitors),	  1	  x	  LiCl	  Wash	  (10mM	  Tris	  pH	  8.1,	  250mM	  LiCl,	  1%	  NP-­‐40,	  
1%	  Na	  Deoxycholate,	  1mM	  EDTA,	  protease	  inhibitor),	  2	  x	  TE	  wash	  (10mM	  Tris	  pH	  
8.0,	  1mM	  EDTA,	  protease	  inhibitor).	  	  Chromatin	  elution	  was	  achieved	  by	  incubating	  
the	  agarose	  beads	  in	  200	  µl	  Elution	  buffer	  (100mM	  NaHCO3,	  1%	  SDS)	  for	  15	  
minutes	  at	  RT	  with	  rotation.	  	  Supernatant	  was	  collected	  and	  NaCl	  added	  to	  a	  final	  
concentration	  of	  200mM.	  	  Samples	  were	  then	  incubated	  at	  65°C	  for	  four	  hours	  to	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reverse	  the	  cross-­‐links.	  	  Twenty	  micrograms	  of	  Proteinase-­‐K	  was	  added	  and	  the	  
buffer	  concentration	  increased	  to	  50mM	  Tris	  and	  10mM	  EDTA.	  	  Samples	  were	  
incubated	  for	  one	  hour	  at	  45°C.	  	  DNA	  was	  isolated	  using	  the	  ChIP	  DNA	  Clean	  and	  
Concentrator	  Kit	  (Zymo	  Research	  D5205)	  and	  eluted	  in	  50	  µl	  TE.	  	  	  
	  
qPCR	  Analysis	  of	  ChIP	  DNA.	  	  Prior	  to	  Illumina	  sequencing,	  each	  ChIP-­‐DNA	  sample	  
was	  first	  analyzed	  to	  assess	  quality	  via	  qPCR	  using	  an	  Applied	  Biosystems	  7900HT	  
Fast	  Real-­‐Time	  PCR	  System.	  	  Each	  reaction	  was	  performed	  in	  triplicate	  and	  
contained	  one	  microliter	  ChIP	  DNA,	  five	  microliters	  SyberGreen	  Master	  Mix	  
(Applied	  Biosystems),	  and	  300	  nM	  forward	  and	  reverse	  primer.	  	  Primers	  for	  the	  
Fshr	  promoter	  are	  FHSR	  Prom	  F	  5’-­‐TTTACTTGCCTGGAAGCGACTAA-­‐3’	  AND	  FSHR	  
Prom	  R	  5’-­‐GCTTGGAGAACGGGCAAA-­‐3’	  and	  for	  the	  Nrxn1	  promoter	  are	  Nrxn1	  Prom	  
F	  5’-­‐GGGAGGAATCTGATCACTGTACTGT-­‐3’	  AND	  Nrnx1	  Prom	  R	  5’-­‐
CATGATCTTCCCAATTGTCCAA-­‐3’.	  	  The	  standard	  cycle	  was	  used,	  without	  any	  
changes	  to	  the	  default	  parameters.	  	  A	  dissociation	  curve	  was	  run	  following	  the	  final	  
cycle	  to	  determine	  if	  contamination	  was	  present.	  	  	  The	  SDS	  Software	  package	  2.4	  
(Applied	  Biosystems)	  was	  used	  to	  calculate	  the	  cycle	  threshold	  (Ct)	  value	  for	  each	  
primer	  set,	  which	  were	  adjusted	  such	  that	  the	  threshold	  was	  set	  at	  the	  initial	  phase	  
of	  linear	  PCR	  amplification.	  	  Data	  was	  exported	  to	  a	  Microsoft	  Excel	  spreadsheet	  and	  
analyzed	  as	  a	  percent	  of	  the	  input	  sample	  [100*2^(Adjusted	  input	  -­‐	  Ct	  sample)].	  	  
Adjusted	  input	  was	  calculated	  based	  on	  the	  Ct	  value	  of	  the	  1%	  input	  sample.	  	  qPCR	  
was	  also	  used	  to	  verify	  regions	  identified	  by	  next	  generation	  sequencing.	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ChIP-­‐DNA	  Sequencing.	  	  ChIP	  DNA	  samples	  from	  two	  independent	  samples	  were	  
pooled,	  analyzed	  via	  qPCR,	  dried	  and	  shipped	  to	  Cofactor	  Genomics	  LLC	  (St.	  Louis,	  
MO)	  for	  library	  preparation	  and	  sequencing.	  	  Samples	  were	  prepared	  following	  
Illumina	  library	  preparation	  protocols	  by	  Cofactor	  and	  sequenced	  on	  the	  Illumina	  
GAIIx.	  	  The	  NEBNext®	  ChIP-­‐Seq	  Library	  Prep	  Reagent	  Set	  for	  Illumina®	  (New	  
England	  Biolabs),	  was	  used	  by	  Cofactor	  to	  prepare	  all	  samples	  for	  sequencing.	  	  	  	  
Briefly,	  10	  ng	  ChIP	  DNA	  was	  treated	  with	  klenow	  and	  T4	  DNA	  Polymerase	  to	  repair	  
fragmented	  ends,	  cleaned	  and	  ligated	  to	  the	  NEBNext	  Adaptor	  sequence.	  	  The	  DNA	  
was	  then	  cleaned	  and	  PCR	  amplified	  for	  15	  cycles	  using	  the	  NEBNext	  High-­‐Fidelity	  
2X	  PCR	  Master	  Mix	  and	  Universal	  PCR	  Primers	  per	  the	  manufacturers	  protocol.	  	  The	  
resultant	  library	  was	  cleaned	  using	  AMPure	  XP	  Beads,	  diluted	  and	  analyzed	  on	  the	  
Agilent	  Bioanalyzer.	  	  Twenty	  picomoles	  of	  Library	  DNA	  were	  prepared	  for	  
sequencing	  using	  the	  Illumina	  Cluster	  station.	  	  This	  ligated	  a	  llumina-­‐supplied	  
adapter	  sequence	  to	  one	  end	  of	  the	  DNA	  fragment,	  amplified	  the	  DNA	  clusters	  and	  
hybridized	  the	  DNA	  to	  the	  flow-­‐cell.	  	  The	  flow-­‐cell	  was	  then	  loaded	  onto	  the	  Genome	  
Analyzer	  IIx.	  	  Sequencing	  data	  output	  was	  in	  FASTQ	  files.	  	  
	  	  
Processing	  and	  Analysis	  of	  Sequencing	  Data.	  	  ChIP-­‐Seq	  data	  was	  analyzed	  
through	  the	  K-­‐INBRE	  Bioinformatics	  Core,	  University	  of	  Kansas,	  by	  Aaron	  Smalter	  
Hall,	  Ph.D.	  	  FASTQ	  files	  representing	  eight	  lanes	  of	  single-­‐end	  Illumina	  ChIP-­‐Seq	  
sequence	  tags	  produced	  by	  Cofactor	  Genomics	  were	  analyzed.	  	  	  FastQC	  (Babraham	  
Bioinformatics-­‐http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)	  was	  
used	  to	  test	  the	  quality	  of	  the	  sequence	  data	  for	  each	  sample	  prior	  to	  alignment.	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FastQC	  is	  a	  quality	  control	  application	  for	  high	  throughput	  sequence	  data	  that	  
provides	  an	  interactive	  application	  to	  review	  the	  results	  of	  several	  different	  QC	  
checks	  relating	  to	  the	  quality	  of	  sequence	  tags.	  	  The	  Trim	  Galore!	  (Babraham	  
Bioinformatics	  -­‐http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/)	  
tool	  was	  used	  to	  trim	  low-­‐quality	  base	  pairs,	  the	  Illumina	  primer	  and	  known	  
adapter	  sequences	  using	  the	  following	  parameters:	  	  Quality	  Phred	  score	  cutoff:	  51,	  
Quality	  encoding	  type	  selected:	  ASCII+64,	  Adapter	  sequence:	  
'GATCGGAAGAGCGGTTCAGCAGGAATGCCG',	  Maximum	  trimming	  error	  rate:	  0.1	  
(default),	  Minimum	  required	  adapter	  overlap	  (stringency):	  1	  bp	  and	  Minimum	  
required	  sequence	  length	  before	  a	  sequence	  gets	  removed:	  20	  bp.	  	  The	  following	  
command	  line	  was	  used:	  -­‐f	  fastq	  -­‐e	  0.1	  -­‐q	  51	  -­‐O	  1	  -­‐a	  
GATCGGAAGAGCGGTTCAGCAGGAATGCCG	  ‘file	  name’.fq.	  	  Removal	  of	  duplicate	  
sequence	  tag	  was	  performed	  using	  the	  "rmdup"	  module	  in	  the	  Samtools	  package	  
(Sourceforge.net-­‐	  http://samtools.sourceforge.net/).	  	  The	  BWA	  alignment	  tool	  
(Sourceforge.net-­‐	  http://bio-­‐bwa.sourceforge.net/)	  was	  used	  to	  align	  the	  resulting	  
files	  to	  the	  latest	  build	  of	  the	  Rattus	  norvegicus	  genome	  (rn5,	  May	  2012)	  using	  the	  
default	  parameters.	  	  Alignment	  was	  performed	  against	  two	  base	  library	  builds	  –	  a	  
‘Soft	  Masked’	  and	  a	  ‘Hard	  Masked’.	  The	  soft	  masked	  file	  contains	  the	  entire	  rn5	  
genome	  with	  repeat	  region	  denoted	  by	  lower	  case	  font	  while	  the	  hard	  masked	  
genome	  masks	  all	  repeat	  regions	  to	  N’s.	  	  These	  will	  be	  referred	  to	  as	  Unmasked	  and	  
Masked	  respectively.	  	  Visualization	  of	  the	  mapped	  sequence	  tags	  was	  achieved	  using	  
the	  UCSC	  Genome	  Browser	  using	  the	  BED,	  BEDGraph	  and	  BigWig	  file	  formats.	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UCSC	  Genome	  Browser	  Custom	  Track	  Settings.	  	  	  To	  visualize	  the	  aligned	  
sequence	  tags,	  bigwig	  files	  were	  imported	  into	  the	  UCSC	  Genome	  Browser	  using	  the	  
‘add	  custom	  track’	  feature.	  	  The	  bigWig	  format	  is	  for	  display	  of	  dense,	  continuous	  
data	  that	  will	  be	  displayed	  in	  the	  Genome	  Browser	  as	  a	  graph.	  	  Each	  track	  was	  
imported	  based	  on	  the	  alignment	  of	  the	  sequence	  tag,	  i.e.	  positive	  or	  negative	  strand	  
alignment.	  	  The	  following	  import	  command	  was	  used:	  track	  type=bigWig	  name="file	  
name"	  description=""	  bigDataUrl=http://[ftp	  location	  of	  file].	  	  Visualization	  settings	  
were	  set	  as	  follows-­‐	  Display	  mode:	  Full,	  Type	  of	  graph:	  bar,	  Track	  height:	  40	  pixels,	  
Vertical	  viewing	  range:	  min-­‐1	  max-­‐30,	  Data	  view	  scaling:	  use	  vertical	  viewing	  range	  
setting,	  Always	  include	  zero:	  off,	  Transform	  function:	  Transform	  data	  point	  by:	  
None,	  Window	  function:	  maximum,	  Smoothing	  window:	  off,	  Dray	  y	  indicator	  lines:	  
at	  y=0.0:	  off	  at	  y=0	  off.	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Results/Discussion	  
	  
qPCR	  Analysis	  of	  ChIP	  DNA.	  	  ChIP-­‐DNA	  was	  prepared	  from	  Sertoli/Germ	  and	  
myoid	  cell	  chromatin	  immunoprecipitated	  with	  antibodies	  to	  H4ac,	  H3K4me3	  and	  
H3K27me3.	  	  To	  ensure	  our	  ChIP-­‐DNA	  was	  of	  good	  quality	  for	  sequencing,	  the	  DNA	  
was	  first	  assessed	  by	  qPCR	  to	  determine	  the	  histone	  modifications	  associated	  with	  
the	  Fshr	  and	  the	  Nrxn1	  promoter.	  	  These	  two	  promoter	  regions	  were	  selected	  for	  
analysis	  because	  of	  their	  known	  expression	  patterns.	  	  Fshr	  is	  expressed	  only	  in	  
Sertoli	  cells	  and	  Nrxn1	  is	  not	  expressed	  in	  either	  cell	  type.	  	  The	  Fshr	  promoter	  was	  
associated	  with	  H4ac	  enrichment	  in	  both	  cell	  types,	  with	  slightly	  higher	  levels	  
observed	  in	  myoid	  cells	  (Figure	  2-­‐1).	  	  Within	  Sertoli	  cells,	  enrichment	  of	  H3K4me3	  
was	  highest	  at	  the	  Fshr	  promoter;	  however,	  H3K27me3	  enrichment	  was	  highest	  in	  
myoid	  cells.	  	  The	  Nrxn1	  promoter	  was	  not	  associated	  with	  enrichment	  of	  any	  
histone	  modifications	  tested	  in	  either	  cell	  type.	  	  We	  didn’t	  expect	  the	  Nrxn1	  
promoter	  to	  have	  much	  enrichment	  for	  any	  modification	  tested	  as	  this	  region	  is	  
likely	  heterochromatic	  in	  both	  cell	  types.	  	  For	  Fshr	  we	  did	  expect	  the	  inverse	  
relationship	  of	  enrichment	  between	  the	  two	  cell	  types	  as	  H3K4me3	  associates	  with	  
active	  promoters	  (Fshr)	  and	  H3K27me3	  associates	  with	  inactive	  promoters	  (Nrxn1).	  	  
We	  concluded	  from	  this	  analysis	  that	  our	  ChIP-­‐DNA	  was	  of	  good	  quality	  and	  
continued	  with	  DNA	  sequencing.	  	  	  
	   	  



























Figure	  2-­‐1.	  	  Analysis	  of	  Fshr	  and	  Nrxn1	  promoters	  in	  ChIP-­‐DNA	  samples.	  	  
Promoter	  regions	  were	  evaluated	  by	  qPCR	  using	  Sertoli/Germ	  cell	  (SC/GC)	  and	  
myoid	  cell	  (MC)	  immunoprecipitated	  chromatin	  identifying	  Histone	  4	  acetylation,	  
Histone	  3	  Lysine	  4	  tri-­‐methylation	  and	  Histone	  3	  Lysine	  27	  tri-­‐methylation.	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Illumina	  Sequencing	  of	  ChIP	  DNA.	  	  ChIP-­‐DNA	  was	  sent	  to	  Cofactor	  Genomics	  (St.	  
Louis,	  MO)	  for	  library	  preparation	  and	  sequencing	  on	  the	  Genome	  Analyzer	  IIx	  
(Illumina	  Inc.,	  San	  Diego,	  CA).	  	  The	  total	  number	  of	  sequencing	  tags	  generated	  for	  
each	  ChIP	  sample	  is	  listed	  in	  Table	  2-­‐1.	  	  The	  Illumina	  GAIIx	  sequencer	  is	  capable	  of	  
generating	  12-­‐30	  million	  sequence	  tags	  per	  lane	  and	  all	  of	  our	  generated	  tag	  counts	  
fall	  within	  this	  range.	  	  	  
	   The	  Input	  sample	  for	  the	  Sertoli	  cells	  produced	  roughly	  3	  million	  fewer	  
sequence	  tags	  than	  the	  input	  sample	  for	  myoid	  cells.	  	  As	  each	  Input	  sample	  was	  
generated	  using	  the	  same	  amount	  of	  chromatin	  for	  each	  cell	  type,	  we	  expected	  each	  
to	  produce	  a	  similar	  amount	  of	  sequence	  tags.	  	  Although	  we	  typically	  think	  of	  
micrococcal	  nuclease	  digest	  as	  equally	  fragmenting	  chromatin,	  this	  is	  not	  
necessarily	  true.	  	  Micrococcal	  nuclease	  not	  only	  cleaves	  at	  nucleosomes,	  but	  also	  will	  
cleave	  naked	  DNA	  as	  well	  as	  sequences	  rich	  in	  AT/TA	  dinucleotides	  (Becker,	  Yau	  et	  
al.	  2013),	  which	  can	  lead	  to	  an	  over	  and/or	  underrepresentation	  of	  certain	  genomic	  
sequences.	  	  Micrococcal	  nuclease	  also	  tends	  to	  digest	  euchromatin	  better	  than	  
heterochromatin	  (Yin,	  Sweeney	  et	  al.	  2011).	  	  Since	  Sertoli	  cells	  are	  fully	  
differentiated	  and	  non-­‐dividing,	  they	  likely	  contain	  more	  heterochromatic	  regions	  
than	  the	  myoid	  cells.	  	  This	  could	  lead	  to	  a	  bias	  in	  our	  fragmentation	  and	  thus	  be	  the	  
cause	  of	  fewer	  sequence	  tags	  being	  identified	  in	  the	  Sertoli	  cell	  input	  sample.	  
	   The	  total	  number	  of	  sequence	  tags	  generated	  for	  the	  Sertoli	  cell	  samples	  H4ac	  
and	  H3K4me3	  are	  several	  million	  bases	  lower	  than	  in	  the	  Myoid	  cell	  sample.	  	  As	  
noted	  above,	  the	  Sertoli	  cells	  likely	  contain	  more	  heterochromatin	  due	  to	  their	  
differentiation	  state	  when	  compared	  to	  myoid	  cells.	  	  This	  could	  explain	  why	  fewer	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sequence	  tags	  were	  generated	  in	  the	  Sertoli	  cell	  sample	  for	  H4ac	  and	  H3K4me3,	  as	  
these	  marks	  are	  commonly	  associated	  with	  euchromatic	  active	  regions.	  	  	  	  
	   For	  our	  studies,	  we	  used	  H3K27me3	  as	  a	  mark	  to	  identify	  repressed	  regions	  in	  
the	  genome.	  	  The	  sequencing	  tags	  generated	  for	  the	  H3K27me3	  samples	  were	  
similar	  across	  both	  cell	  types.	  	  A	  study	  by	  Young	  et.	  al.	  identified	  similar	  amounts	  of	  
H3K27me3	  enrichment	  across	  two	  cell	  types	  (mouse	  Embryonic	  Stem	  Cells	  and	  
G1ME	  cells)	  yet	  noted	  that	  the	  locations	  of	  enrichment	  differed	  within	  each	  cell	  type	  
(Young,	  Willson	  et	  al.	  2011).	  	  This	  could	  indicate	  that	  Sertoli/Germ	  cells	  and	  myoid	  
cells	  share	  a	  similar	  number	  of	  silenced	  or	  repressed	  genes.	  	  	  	  	  	  
	   	  








Table	  2-­‐1.	  	  Total	  sequence	  tags	  generated	  from	  Illumina	  sequencing.	  
	  
	  







Input	   21,384,126	  
H4ac	   15,285,827	  
H3K4me3	   14,888,624	  
H3K27me3	   19,192,554	  
Myoid	  
Cells	  
Input	   24,406,389	  
H4ac	   20,022,701	  
H3K4me3	   18,352,272	  
H3K27me3	   19,072,572	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Quality	  Control	  Analysis	  to	  Assess	  Sequence	  Tag	  Quality.	  	  Before	  aligning	  the	  
sequence	  data	  for	  each	  sample	  to	  the	  reference	  genome,	  the	  sequence	  was	  analyzed	  
using	  FastQC,	  a	  software	  program	  that	  tests	  the	  quality	  of	  raw	  sequence	  data.	  	  The	  
program	  analyzes	  multiple	  parameters	  assess	  problems	  that	  need	  corrected	  before	  
alignment	  a	  reference	  genome.	  	  Each	  ChIP-­‐Seq	  sample	  was	  analyzed	  independently,	  
for	  eight	  different	  parameters,	  each	  of	  which	  is	  discussed	  below	  followed	  by	  the	  
graphic	  data	  for	  each	  report.	  	  
Per	  Base	  Sequence	  Quality	  	  
The	  per	  base	  sequence	  quality	  report	  gives	  an	  overview	  of	  the	  quality	  score	  
across	  all	  bases	  at	  each	  position	  in	  the	  sequence	  tag,	  across	  all	  sequence	  tags	  in	  the	  
sample.	  	  The	  quality	  score	  is	  determined	  using	  the	  Phred	  score	  assigned	  to	  each	  
base	  call,	  which	  is	  determined	  by	  the	  Illumina	  sequencer	  (Ewing	  and	  Green	  1998;	  
Ewing,	  Hillier	  et	  al.	  1998).	  	  The	  quality	  score	  data	  is	  graphed	  using	  standard	  box-­‐
whisker	  plots.	   The	  central	  red	  line	  is	  the	  median	  value,	  the	  yellow	  box	  represents	  
the	  inter-­‐quartile	  range	  (25-­‐75%),	  the	  upper	  and	  lower	  whiskers	  represent	  the	  10%	  
and	  90%	  points	  and	  the	  blue	  line	  represents	  the	  mean	  quality.	  	  A	  Phred	  score	  of	  20	  
indicates	  a	  base	  call	  accuracy	  of	  99%,	  a	  score	  of	  30	  indicates	  accuracy	  of	  99.9%	  and	  
a	  score	  of	  40	  indicates	  accuracy	  of	  99.99%	  at	  each	  base	  (Ewing,	  Hillier	  et	  al.	  1998).	  A	  
quartile	  Phred	  value	  of	  less	  than	  10,	  or	  a	  median	  Phred	  value	  of	  less	  that	  25	  at	  any	  
base	  will	  cause	  a	  warning,	  and	  a	  quartile	  Phred	  value	  of	  less	  than	  5	  or	  a	  median	  
Phred	  value	  of	  less	  than	  20	  at	  any	  base	  will	  cause	  a	  failure.	  	  Each	  sequenced	  ChIP	  
sample	  passed	  this	  quality	  report	  indicating	  that	  each	  base	  called	  during	  sequencing	  
was	  of	  good	  quality	  (Figure	  2-­‐2	  A-­‐H).	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   Although	  the	  SC	  H3K4me3	  and	  SC	  H3K27me3	  samples	  passed	  this	  report,	  it	  
is	  important	  to	  note	  that	  the	  3’	  bases	  of	  these	  sequences	  contain	  base	  calls	  that	  are	  
suboptimal	  (Figure	  2-­‐2	  C	  and	  D).	  	  The	  SC	  H3K4me3	  sample	  disparity	  is	  refined	  to	  
the	  distal	  four	  bases	  but	  the	  SC	  H3K27me3	  sample	  disparity	  includes	  the	  distal	  11	  
bases.	  	  It	  is	  difficult	  to	  determine	  from	  these	  graphs	  how	  many	  of	  sequence	  tags	  
within	  each	  sample	  contain	  poor	  Phred	  scores	  at	  the	  3’	  end.	  	  However,	  should	  these	  
samples	  align	  poorly,	  trimming	  of	  the	  3’	  bases	  may	  increase	  the	  number	  of	  sequence	  
tags	  that	  align	  to	  the	  reference	  genome.	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Per	  Sequence	  Quality	  	  
	   The	  per	  sequence	  quality	  report	  uses	  the	  average	  Phred	  quality	  scores	  across	  
a	  sequence	  tag	  to	  determine	  if	  a	  subset	  of	  your	  sequence	  tags	  have	  overall	  low	  score	  
values.	  	  Graphic	  reports	  identify	  the	  total	  number	  of	  sequence	  tags	  (y-­‐axis)	  and	  the	  
average	  Phred	  score	  across	  each	  sequence	  tag	  (x-­‐axis).	  	  The	  average	  Phred	  score	  for	  
each	  sequence	  tag	  was	  calculate	  by	  averaging	  the	  Phred	  scores	  at	  each	  base	  call	  
across	  the	  sequence	  tag	  length	  (59	  bases).	  	  Samples	  failing	  this	  control	  test	  indicate	  
there	  was	  a	  problem	  during	  the	  sequencing	  run,	  usually	  attributed	  to	  poor	  starting	  
DNA	  quality.	  	  If	  the	  most	  frequently	  observed	  Phred	  score	  is	  below	  27	  (=0.2%	  error	  
rate),	  then	  a	  warning	  will	  be	  issued.	  	  If	  the	  most	  frequently	  observed	  Phred	  score	  is	  
below	  20	  (=1%	  error	  rate),	  then	  a	  failure	  will	  be	  issued.	  	  	  Each	  sequenced	  ChIP	  
sample	  passed	  this	  quality	  report	  indicating	  that	  each	  sequence	  is	  of	  good	  quality	  
(Figure	  2-­‐3	  A-­‐H).	  
	   Two	  samples	  did	  display	  a	  slight	  increase	  associated	  with	  a	  very	  low	  mean	  
sequence	  quality	  (Mean	  sequence	  quality	  of	  2	  on	  the	  x-­‐axis):	  	  SC	  H3K4me3	  and	  SC	  
H3K27me3	  (Figure	  2-­‐3	  C	  and	  D).	  	  	  Roughly	  300,000	  and	  800,000	  sequence	  tags	  
respectively	  are	  of	  poor	  sequence	  quality	  and	  may	  be	  difficult	  to	  align	  to	  a	  reference	  
genome.	  	  The	  poor	  quality	  is	  likely	  due	  to	  the	  poor	  quality	  scores	  associated	  with	  the	  
3’	  bases	  of	  these	  sequences	  as	  outlined	  above	  in	  the	  per	  base	  sequence	  quality	  
report.	  	  Again,	  this	  data	  indicates	  that	  the	  3’	  bases	  of	  these	  sequence	  tags	  may	  need	  
trimmed	  prior	  to	  alignment	  to	  a	  reference	  genome.	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Per	  Base	  Sequence	  Content	  
The	  per	  base	  sequence	  content	  was	  graphed	  as	  the	  proportion	  of	  each	  called	  
base	  across	  each	  position	  of	  the	  sequence	  tag.	  	  The	  percentage	  of	  each	  base	  called	  
(A,	  T,	  C	  or	  G)	  is	  graphed	  (y-­‐axis)	  corresponding	  each	  base	  call	  across	  the	  sequence	  
tag	  (x-­‐axis,	  59	  bp).	  	  A	  strong	  bias	  of	  any	  base	  at	  any	  position	  indicates	  the	  presence	  
of	  overrepresented	  sequence.	  	  Theoretically,	  the	  proportion	  of	  bases	  in	  each	  
position	  across	  the	  sequence	  tag	  should	  be	  the	  same.	  	  A	  failure	  of	  this	  quality	  report	  
indicates	  that	  either	  the	  original	  library	  was	  biased,	  or	  that	  there	  was	  an	  
overrepresented	  sequence	  occurring	  in	  the	  sample.	  	  An	  overrepresented	  sequence	  
can	  be	  identified	  by	  a	  strong	  bias	  associated	  with	  specific	  bases,	  and	  if	  the	  original	  
library	  had	  sequence	  bias,	  the	  bias	  association	  will	  occur	  across	  all	  the	  bases	  within	  
the	  sequence	  tag.	  	  Bias	  is	  usually	  attributed	  to	  the	  sequencing	  of	  linkers	  or	  adapters	  
within	  the	  5’	  or	  3’	  bases	  of	  a	  sequence	  tag,	  or	  could	  occur	  across	  the	  sequence	  tag	  if	  
there	  is	  an	  overrepresented	  sequence	  present	  that	  is	  likely	  caused	  by	  PCR	  
duplicates.	  	  
This	  report	  will	  issue	  a	  warning	  if	  the	  difference	  between	  A	  and	  T,	  or	  C	  and	  G	  
is	  greater	  that	  10%	  at	  any	  base	  or	  a	  failure	  if	  the	  difference	  is	  greater	  than	  25%	  at	  
any	  base.	  	  Each	  sequenced	  ChIP	  sample	  either	  failed	  or	  demonstrated	  a	  warning	  for	  
this	  quality	  report	  (Figure	  2-­‐4	  A-­‐H).	  	  However,	  upon	  further	  review,	  the	  disparity	  
that	  occurs	  within	  our	  samples	  is	  always	  confined	  to	  the	  first	  five	  bases	  of	  the	  
sequence	  tag.	  	  This	  indicates	  the	  presence	  of	  a	  similar	  sequence;	  most	  likely	  the	  
sequencing	  primer	  or	  adapter	  sequence	  ligated	  to	  the	  sequence	  tags	  for	  library	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preparation.	  	  This	  report	  tells	  us	  that	  we	  need	  to	  trim	  the	  initial	  bases	  of	  each	  
sequence	  tag	  before	  continuing	  with	  alignment	  to	  the	  reference	  genome.	  
When	  comparing	  the	  graphs	  beyond	  the	  first	  five	  bases,	  each	  sample	  is	  
associated	  with	  equally	  distributed	  bases	  calls	  except	  the	  MC	  H3K27me3	  sample	  
(Figure	  2-­‐4	  H).	  	  This	  graph	  identifies	  a	  disparity	  of	  ~4%	  between	  the	  A/T	  and	  G/C	  
base	  calls	  across	  the	  length	  of	  the	  sequence	  tag.	  	  This	  indicates	  the	  presence	  of	  
numerous	  similar	  sequences	  within	  the	  sample.	  	  These	  similar	  sequences	  often	  arise	  
from	  PCR	  duplicates	  generated	  during	  the	  sequencing	  run	  and	  should	  be	  filtered	  out	  
prior	  to	  genome	  alignment.	  	  Failure	  to	  remove	  duplicate	  sequences	  could	  lead	  to	  
false	  identification	  of	  enriched	  regions	  when	  using	  peak	  finding	  software.	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Per	  Base	  GC	  Content	  
The	  per	  base	  GC	  content	  report	  was	  graphed	  as	  the	  percent	  of	  GC	  bases	  (y-­‐axis)	  at	  
each	  position	  in	  the	  sequence	  tag	  (x-­‐axis).	  	  The	  GC	  content	  should	  reflect	  the	  GC	  
content	  of	  the	  sequenced	  genome,	  which	  for	  the	  rat	  genome	  is	  ~42%,	  and	  should	  
not	  change	  across	  the	  sequence	  tag	  (Cooper,	  Brudno	  et	  al.	  2004;	  Hammond,	  
Swanberg	  et	  al.	  2011).	  	  Changes	  in	  the	  GC	  content	  across	  the	  sequence	  tag	  would	  
indicate	  the	  presence	  of	  a	  contaminating	  sequence,	  i.e.	  sequencing	  primers	  or	  
adapters,	  or	  the	  presence	  of	  duplicate	  sequence	  tags.	  
If	  the	  GC	  content	  varies	  more	  than	  five	  percent	  from	  the	  baseline,	  a	  warning	  is	  
issued	  and	  if	  the	  GC	  content	  varies	  more	  than	  10	  percent	  a	  failure	  is	  issued.	  	  Only	  
one	  ChIP	  sample	  passed	  this	  quality	  report	  (SC	  H3K27me3,	  Figure	  2-­‐5	  D)	  while	  the	  
others	  either	  failed	  or	  demonstrated	  a	  warning	  (Figure	  2-­‐5	  A-­‐H).	  	  Again,	  similar	  to	  
the	  Per	  Base	  Sequence	  report,	  the	  disparity	  in	  the	  GC	  content	  that	  caused	  the	  
warning	  or	  failure	  occurred	  within	  the	  first	  five	  to	  seven	  bases	  of	  the	  sequence	  tags;	  
indicating	  the	  presence	  of	  a	  similar	  sequence	  (i.e.	  sequencing	  adapter)	  at	  the	  
beginning	  of	  each	  sequence	  tag	  that	  needs	  removed	  prior	  to	  alignment.	  	  The	  MC	  
H3K27me3	  sample	  also	  indicates	  a	  variance	  across	  the	  length	  of	  the	  sequence	  tag	  
implying	  the	  presence	  of	  duplicate	  sequences	  (Figure	  2-­‐5	  H)	  that	  will	  need	  removed	  
prior	  to	  alignment.	  	  	  
	   	  
	   54	  
	   	  
	   55	  
	  































































































	   56	  
Per	  Sequence	  GC	  Content	  
The	  Per	  Sequence	  GC	  content	  report	  is	  graphed	  as	  a	  Gaussian	  (normal)	  distribution	  
curve.	  	  It	  measures	  the	  GC	  distribution	  across	  sequence	  tags	  for	  each	  sample	  and	  
compares	  it	  to	  a	  modeled	  theoretical	  distribution	  where	  the	  central	  peak	  
corresponds	  to	  the	  overall	  theoretical	  GC	  content	  of	  the	  genome,	  which	  is	  calculated	  
based	  on	  the	  sample	  since	  no	  reference	  genome	  is	  selected	  for	  this	  analysis.	  	  A	  
biased	  sample	  that	  does	  not	  follow	  the	  normal	  distribution	  pattern	  suggests	  that	  the	  
library	  was	  contaminated	  or	  there	  was	  a	  significantly	  overrepresented	  sequence.	  	  	  
If	  the	  distribution	  deviates	  more	  than	  15%	  a	  warning	  is	  issued	  and	  if	  the	  deviation	  is	  
more	  than	  30%	  a	  failure	  is	  issued.	  	  Half	  of	  our	  ChIP-­‐Seq	  samples	  passed	  this	  report	  
(SC	  Input,	  SC	  H4ac,	  SC	  H3K27me3	  and	  MC	  Input	  –	  Figure	  2-­‐6	  A,	  B,	  D	  and	  E)	  while	  the	  
other	  half	  either	  generated	  a	  warning	  (MC	  H3K4me3	  and	  MC	  H3K27me3	  –	  Figure	  2-­‐
6	  G	  and	  H)	  or	  failed	  (SC	  H3K4me3	  and	  MC	  H4ac	  –	  Figure	  2-­‐6	  C	  and	  E).	  	  The	  distinct	  
peaks	  in	  the	  GC	  content	  identified	  in	  the	  MC	  H4ac	  and	  MC	  H3K27me3	  (Figure	  2-­‐6	  F	  
and	  H)	  indicates	  the	  presence	  of	  biased	  sequence/s,	  likely	  due	  to	  the	  presence	  of	  an	  
overrepresented	  sequence,	  as	  the	  peak	  is	  sharp	  and	  distinct	  from	  the	  rest	  of	  the	  
normal	  curve.	  	  The	  remaining	  samples	  that	  generated	  or	  failed	  are	  more	  difficult	  to	  
identify	  the	  underlying	  cause	  of	  the	  failure	  based	  on	  the	  distribution	  of	  the	  graph.	  	  
Each	  of	  these	  samples	  generated	  a	  smooth	  distribution	  curve;	  the	  curve	  just	  
deviates	  from	  the	  theoretical,	  usually	  in	  the	  uppermost	  portion	  of	  the	  curve.	  	  This	  
type	  of	  deviation	  indicates	  that	  either	  too	  many	  (C,	  E	  and	  G)	  or	  too	  few	  (A,	  B	  and	  D)	  
sequence	  tags	  were	  associated	  with	  the	  theoretical	  average.	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Per	  Base	  N	  Content	  
The	  Per	  Base	  N	  Content	  was	  graphed	  as	  the	  percent	  of	  bases	  that	  could	  not	  be	  called	  
across	  each	  position	  in	  the	  sequence	  tag.	  	  This	  report	  summarizes	  the	  number	  of	  
bases	  that	  could	  not	  be	  called	  within	  the	  sequence	  tag	  by	  the	  sequencer.	  	  A	  warning	  
was	  issued	  if	  the	  percent	  of	  uncalled	  bases	  is	  greater	  than	  five	  percent	  at	  any	  
sequence	  position,	  and	  a	  failure	  was	  issued	  if	  the	  N	  content	  is	  greater	  than	  20%	  a	  
any	  sequence	  position.	  	  Every	  ChIP-­‐Seq	  sample	  passed	  this	  quality	  control	  test	  
(Figure	  2-­‐7	  A-­‐H)	  indicating	  that	  there	  were	  very	  few	  bases	  of	  such	  poor	  quality	  that	  
a	  base	  call	  was	  not	  possible.	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Sequence	  Length	  Distribution	  
	  
The	  Sequence	  Length	  Distribution	  report	  is	  graphed	  as	  the	  number	  of	  sequence	  tags	  
(y-­‐axis)	  versus	  the	  length	  of	  the	  sequence	  tag	  (x-­‐axis).	  	  This	  figure	  represents	  the	  
length	  of	  each	  sequence	  tag	  represented	  in	  each	  ChIP	  sample	  library.	  	  As	  sequencing	  
was	  performed	  on	  the	  Illumina	  Genome	  Analyzer	  IIx,	  each	  sequence	  tag	  should	  be	  
59	  base	  pairs	  long.	  	  	  Every	  ChIP-­‐Seq	  sample	  passed	  this	  quality	  control	  test	  
indicating	  each	  sequence	  tag	  was	  the	  appropriate	  length.	  	  This	  tells	  us	  that	  there	  
was	  not	  an	  issue	  with	  the	  sequencing	  run	  (i.e.	  early	  termination	  or	  mispriming)	  and	  
all	  samples	  were	  adequately	  sequenced	  (Figure	  2-­‐8	  A-­‐H).	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Duplicate	  Sequences	  
	  
Comparing	  the	  first	  50	  bases	  across	  the	  first	  200,000	  sequence	  tags	  within	  
each	  sample	  identifies	  duplicate	  sequences.	  	  Two	  sequence	  tags	  are	  considered	  
identical	  if	  they	  are	  100%	  identical	  across	  the	  first	  50.	  	  A	  warning	  is	  issued	  for	  
samples	  with	  duplicates	  greater	  than	  20%	  of	  the	  total,	  and	  a	  failure	  issued	  for	  
samples	  with	  duplicates	  greater	  than	  50%	  of	  the	  total.	  	  	  
Duplicate	  sequence	  tags	  are	  thought	  to	  arise	  during	  the	  library	  preparation.	  	  
During	  this	  step,	  ChIP	  DNA	  is	  intentionally	  amplified	  to	  increase	  the	  amount	  of	  DNA	  
required	  for	  sequencing.	  	  Numerous	  duplicates	  suggest	  that	  insufficient	  starting	  
material	  was	  used	  in	  preparing	  the	  library	  or	  that	  the	  DNA	  was	  not	  appropriately	  
size	  fractionated	  prior	  to	  library	  preparation	  (smaller	  fragments	  will	  amplify	  more	  
than	  larger	  fragments).	  
The	  number	  of	  duplicate	  sequence	  tags	  in	  each	  sample	  set	  was	  graphed	  as	  
percentage	  of	  the	  total	  number	  of	  sequence	  tags	  (y-­‐axis)	  versus	  the	  number	  of	  times	  
that	  a	  specific	  sequence	  occurred	  in	  the	  library	  (x-­‐axis).	  	  Only	  one	  ChIP	  sample,	  MC	  
H4ac,	  passed	  this	  quality	  report	  while	  the	  others	  either	  failed	  or	  evoked	  a	  warning,	  
indicating	  the	  need	  to	  remove	  duplicate	  sequence	  tags	  prior	  to	  alignment	  (Figure	  2-­‐
9	  A-­‐H).	  	  The	  MC	  H4ac	  and	  MC	  H3K27me3	  samples	  had	  the	  highest	  duplication	  rates,	  
51%	  and	  71%	  respectively	  (Figure	  2-­‐9	  F	  and	  H).	  	  This	  agrees	  with	  the	  per	  sequence	  
GC%	  report	  discussed	  above	  that	  indicated	  there	  were	  biased	  sequences	  in	  the	  MC	  
H3K27me3	  sample.	  	  All	  duplicate	  sequence	  tags	  were	  removed	  from	  the	  samples	  
prior	  to	  genome	  alignment.	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Overrepresented	  Sequences	  
	   This	  report	  identifies	  any	  linker	  DNA	  sequences	  that	  may	  present	  within	  
sequence,	  i.e.	  adapter	  sequences	  and	  primer	  sequences.	  	  The	  first	  200,000	  sequence	  
tags	  in	  each	  sample	  are	  analyzed	  and	  any	  similar	  sequences	  present	  in	  at	  least	  0.1%	  
of	  the	  total	  sequence	  tags	  are	  identified.	  	  Identified	  sequences	  are	  then	  cross-­‐
referenced	  with	  a	  database	  of	  known	  sequencing	  primers	  and	  adapters.	  	  Any	  
adapter	  and	  primer	  sequences	  present	  need	  trimmed	  from	  each	  sequence	  tag	  prior	  
to	  genome	  alignment.	  	  	  
Analysis	  of	  the	  data	  showed	  that	  only	  the	  input	  samples	  were	  free	  of	  linker	  
DNA	  (Table	  2-­‐2).	  	  ChIP	  Sertoli/germ	  and	  myoid	  cell	  samples	  shared	  sequence	  
identity	  similar	  to	  sequences	  in	  the	  database.	  	  A	  sequence	  similar	  to	  the	  Illumina	  
Paired	  end	  primer	  2	  and	  the	  Illumina	  adapter	  sequence	  were	  identified,	  the	  primer	  
sequence	  is	  underlined	  and	  the	  adapter	  sequence	  is	  italicized	  in	  Table	  2-­‐2.	  	  This	  
primer/adapter	  sequence	  was	  ligated	  to	  all	  of	  the	  sequences	  prior	  to	  cluster	  
amplification	  and	  sequencing.	  	  Two	  of	  the	  myoid	  cell	  samples,	  H4ac	  and	  H3K27me3,	  
were	  also	  associated	  with	  a	  duplicate	  of	  the	  sequencing	  primer,	  this	  is	  likely	  an	  
artifact	  that	  occurred	  during	  the	  ligation	  step	  and	  these	  sequence	  tags	  will	  be	  
discarded.	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Input	   None	   	  	  
H4ac	   GATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTT	  
Illumina	  Paired	  End	  PCR	  
Primer	  2	  (100%	  over	  
59bp)	  
H3K4me3	   GATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTT	  
Illumina	  Paired	  End	  PCR	  
Primer	  2	  (100%	  over	  
59bp)	  
H3K27me3	   GATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTT	  
Illumina	  Paired	  End	  PCR	  










Illumina	  Paired	  End	  PCR	  




Illumina	  Paired	  End	  PCR	  
Primer	  2	  (97%	  over	  36bp)	  
H3K4me3	   GATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCTGCTT	  
Illumina	  Paired	  End	  PCR	  





Illumina	  Paired	  End	  PCR	  




Illumina	  Paired	  End	  PCR	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Summary	  of	  FastQC	  analysis	  
	  
A	  summary	  of	  the	  FastQC	  reports	  is	  listed	  in	  Table	  2-­‐3.	  	  Overall,	  the	  reports	  
identified	  two	  key	  issues	  with	  our	  sequence	  files	  that	  need	  to	  be	  addressed	  before	  
the	  sequence	  files	  can	  be	  aligned	  to	  the	  reference	  genome.	  	  Each	  sequence	  tag	  needs	  
the	  adapter	  and	  primer	  sequence	  trimmed,	  if	  present,	  and	  each	  sequence	  file	  needs	  
to	  have	  all	  duplicate	  sequences	  removed.	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Preparing	  Sequence	  Files	  for	  Alignment.	  	  To	  prepare	  the	  sequence	  files	  for	  
alignment,	  ligated	  primer/adapter	  sequences	  and	  duplicate	  sequences	  were	  
removed.	  	  Primer/adapter	  sequence	  trimming	  was	  performed	  using	  Trim	  Galore!,	  a	  
software	  program	  that	  removed	  the	  ligated	  sequence	  from	  each	  sequence	  tag	  within	  
the	  sample	  sets.	  	  Sequence	  tags	  that	  were	  trimmed	  to	  <20	  base	  pairs	  were	  removed	  
from	  the	  sample	  set	  (Table	  2-­‐4).	  	  Duplicate	  sequence	  tags	  (tags	  sharing	  100%	  
identity	  across	  59	  base	  pairs)	  were	  removed	  from	  all	  sample	  sets	  using	  the	  using	  the	  
‘rmdup’	  command	  in	  Samtools.	  	  As	  noted	  in	  the	  Duplicate	  Sequences	  report	  the	  MC	  
H4ac	  and	  MC	  H3K27me3	  had	  the	  highest	  number	  of	  duplicates	  to	  be	  removed	  
(Figure	  2-­‐9	  F	  and	  H).	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Table	  2-­‐4.	  	  ChIP-­‐Seq	  trimming	  and	  duplicate	  removal.	  
	  
	  











Input	   21,384,126	   316,649	   1,483,654	  
H4ac	   15,285,827	   340,378	   174,026	  
H3K4me3	   14,888,624	   443,820	   1,145,536	  
H3K27me3	   19,192,554	   951,948	   407,132	  
Myoid	  	  
Cells	  
Input	   24,406,389	   96,544	   1,863,592	  
H4ac	   20,022,701	   432,591	   3,693,225	  
H3K4me3	   18,352,272	   245,562	   2,915,671	  
H3K27me3	   19,072,572	   834,186	   4,546,020	  
	  
	   	  
	   74	  
Alignment	  to	  the	  rattus	  norvegicus	  genome.	  	  After	  trimming	  and	  duplication	  
removal,	  each	  ChIP-­‐Seq	  sequence	  file	  was	  aligned	  to	  the	  rn5	  build	  of	  the	  rat	  genome	  
using	  the	  BWA	  alignment	  tool	  with	  default	  parameters.	  	  Two	  genome	  assemblies	  
were	  used	  to	  create	  our	  libraries	  -­‐	  Unmasked	  and	  Masked.	  	  The	  Unmasked	  genome	  
contains	  all	  repetitive	  elements	  and	  is	  considered	  the	  ‘complete’	  genome.	  	  The	  
Masked	  genome	  does	  not	  contain	  known	  repetitive	  elements.	  	  These	  two	  
distinctions	  are	  important	  when	  considering	  alignments	  because	  alignment	  
programs	  have	  a	  difficult	  time	  aligning	  repetitive	  sequences.	  	  A	  sequence	  tag	  
mapping	  to	  a	  repetitive	  region	  may	  align	  to	  several	  repetitive	  regions	  equally	  well	  
and	  the	  program	  has	  no	  way	  of	  determining	  the	  correct	  alignment	  location.	  	  Thus,	  
interpreting	  alignments	  and	  therefore	  enrichment	  patterns	  in	  repetitive	  regions	  is	  
difficult.	  	  We	  have	  therefore	  aligned	  our	  samples	  using	  both	  genome	  assemblies	  to	  
facilitate	  the	  identification	  of	  specific	  enriched	  regions	  (Chapter	  3).	  
	  As	  expected,	  a	  higher	  percentage	  of	  sequence	  tags	  mapped	  to	  the	  unmasked	  
genome	  (Table	  2-­‐5).	  	  For	  this	  alignment,	  40-­‐60%	  of	  the	  total	  sequence	  tags	  mapping	  
to	  the	  reference	  genome	  is	  considered	  good	  (open	  communication	  forum:(Li,	  
Schmieder	  et	  al.	  2012)).	  	  All	  of	  our	  samples	  fall	  within	  this	  range	  except	  for	  two,	  the	  
SC	  H4ac	  (11.5%)	  and	  SC	  H3K27me3	  (21.5%)	  and	  will	  be	  discussed	  further	  below.	  	  A	  
small	  percentage	  of	  sequence	  tags	  mapped	  to	  the	  Masked	  genome,	  as	  expected	  since	  
this	  genome	  assembly	  is	  significantly	  smaller	  due	  to	  the	  exclusion	  of	  repetitive	  
regions	  (Table	  2-­‐6).	  	  Again,	  only	  a	  very	  small	  portion	  of	  the	  SC	  H4a	  (3%)	  and	  SC	  
H3K27me3	  (7%)	  aligned	  to	  the	  reference	  genome.	  
	  
	   75	  
The	  decreased	  percentage	  of	  aligned	  sequence	  tags	  in	  the	  SC	  H4ac	  and	  
H3K27me3	  samples	  could	  be	  remedied	  by	  trimming	  the	  sequence	  tags	  to	  include	  
only	  the	  first	  25	  bases	  and	  allowing	  up	  to	  six	  mismatches.	  	  This	  would	  increase	  the	  
percentage	  of	  mapped	  sequence	  tags	  to	  ~50%.	  Caution	  must	  be	  taken	  as	  shortening	  
the	  sequence	  tag	  length	  and	  increasing	  the	  number	  of	  allowed	  mismatches	  severely	  
decreases	  the	  alignment	  quality.	  	  For	  this	  reason,	  the	  alignments	  for	  these	  samples	  
were	  kept	  using	  the	  original	  alignment	  parameters.	  	  	  
To	  determine	  if	  these	  samples	  were	  contaminated	  with	  other	  DNA,	  the	  
samples	  were	  aligned	  against	  several	  genome	  assemblies	  (mouse,	  human,	  yeast,	  E.	  
coli,	  C.	  elegans	  and	  common	  vectors).	  	  Neither	  sample	  aligned	  well	  to	  these	  genomes,	  
the	  best	  alignment	  was	  to	  the	  mouse	  genome	  at	  ~4%	  aligning	  (Data	  not	  shown).	  	  To	  
further	  determine	  why	  the	  sequence	  tags	  were	  not	  aligning,	  a	  blast	  search	  was	  
preformed	  on	  ~1000	  sequence	  tags	  that	  did	  not	  align	  to	  the	  reference	  genome.	  	  
These	  results	  indicate	  that	  ~30%	  of	  the	  1000	  sequences	  tested	  aligned	  to	  various	  
species	  of	  fish.	  	  It	  is	  possible	  that	  the	  salmon	  sperm	  blocked	  agarose	  beads	  used	  in	  
the	  ChIP	  experiment	  carried	  over	  and	  contaminated	  the	  sequencing	  library.	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Annotation	  of	  histone	  modifications	  across	  the	  rat	  genome.	  	  	  The	  aligned	  ChIP-­‐
Seq	  files	  were	  viewed	  by	  converting,	  the	  sam	  (.sam)	  file	  format	  to	  a	  BigWig	  (.bw)	  file	  
format,	  which	  were	  imported	  to	  and	  viewed	  in	  the	  UCSC	  Genome	  Browser.	  	  The	  
histone	  modifications	  visualized	  across	  Chromosome	  2	  of	  the	  rattus	  norvegicus	  
genome,	  rn5	  build	  and	  a	  smaller	  region	  of	  Chromosome	  2	  are	  shown	  in	  Figures	  2-­‐10	  
and	  2-­‐11,	  respectively.	  	  Chromosome	  2	  was	  to	  represent	  general	  patters	  associated	  
with	  the	  entire	  genome.	  	  Several	  features	  are	  represented	  within	  the	  Genome	  
Browser	  view.	  	  A	  scale	  bar	  is	  listed	  across	  the	  top	  of	  the	  chart	  for	  reference,	  known	  
RefSeq	  Genes	  are	  identified	  with	  purple	  bars,	  and	  the	  histogram	  shows	  enrichment	  
of	  sequence	  tags	  mapped	  to	  the	  masked	  genome.	  	  Enrichment	  in	  each	  location	  is	  
reflected	  by	  the	  height	  of	  the	  histogram.	  	  As	  noted	  above,	  the	  Sertoli	  cell	  H4ac	  and	  
H3K27me3	  did	  not	  demonstrate	  significant	  enrichment	  as	  only	  2.6%	  and	  6.8%	  of	  
sequence	  tags	  aligned	  to	  the	  reference	  genome.	  	  This	  low	  percentage	  of	  aligned	  
sequence	  tags	  prevents	  detailed	  evaluation	  of	  any	  trends	  within	  these	  samples.	  	  	  
As	  expected,	  the	  input	  samples	  for	  each	  cell	  type	  analyzed	  show	  relatively	  
low	  enrichment	  across	  the	  chromosome.	  	  The	  tall,	  slender	  peaks	  observed	  in	  the	  
input	  samples,	  as	  well	  as	  other	  samples,	  likely	  correspond	  to	  regions	  of	  DNA	  that	  
were	  inadvertently	  enriched	  by	  the	  imperfect	  nature	  of	  nuclease	  digestion.	  	  As	  these	  
peaks	  were	  seen	  in	  all	  samples	  within	  the	  same	  genomic	  location	  across	  each	  cell	  
type,	  they	  do	  not	  represent	  regions	  enriched	  for	  specific	  histone	  modifications.	  	  
H4ac	  enrichment	  in	  the	  myoid	  cell	  sample	  followed	  a	  fluctuating	  pattern	  that	  
appears	  to	  coordinate	  with	  gene	  locations	  (Figure	  2-­‐11).	  	  This	  histone	  modification	  
is	  typically	  found	  in	  euchromatic	  regions	  and	  is	  correlated	  with	  active	  gene	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expression,	  suggesting	  that	  genes	  in	  this	  region	  are	  active	  or	  can	  be	  readily	  
activated.	  	  The	  H3K27me3	  density	  in	  myoid	  cells	  followed	  a	  more	  consistent	  pattern	  
across	  the	  chromosome,	  and	  this	  pattern	  was	  also	  similar	  across	  other	  
chromosomes	  (data	  not	  shown).	  	  As	  enrichment	  peaks	  associated	  with	  H3K27me3	  
are	  relatively	  small,	  visual	  association	  and	  comparative	  analysis	  of	  enrichment	  with	  
other	  histone	  modifications	  will	  require	  bioinformatic	  analysis.	  	  The	  H3K4me3	  
enrichment	  profile	  follows	  a	  similar,	  more	  site-­‐specific	  profile	  across	  both	  cell	  types,	  
and	  this	  pattern	  is	  also	  found	  across	  other	  chromosomes	  (data	  not	  shown).	  	  
H3K4me3	  enrichment	  was	  similar	  between	  Sertoli	  and	  myoid	  cells;	  however,	  
several	  distinct	  cell-­‐specific	  peaks	  could	  be	  identified	  (Figure	  2-­‐11).	  	  Within	  the	  
myoid	  cell	  samples,	  H3K4me3	  seems	  to	  follow	  enrichment	  of	  H4ac	  although	  there	  
are	  regions	  of	  H4ac	  that	  do	  not	  contain	  H3K4me3	  enrichment.	  	  This	  corresponds	  
with	  the	  theory	  that	  H4ac	  is	  a	  broader	  mark	  identifying	  larger	  genomic	  regions	  
whereas	  H3K4me3	  tends	  to	  associate	  with	  transcriptional	  start	  sites	  and	  enhancer	  
regions.	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Summary	  
	   Chromatin	  immunoprecipitation	  has	  allowed	  investigators	  to	  readily	  identify	  
protein/DNA	  interactions	  in	  vivo,	  providing	  a	  snapshot	  view	  of	  DNA-­‐bound	  protein	  
interactions	  at	  specific	  loci	  at	  a	  specific	  time.	  	  When	  combined	  with	  next-­‐generation	  
sequencing	  capabilities,	  ChIP	  provides	  a	  genome-­‐wide	  view	  of	  protein/DNA	  
interactions.	  
	   Many	  factors	  contribute	  to	  the	  successful	  outcome	  of	  a	  ChIP-­‐Seq	  experiment.	  	  
As	  library	  preparation	  and	  sequencing	  are	  often	  outsourced,	  it	  is	  in	  the	  hands	  of	  the	  
investigator	  to	  prepare	  the	  best	  possible	  DNA	  for	  sequencing.	  	  The	  initial	  step	  
involves	  cross-­‐linking	  the	  proteins	  to	  the	  DNA,	  followed	  by	  shearing	  the	  DNA.	  	  If	  the	  
cells	  are	  over	  or	  under	  cross-­‐linked,	  interactions	  may	  be	  falsely	  identified	  or	  
relevant	  interactions	  may	  be	  missed	  completely.	  	  To	  ensure	  proper	  fixation	  in	  our	  
cells,	  known	  protein/DNA	  interactions	  were	  assessed	  prior	  to	  sequencing.	  	  
Fragmenting	  the	  DNA	  to	  the	  appropriate	  size	  (~200-­‐600	  bp	  for	  standard	  ChIP-­‐PCR	  
~100-­‐300	  bp	  for	  ChIP-­‐Seq)	  is	  a	  critical	  step	  that	  ensures	  proper	  identification	  of	  
enrichment	  and,	  perhaps	  more	  importantly,	  the	  resolution	  of	  enrichment.	  	  For	  our	  
studies	  we	  used	  micrococcal	  nuclease	  uniformly	  fragment	  the	  DNA	  to	  ~150	  base	  
pairs,	  and	  increase	  the	  resolution	  of	  our	  ChIP	  experiments.	  	  Another	  important	  
factor	  contributing	  to	  the	  success	  of	  ChIP	  is	  antibody	  selection.	  	  For	  our	  studies,	  only	  
antibodies	  known	  to	  work	  in	  ChIP	  assays	  were	  selected	  and	  enrichment	  for	  each	  
antibody	  was	  tested	  using	  known	  regions	  of	  protein/DNA	  interaction	  prior	  to	  
sequencing.	  	  The	  resulting	  ChIP-­‐DNA	  must	  be	  eluted,	  washed	  and	  free	  of	  
contaminating	  salts	  for	  accurate	  library	  preparation	  and	  sequencing.	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   Aside	  from	  requiring	  high	  quality	  ChIP-­‐DNA	  and	  good	  quality	  sequencing,	  the	  
ability	  to	  accurately	  align	  the	  generated	  sequence	  tags	  is	  the	  most	  difficult	  step	  
facing	  whole	  genome	  analysis	  of	  protein/DNA	  interactions.	  	  It	  is	  often	  necessary	  to	  
outsource	  the	  analysis	  of	  sequencing	  datasets	  to	  departments	  that	  specialize	  in	  the	  
manipulation	  and	  analysis	  of	  such	  large	  data	  files.	  	  Numerous	  programs	  are	  now	  
available	  for	  aligning	  raw	  sequence	  data,	  but	  often	  times	  a	  solid	  understanding	  of	  
programming	  and	  computer	  language	  are	  required	  to	  accurately	  process	  and	  align	  
such	  data	  sets.	  	  	  
	   Before	  alignment	  can	  proceed,	  raw	  sequence	  tags	  (often	  obtained	  as	  .fastq	  
files)	  require	  processing,	  as	  failure	  to	  do	  so	  will	  result	  in	  poor	  genome	  alignments.	  	  
Running	  the	  FastQC	  analysis	  software	  on	  raw	  sequence	  files	  identifies	  problems	  
associated	  with	  each	  sequence	  file.	  	  Short	  sequence	  tags	  will	  often	  contain	  sequence	  
belonging	  to	  the	  adapter	  and	  primer	  sequences	  used	  for	  library	  preparation,	  and	  
need	  trimmed	  from	  all	  sequence	  tags	  within	  the	  data	  set.	  	  Several	  programs	  exist	  to	  
accomplish	  this	  and	  we	  used	  Trim	  Galore!	  to	  trim	  our	  sequence	  tags.	  
	   Another	  processing	  step	  that	  must	  be	  performed	  before	  aligning	  the	  
sequence	  tags	  to	  a	  reference	  genome	  is	  removal	  of	  duplicate	  sequence	  tags.	  	  
Duplicate	  sequence	  tags	  are	  tags	  that	  contain	  identical	  start	  and	  stop	  coordinates,	  
and	  arise	  within	  data	  sets	  as	  a	  PCR	  artifact	  during	  library	  preparation.	  	  Theoretically	  
immunoprecipitated	  DNA	  fragments	  generated	  by	  shearing	  or	  micrococcal	  nuclease	  
digestion	  will	  rarely	  lead	  to	  identical	  fragment	  isolation,	  thus	  duplicate	  sequence	  
tags	  are	  removed	  to	  prevent	  the	  false	  identification	  of	  enriched	  regions.	  	  	  For	  this	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study,	  the	  ‘rmdup’	  tool	  included	  in	  the	  BWA	  alignment	  software	  package	  was	  used	  
to	  remove	  identical	  sequences.	  	  	  
	   After	  these	  two	  steps	  are	  complete,	  the	  resulting	  sequence	  tags	  are	  ready	  for	  
alignment.	  	  For	  our	  data	  sets,	  the	  Burrows-­‐Wheeler	  Aligner	  (a.k.a.	  BWA)	  was	  used.	  	  
This	  alignment	  program	  was	  designed	  to	  align	  short	  sequence	  tags	  with	  a	  balance	  
between	  accuracy	  and	  performance	  (speed	  of	  alignment).	  	  This	  program	  
automatically	  adjusts	  the	  alignment	  parameters’	  based	  on	  sequence	  tag	  length	  and	  
detected	  error	  rate,	  aligning	  sequence	  tags	  with	  a	  <3%	  error	  only.	  	  The	  BWA	  aligner	  
will	  also	  index	  the	  raw	  FASTQ	  sequence	  file	  prior	  to	  alignment	  without	  the	  need	  for	  
additional	  software.	  	  Indexing	  basically	  converts	  the	  .fastq	  format	  into	  a	  tab	  
delineated	  text	  (.txt)	  format	  that	  the	  alignment	  software	  can	  process.	  	  	  
	   All	  software	  programs	  available	  for	  aligning	  sequencing	  data	  will	  produce	  
alignment	  files;	  however,	  the	  quality	  of	  the	  alignments	  must	  be	  considered.	  	  Short	  
communications	  in	  sequencing	  blog	  sites	  imply	  that	  anywhere	  from	  40-­‐90%	  of	  the	  
trimmed	  and	  de-­‐duped	  sequence	  tags	  should	  align	  to	  the	  unmasked	  reference	  
genome.	  	  The	  mouse	  and	  human	  genome	  are	  more	  complete	  and	  thus	  should	  
generate	  better	  alignment	  scores.	  	  The	  rat	  genome,	  with	  the	  latest	  build	  released	  
March	  2012,	  is	  only	  about	  90%	  complete.	  	  When	  aligning	  sequence	  tags	  to	  
incomplete	  genomes,	  one	  cannot	  expect	  all	  sequence	  tags	  to	  align.	  	  Overall,	  most	  of	  
our	  samples	  mapped	  well	  (~50-­‐80%	  sequence	  tags	  mapping	  to	  the	  reference	  
genome).	  
When	  aligning	  sequencing	  tags	  to	  masked	  genomes	  or	  specifically	  to	  
promoter	  regions	  (genome	  files	  that	  only	  contain	  1,	  2	  or	  5	  kb	  regions	  5’	  of	  the	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transcription	  start	  site)	  the	  accuracy	  of	  alignment	  increases	  at	  the	  as	  these	  regions	  
usually	  fully	  sequenced.	  	  Thus	  the	  statistical	  power	  of	  the	  alignment	  increases	  
although	  the	  overall	  percentage	  of	  mapped	  sequencing	  tags	  will	  decrease.	  
	   Two	  sequencing	  samples	  within	  our	  data	  sets	  did	  not	  align	  well	  to	  the	  
reference	  genome.	  	  There	  are	  numerous	  reasons	  as	  to	  how	  this	  can	  occur	  including	  
poor	  ChIP-­‐DNA	  sample	  quality,	  poor	  library	  preparation	  and/or	  poor	  sequencing	  
run.	  	  In	  our	  case,	  all	  ChIP-­‐DNA	  was	  tested	  before	  sequencing	  by	  qPCR	  and	  each	  
sample	  displayed	  an	  enrichment	  profile	  within	  Fshr	  promoter	  region	  that	  matched	  
previous	  ChIP	  results.	  	  We	  used	  this	  as	  an	  indication	  that	  the	  ChIP	  assay	  worked	  
correctly	  and	  yielded	  quality	  DNA.	  	  The	  library	  preparation	  and	  sequencing	  were	  all	  
preformed	  by	  Cofactor	  Genomics	  and	  passed	  all	  of	  their	  quality	  analysis	  tests	  before	  
and	  during	  the	  library	  preparation	  and	  sequencing	  process.	  	  	  
	   Several	  steps	  were	  taken	  to	  identify	  the	  why	  the	  SC-­‐H4ac	  and	  SC-­‐H3K27me3	  
samples	  had	  poor	  alignment	  scores.	  	  To	  determine	  if	  the	  unmapped	  sequencing	  tags	  
were	  not	  aligned	  due	  to	  an	  increase	  in	  mismatched	  bases,	  the	  alignment	  parameters	  
were	  relaxed	  to	  allow	  for	  more	  miss	  paired	  base	  calls.	  	  This	  did	  increase	  the	  number	  
of	  aligned	  sequence	  tags,	  but	  the	  alignment	  quality	  could	  not	  be	  assured	  due	  to	  
allowance	  of	  numerous	  mismatches	  (data	  not	  shown).	  	  To	  determine	  if	  the	  original	  
ChIP-­‐DNA	  was	  contaminated	  with	  another	  species	  of	  DNA,	  the	  samples	  were	  aligned	  
to	  the	  human,	  mouse	  and	  yeast	  genomes.	  	  These	  alignments	  generated	  <5%	  mapped	  
sequence	  tags	  for	  each	  genome	  (data	  not	  shown)	  indicating	  that	  other	  DNA	  used	  in	  
our	  lab	  did	  not	  contaminate	  the	  ChIP	  samples.	  	  To	  determine	  the	  origin	  of	  the	  DNA	  
within	  the	  unmapped	  sequence	  tags,	  random	  sets	  of	  sequences	  were	  entered	  into	  a	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blastn	  search.	  	  Interestingly,	  ~30%	  of	  the	  sequences	  checked	  (~1000	  sequence	  
tags)	  mapped	  to	  various	  members	  of	  the	  Osteichthyes	  class.	  	  One	  possible	  source	  of	  
this	  contamination	  is	  that	  the	  agarose	  beads	  used	  for	  the	  ChIP	  assay	  were	  blocked	  in	  
salmon	  sperm	  DNA.	  	  However,	  this	  is	  the	  case	  for	  all	  of	  the	  samples.	  	  In	  short,	  these	  
two	  samples	  will	  need	  re-­‐sequenced	  before	  further	  anlaysis.	  	  	  
	   Overall,	  we	  have	  generated	  a	  reference	  database	  that	  maps	  H4ac,	  H3K4me3	  
and	  H3K27me3	  enrichment	  in	  myoid	  cells	  and	  H3K4me3	  enrichment	  in	  Sertoli	  cells	  
across	  the	  rattus	  norvigicus	  genome.	  	  These	  genomic	  databases	  can	  be	  further	  mined	  
to	  identify	  genomic	  regions	  and	  patterns	  associated	  with	  each	  enrichment	  profile.	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Abstract	  
Genome	  wide	  mapping	  of	  post-­‐translational	  histone	  modifications	  identified	  	  
specific	  patterns	  associated	  with	  chromatin	  states	  and	  gene	  activity	  which	  have	  
facilitated	  identification	  of	  regulatory	  elements.	  	  As	  a	  means	  to	  better	  understand	  
transcriptional	  regulation	  in	  Sertoli	  cells,	  we	  used	  ChIP-­‐Seq	  to	  reveal	  regions	  across	  
the	  genome	  enriched	  for	  Histone	  3	  Lysine	  4	  tri-­‐methylation	  (H3K4me3),	  a	  
modification	  associated	  with	  active	  promoter	  and	  enhancer	  elements.	  	  
Bioinformatic	  analysis	  comparing	  regions	  enriched	  for	  H3K4me3	  in	  both	  Sertoli	  and	  
myoid	  cells	  was	  used	  to	  identify	  Sertoli	  cell	  specific	  enriched	  regions.	  	  Three	  genome	  
assemblies	  were	  used	  for	  database	  generation:	  	  Unmasked,	  masked	  and	  a	  build	  
containing	  only	  1000	  bp	  upstream	  of	  RefSeq	  genes.	  	  These	  three	  assemblies	  allow	  
for	  the	  identification	  of	  enriched	  regions	  across	  the	  entire	  genome,	  in	  a	  genome	  that	  
doesn’t	  contain	  repetitive	  regions,	  and	  within	  upstream	  promoter	  regions	  
respectively.	  	  Within	  Sertoli	  cells	  37,371,	  26,804	  and	  2,372	  enriched	  regions	  were	  
identified	  using	  the	  unmasked,	  masked	  and	  promoter	  only	  genome	  assemblies	  
respectively.	  	  Within	  myoid	  cells	  59,441,	  27,509	  and	  2,015	  enriched	  regions	  were	  
identified	  using	  the	  unmasked,	  masked	  and	  promoter	  only	  genome	  assemblies	  
respectively.	  	  Enrichment	  in	  the	  unmasked	  myoid	  cell	  database	  was	  roughly	  1.6	  
times	  higher	  than	  that	  in	  Sertoli	  cells	  and	  may	  be	  attributed	  to	  the	  fact	  that	  myoid	  
cells	  are	  largely	  undifferentiated	  compared	  to	  Sertoli	  cells.	  	  Of	  the	  identified	  regions	  
22,914,	  9,777	  and	  944	  respectively	  were	  identified	  as	  Sertoli	  cell	  specific	  for	  each	  
genome	  assembly.	  	  For	  both	  Sertoli	  and	  myoid	  cells	  just	  over	  half	  of	  the	  identified	  
regions	  enriched	  for	  H3K4me3	  lie	  outside	  the	  promoter	  region/Exon	  1,	  which	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contradicts	  several	  studies	  that	  identify	  this	  mark	  primarily	  with	  promoter	  regions.	  	  
Only	  when	  looking	  at	  the	  Sertoli	  cell	  specific	  enriched	  regions	  was	  H3K4me3	  
enrichment	  primarily	  identified	  within	  promoter	  and	  intragenic	  regions.	  	  GEO	  
expression	  analysis	  indicates	  that	  the	  top	  40	  Sertoli	  cell	  specific	  genes	  identified	  
using	  the	  upstream	  promoter	  region	  were	  are	  correlated	  gene	  expression	  in	  E13	  
Sertoli	  cells.	  	  Overall,	  we	  have	  identified	  H3K4me3	  enriched	  regions	  in	  Sertoli	  and	  
myoid	  cells	  and	  generated	  a	  searchable	  database	  for	  future	  analysis.	  	  	  Our	  data	  
follows	  similar	  enrichment	  patterns	  identified	  by	  other	  groups	  for	  other	  cell	  types	  
tested	  indicating	  that	  H3K4me3	  can	  be	  used	  as	  a	  mark	  to	  access	  active	  genomic	  
regions.	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Introduction	  
	   Linking	  specific	  covalent	  histone	  modifications	  to	  a	  specific	  function	  has	  been	  
the	  focus	  of	  numerous	  research	  projects	  over	  the	  last	  several	  years,	  and	  numerous	  
sites	  have	  been	  identified	  within	  histone	  tails	  that	  can	  be	  post-­‐translationally	  
modified.	  	  This	  has	  led	  to	  the	  idea	  that	  a	  ‘code’	  may	  exist	  where	  by	  specific	  
combinations	  of	  modifications	  may	  recruit	  specific	  proteins	  and	  initiate	  a	  specific	  
action;	  However,	  there	  are	  arguments	  for	  and	  against	  whether	  or	  not	  this	  type	  of	  
‘code’	  exists	  in	  vivo	  (reviewed	  in	  (Rando	  2012)).	  	  Overall,	  one	  theme	  does	  prevail	  –	  
some	  modifications	  are	  consistently	  associated	  with	  a	  specific	  function	  across	  
numerous	  species	  and	  cell	  types	  (O'Neill	  and	  Turner	  1995;	  Roh,	  Ngau	  et	  al.	  2004;	  
Calestagne-­‐Morelli	  and	  Ausio	  2006;	  Akkers,	  van	  Heeringen	  et	  al.	  2009;	  Pauler,	  
Sloane	  et	  al.	  2009;	  Young,	  Willson	  et	  al.	  2011).	  	  As	  described	  in	  Chapter	  2,	  we	  have	  
generated	  a	  genome	  wide	  map	  of	  H3K4me3	  in	  Sertoli	  and	  myoid	  cells,	  which	  was	  
the	  focus	  of	  this	  investigation.	  
Enrichment	  of	  H3K4me3	  is	  commonly	  associated	  with	  ‘active’	  chromatin	  
regions.	  	  Enrichment	  is	  found	  at	  the	  transcriptional	  start	  site	  (TSS)	  and	  within	  the	  
promoter	  regions	  of	  active	  genes.	  	  H3K4me3	  enrichment	  in	  combination	  with	  
H3K27me3	  enrichment	  is	  also	  found	  within	  the	  promoter	  regions	  of	  genes	  that	  are	  
poised	  for	  transcriptional	  activation.	  	  More	  recently,	  H3K4me3	  enrichment	  was	  
associated	  with	  cell-­‐type	  specific	  enhancers	  (Heintzman,	  Hon	  et	  al.	  2009;	  Pekowska,	  
Benoukraf	  et	  al.	  2011;	  Tian,	  Jia	  et	  al.	  2011).	  	  Therefore,	  H3K4me3	  is	  a	  useful	  mark	  
highlighting	  active	  regions	  within	  chromatin,	  as	  putative	  to	  promoters,	  regulatory	  
elements	  and	  cell-­‐specific	  enhancers.	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To	  help	  identify	  active	  elements	  and	  promoters	  specific	  to	  Sertoli	  cells,	  we	  
compared	  the	  genome	  wide	  H3K4me3	  enrichment	  profiles	  of	  Sertoli	  cells	  to	  that	  of	  
peritubular	  myoid	  cells.	  	  ChIP-­‐Seq	  data	  was	  analyzed	  using	  SICER-­‐	  a	  software	  
program	  that	  identifies	  H3K4me3	  enriched	  regions-­‐	  to	  identify	  and	  compare	  
enriched	  regions	  in	  Sertoli	  and	  myoid	  cells	  (Zang,	  Schones	  et	  al.	  2009).	  	  Our	  analysis	  
identified	  enriched	  regions	  based	  on	  the	  number	  of	  sequence	  reads	  across	  a	  defined	  
region	  compared	  to	  a	  control	  (input)	  sample	  for	  both	  Sertoli	  and	  myoid	  cells.	  	  Both	  
databases	  were	  then	  compared	  and	  a	  list	  was	  generated	  based	  on	  enrichment	  only	  
found	  within	  the	  Sertoli	  cell	  population.	  	  These	  databases	  provide	  not	  only	  cell-­‐type	  
specific	  enrichment	  profiles,	  but	  also	  offer	  a	  comparison	  between	  differentiated	  
(Sertoli)	  and	  undifferentiated	  (myoid)	  cell	  types.	  
To	  date,	  the	  profile	  of	  H3K4me3	  within	  Sertoli	  and	  myoid	  cells	  remains	  
unexplored.	  	  Cui	  et.	  al.	  have	  explored	  the	  H3K4me3	  profile	  in	  whole	  testis	  
preparations	  and	  discovered	  that	  ~74%	  of	  promoters	  were	  marked	  by	  H3K4me3	  
within	  the	  testis	  (Cui,	  Liu	  et	  al.	  2012).	  	  They	  also	  identified	  1611‘testis	  specific’	  
promoters	  marked	  by	  H3K4me3	  that	  were	  not	  identified	  within	  the	  cerebrum	  (Cui,	  
Liu	  et	  al.	  2012).	  	  As	  their	  study	  did	  not	  differentiate	  between	  testicular	  cell	  types,	  it	  
is	  difficult	  to	  compare	  our	  results	  to	  theirs.	  	  We	  did	  identify	  fewer	  enriched	  regions,	  
which	  may	  be	  attributed	  to	  the	  smaller	  sample	  population.	  	  Of	  the	  top	  40	  H3K4me3	  
enriched	  regions	  analyzed	  for	  each	  of	  our	  genome	  assemblies,	  over	  half	  of	  the	  
Sertoli	  and	  myoid	  cell	  regions	  corresponded	  to	  5’	  flanking	  and	  Exon	  1	  gene	  regions.	  	  
The	  other	  regions	  were	  associated	  with	  intergenic	  sequence.	  	  Only	  when	  looking	  at	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Sertoli	  cell	  specific	  enriched	  regions	  did	  the	  number	  of	  5’	  flanking/Exon1	  regions	  
associated	  with	  H3K4me3	  increase.	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Materials	  and	  Methods	  
Animal	  Use,	  Cell	  Isolation,	  Chromatin	  Immunoprecipitation	  and	  Genome	  
Sequencing.	  	  Animal	  use,	  cell	  isolation,	  ChIP-­‐Seq	  and	  genome	  alignment	  were	  
described	  in	  Chapter	  2	  of	  this	  text.	  	  It	  is	  important	  to	  note	  that	  Rattus	  norvegicus	  
genome	  is	  only	  ~90%	  sequenced	  at	  this	  time	  (current	  build	  rn5	  March	  2012)	  and	  
does	  not	  contain	  any	  sequence	  information	  for	  the	  Y	  chromosome.	  	  
	  
Peak	  finding	  analysis.	  	  Differential	  identification	  of	  enriched	  domains	  was	  used	  to	  
compare	  H3K4me3	  enrichment	  in	  ChIP-­‐Seq	  data	  obtained	  from	  Sertoli	  and	  myoid	  
cells.	  	  SICER	  v1.1,	  a	  software	  package	  that	  employs	  the	  SICER	  clustering	  
methodology,	  was	  used	  to	  identify	  enriched	  H3K4me3	  regions	  within	  both	  Sertoli	  
and	  myoid	  cells	  for	  three	  genome	  assemblies:	  	  Unmasked,	  Masked	  and	  Promoter	  
(1000	  bp	  upstream	  of	  TSS)	  (Zang,	  Schones	  et	  al.	  2009).	  	  A	  redundancy	  threshold	  of	  1	  
was	  used	  to	  eliminate	  all	  duplicate	  reads	  from	  the	  data	  set	  prior	  to	  peak	  calling	  and	  
comparison.	  	  A	  window	  size	  of	  200,	  fragment	  size	  of	  150,	  and	  gap	  size	  of	  200	  was	  
used,	  as	  recommended	  for	  H3K4me3	  histone	  data	  sets	  by	  the	  SICER	  documentation.	  	  
For	  statistical	  cutoffs,	  an	  E-­‐value	  of	  1000	  and	  a	  false	  discovery	  rate	  (FDR)	  of	  1E-­‐2	  
were	  used.	  	  Each	  database	  was	  normalized	  to	  an	  input	  control	  sample	  prior	  to	  
identifying	  enriched	  regions	  within	  the	  genome.	  	  For	  the	  input	  sample,	  enriched	  
regions	  were	  identified	  using	  a	  random	  background	  model	  with	  a	  lenient	  E-­‐value	  
threshold,	  and	  then	  the	  ChIP	  read	  count	  and	  control	  read	  count	  for	  each	  enriched	  
region	  was	  used	  to	  determine	  the	  significance	  of	  enrichment,	  with	  the	  control	  read	  
count	  rescaled	  to	  account	  for	  the	  size	  difference	  in	  the	  control	  library	  and	  the	  ChIP	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library	  (Zang,	  Schones	  et	  al.	  2009).	  	  Subtractive	  analysis	  was	  used	  to	  determine	  
enriched	  regions	  that	  were	  present	  in	  Sertoli	  cells	  but	  not	  in	  myoid	  cells	  masked	  and	  
unmasked	  genome	  assemblies.	  	  Additionally,	  H3K4me3	  ChIP-­‐Seq	  reads	  were	  aligned	  
to	  only	  promoter	  regions	  (1000	  bp	  upstream	  of	  TSS)	  and	  a	  differential	  comparison	  
of	  peak	  locations	  were	  performed.	  For	  this	  analysis	  the	  same	  parameters	  were	  used	  
for	  both	  alignment,	  peak	  calling,	  and	  peak	  comparison	  as	  were	  used	  for	  the	  whole-­‐
genome	  analysis.	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Results	  
Identification	  of	  H3K4me3	  Enrichment.	  	  To	  identify	  regions	  of	  H3K4me3	  
enrichment,	  whole	  genome	  alignments	  for	  Sertoli	  and	  myoid	  cells	  were	  imported	  
into	  SICER	  v1.1	  along	  with	  their	  corresponding	  Input	  controls.	  	  	  The	  program	  used	  
the	  standard,	  published	  settings	  for	  H3K4me3	  localization	  and	  the	  corresponding	  
input	  samples	  to	  control	  for	  background.	  	  Alignments	  were	  performed	  on	  three	  
assemblies	  of	  the	  Rattus	  norvegicus	  genome	  Build	  5	  including	  the	  unmasked	  
genome,	  masked	  genome	  (which	  does	  not	  include	  repeat	  regions)	  and	  a	  promoter-­‐
based	  genome	  that	  contains	  1000	  bp	  upstream	  from	  transcriptional	  start	  sites	  (TSS)	  
of	  RefSeq	  genes.	  	  SICER	  v1.1	  was	  also	  used	  to	  identify	  the	  Sertoli	  cell	  specific	  peaks	  
by	  comparing	  the	  Sertoli	  and	  myoid	  cell	  enrichment	  profiles.	  
	   	  The	  total	  number	  of	  enriched	  regions	  identified	  by	  SICER	  cluster	  analysis	  is	  
shown	  in	  Table	  3-­‐1	  for	  Sertoli	  and	  myoid	  cells.	  	  Total	  enrichment	  was	  similar	  
between	  Sertoli	  and	  myoid	  cells	  for	  the	  masked	  genome	  (26,804	  vs.	  27,509	  
respectively)	  and	  9,777	  regions	  were	  identified	  as	  Sertoli	  cell	  specific.	  	  Enrichment	  
was	  higher	  in	  the	  unmasked	  genome	  (37,371	  vs.	  59,441)	  with	  an	  increased	  number	  
of	  regions	  identified	  in	  the	  Myoid	  cell	  population.	  	  22,914	  of	  these	  regions	  were	  
identified	  as	  Sertoli	  cell	  specific.	  	  Similar	  enrichment	  was	  found	  between	  Sertoli	  and	  
myoid	  cell	  populations	  within	  the	  upstream	  promoter	  region	  (2,372	  vs.	  2,015	  
respectively)	  and	  944	  of	  those	  peaks	  were	  specific	  to	  Sertoli	  cells.	  	  Enriched	  regions	  
not	  classified	  as	  Sertoli	  cell	  specific	  are	  not	  necessarily	  regions	  that	  are	  myoid	  cell	  
specific	  as	  the	  identified	  regions	  may	  be	  present	  in	  both	  cell	  types	  and	  thus	  not	  
considered	  Sertoli	  cell	  specific.	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   More	  enriched	  regions	  were	  identified	  in	  the	  Unmasked	  genome	  assembly.	  	  
The	  increased	  number	  of	  enriched	  regions	  found	  in	  this	  assembly	  is	  due	  to	  the	  
inclusion	  of	  repetitive	  sequences.	  	  Repetitive	  elements	  are	  biologically	  relevant	  to	  
the	  structure	  and	  function	  of	  the	  genome,	  so	  is	  important	  to	  include	  repetitive	  
regions	  in	  genome	  wide	  analysis	  (Conley	  and	  Jordan	  2010;	  Ward,	  Wilson	  et	  al.	  
2013).	  Our	  results	  indicate	  that	  the	  myoid	  cell	  population	  contains	  more	  enrichment	  
in	  repetitive	  regions	  than	  the	  Sertoli	  cell	  population.	  	  Myoid	  cells	  are	  continuously	  
dividing	  whereas	  Sertoli	  cells	  are	  quiescent,	  implying	  that	  the	  Sertoli	  cell	  population	  
contains	  more	  heterochromatin	  and	  thus	  less	  activity	  within	  the	  repetitive	  regions	  
of	  the	  genome.	  	  This	  could	  explain	  this	  disparity	  of	  enrichment	  seen	  between	  the	  
Sertoli	  and	  myoid	  cells	  in	  the	  unmasked	  genome	  assembly.	  









	   	  





















Rn5	  Unmasked	   37,371	   59,441	   22,914	  
Rn5	  Masked	   26,804	   27,509	   9,777	  
Rn5	  1000bp	  Upstream	  of	  TSS	   2,372	   2,015	   944	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  Sertoli	  cell	  H3K4me3	  enriched	  sites.	  	  	  	  The	  top	  Sertoli	  cell	  enriched	  H3K4me3	  
regions	  were	  identified	  by	  comparing	  the	  number	  of	  reads	  associated	  with	  the	  
H3K4me3	  sample	  to	  that	  in	  the	  input	  control.	  	  A	  list	  of	  genomic	  locations	  for	  each	  
genome	  build	  (unmasked,	  masked	  and	  1000	  bp	  upstream	  region)	  was	  generated,	  
and	  sorted	  for	  significance	  based	  on	  the	  fold	  enrichment	  of	  sample	  reads	  vs.	  input	  
reads.	  	  The	  top	  40	  enriched	  locations	  (based	  on	  highest	  fold	  change)	  are	  listed	  in	  
Tables	  3-­‐2,	  3-­‐3	  and	  3-­‐4	  for	  the	  unmasked,	  masked	  and	  1000	  bp	  upstream	  region	  
genome	  assemblies.	  
Table	  3-­‐2	  identifies	  the	  location	  of	  peaks	  identified	  using	  the	  unmasked	  
genome	  build	  for	  alignment	  (i.e.	  contains	  all	  repeat	  elements).	  	  	  Of	  the	  40	  regions,	  24	  
were	  located	  within	  the	  5’	  flanking	  region	  and	  first	  exon/intron	  of	  a	  gene,	  two	  were	  
located	  within	  the	  gene	  body	  and	  14	  were	  located	  in	  intergenic	  regions.	  	  For	  the	  
peaks	  located	  within	  intergenic	  regions,	  the	  closest	  5’	  and	  3’	  genes	  are	  listed	  
(respectively).	  	  Table	  3-­‐3	  identifies	  the	  top	  40	  enriched	  regions	  identified	  using	  the	  
masked	  genome	  build	  for	  alignment.	  	  Of	  these,	  24	  were	  located	  within	  the	  5’	  flanking	  
region	  and	  first	  exon/intron	  a	  gene,	  two	  were	  located	  within	  the	  gene	  body	  and	  14	  
were	  located	  in	  intergenic	  regions.	  	  This	  data	  suggests	  that	  H3K4me3	  enrichment	  
primarily	  centers	  around	  transcriptional	  start	  sites,	  but	  may	  also	  identify	  important	  
intergenic	  regulatory	  regions.	  
When	  the	  regions	  identified	  using	  the	  unmasked	  genome	  were	  compared	  to	  
those	  from	  the	  masked	  genome,	  10	  regions	  were	  identified	  in	  both	  lists	  –	  seven	  
corresponding	  to	  promoter	  regions	  and	  three	  to	  intergenic	  regions	  (indicated	  Table	  
3-­‐2	  and	  3-­‐3	  by	  italic	  type	  font).	  	  Identification	  of	  enriched	  regions	  across	  both	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genome	  assemblies	  indicates	  a	  higher	  level	  of	  significance	  since	  the	  tables	  are	  
ranked	  by	  fold	  enrichment.	  	  Regions	  not	  cross-­‐identified	  in	  both	  genome	  assemblies	  
does	  not	  mean	  that	  the	  region	  is	  not	  found	  within	  both	  assemblies-­‐	  only	  the	  top	  40	  
enriched	  regions	  were	  cross-­‐compared	  and	  displayed	  here.	  	  Numerous	  regions	  are	  
found	  in	  both	  datasets,	  but	  the	  level	  of	  significance	  is	  not	  the	  same	  between	  the	  two	  
(data	  not	  shown).	  	  	  
Table	  3-­‐4	  identifies	  Sertoli	  cell	  H3K4me3	  enriched	  regions	  located	  1000	  bp	  
upstream	  of	  known	  TSS.	  	  As	  whole	  genome	  expression	  analysis	  for	  P15	  Sertoli	  cells	  
is	  not	  currently	  available,	  gene	  expression	  was	  determined	  by	  searching	  the	  GEO	  
database	  for	  whole	  testis	  expression	  at	  any	  age.	  	  All	  of	  the	  genes	  identified	  were	  
associated	  with	  testis	  gene	  expression	  except	  one	  and	  no	  expression	  data	  was	  
available	  for	  that	  gene	  (RGD1563714).	  	  This	  suggests	  that	  H3K4me3	  enrichment	  can	  
also	  identify	  transcriptionally	  active	  genes	  in	  Sertoli	  cells	  as	  in	  other	  tested	  cell	  
types.	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Myoid	  cell	  H3K4me3	  enriched	  sites.	  	  	  	  The	  top	  myoid	  cell	  enriched	  H3K4me3	  
regions	  were	  identified	  by	  comparing	  the	  number	  of	  reads	  associated	  with	  the	  
H3K4me3	  sample	  to	  that	  in	  the	  input	  control.	  	  A	  list	  of	  genomic	  locations	  for	  each	  
genome	  build	  (unmasked,	  masked	  and	  1000	  bp	  upstream	  region)	  was	  generated,	  
and	  sorted	  for	  significance	  based	  on	  the	  fold	  enrichment	  of	  sample	  reads	  vs.	  input	  
reads.	  	  The	  top	  40	  enriched	  locations	  (based	  on	  highest	  fold	  change)	  are	  listed	  in	  
Tables	  3-­‐5,	  3-­‐6	  and	  3-­‐7	  for	  the	  unmasked,	  masked	  and	  1000	  bp	  upstream	  region	  
genome	  assemblies.	  
Table	  3-­‐5	  identifies	  the	  location	  of	  peaks	  identified	  using	  the	  unmasked	  
genome	  build	  for	  alignment.	  	  Of	  the	  40	  regions,	  28	  were	  located	  within	  the	  5’	  
flanking	  region	  and	  first	  exon/intron	  of	  a	  gene,	  three	  were	  located	  within	  the	  gene	  
body	  and	  nine	  were	  located	  in	  intergenic	  regions.	  	  Table	  3-­‐6	  identifies	  the	  top	  40	  
enriched	  regions	  identified	  using	  the	  masked	  genome	  build	  for	  alignment.	  	  Of	  these,	  
30	  were	  located	  within	  the	  5’	  flanking	  region	  and	  first	  exon/intron	  a	  gene	  and	  10	  
were	  located	  in	  intergenic	  regions.	  	  This	  data	  suggests	  that	  H3K4me3	  enrichment	  
primarily	  centers	  on	  transcriptional	  start	  sites,	  but	  may	  also	  identify	  important	  
intergenic	  regulatory	  regions.	  
When	  the	  regions	  identified	  using	  the	  unmasked	  genome	  were	  compared	  to	  
those	  from	  the	  masked	  genome,	  13	  regions	  were	  identified	  in	  both	  lists	  –	  nine	  
corresponding	  to	  promoter	  regions	  and	  four	  to	  intergenic	  regions	  (indicated	  Table	  
3-­‐5	  and	  3-­‐6	  by	  italic	  type	  font).	  	  Identification	  of	  enriched	  regions	  across	  both	  
genome	  assemblies	  indicates	  a	  higher	  level	  of	  significance	  since	  the	  tables	  are	  
ranked	  by	  fold	  enrichment.	  	  Regions	  not	  cross-­‐identified	  in	  both	  genome	  assemblies	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does	  not	  mean	  that	  the	  region	  is	  not	  found	  within	  both	  assemblies-­‐	  only	  the	  top	  40	  
enriched	  regions	  were	  cross-­‐compared	  and	  displayed	  here.	  	  Numerous	  regions	  are	  
found	  in	  both	  datasets,	  but	  the	  level	  of	  significance	  is	  not	  the	  same	  between	  the	  two	  
(data	  not	  shown).	  	  	  
Table	  3-­‐7	  identifies	  myoid	  cell	  H3K4me3	  enriched	  regions	  located	  1000	  bp	  
upstream	  of	  known	  TSS.	  	  As	  whole	  genome	  expression	  analysis	  for	  myoid	  cells	  is	  not	  
currently	  available,	  gene	  expression	  was	  determined	  by	  searching	  the	  GEO	  database	  
for	  whole	  testis	  expression	  at	  any	  age.	  	  All	  of	  the	  genes	  identified	  were	  associated	  
with	  testis	  gene	  expression.	  	  This	  suggests	  that	  H3K4me3	  enrichment	  can	  also	  
identify	  transcriptionally	  active	  genes	  in	  myoid	  cells	  as	  in	  other	  tested	  cell	  types.	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Sertoli	  cell	  specific	  H3K4me3	  enriched	  regions.	  	  	  To	  gain	  insight	  on	  potential	  
regulatory	  regions	  specific	  to	  Sertoli	  cells,	  subtractive	  analysis	  identified	  enriched	  
regions	  specific	  to	  the	  Sertoli	  cell	  list	  (i.e.	  regions	  not	  also	  present	  in	  the	  myoid	  cell	  
list)	  for	  each	  genome	  build	  (unmasked,	  masked	  and	  the	  upstream	  promoter	  region).	  	  
Enrichment	  was	  determined	  by	  analyzing	  the	  relative	  fold	  change	  between	  the	  
number	  of	  sequence	  reads	  within	  the	  identified	  regions	  between	  Sertoli	  and	  myoid	  
cell	  populations.	  	  The	  top	  40	  enriched	  locations	  (based	  on	  highest	  fold	  change)	  are	  
listed	  in	  Tables	  3-­‐8,	  3-­‐9	  and	  3-­‐10	  for	  the	  unmasked,	  masked	  and	  1000	  bp	  upstream	  
region	  genome	  assemblies.	  
	   Table	  3-­‐8	  identifies	  the	  top	  40	  Sertoli	  cell	  specific	  enriched	  regions	  using	  the	  
unmasked	  genome	  build	  for	  alignment.	  	  Of	  these,	  12	  are	  located	  within	  introns	  and	  
28	  are	  intergenic.	  	  This	  differs	  significantly	  from	  the	  top	  regions	  identified	  in	  Sertoli	  
cells	  as	  the	  Sertoli	  cell	  specific	  regions	  correspond	  to	  introns	  instead	  of	  5’	  
flanking/exon1	  regions	  and	  more	  intergenic	  regions	  were	  identified.	  	  Table	  3-­‐9	  
identifies	  the	  top	  40	  Sertoli	  cell	  specific	  peaks	  identified	  using	  the	  masked	  genome	  
build	  for	  alignment.	  	  Of	  these,	  21	  are	  associated	  with	  introns/exons	  and	  19	  are	  
intergenic.	  	  Again,	  this	  differs	  from	  the	  Sertoli	  cell	  list	  in	  that	  identified	  regions	  
correspond	  to	  introns	  instead	  of	  5’	  flanking/exon1	  regions	  and	  an	  increase	  in	  the	  
number	  of	  intergenic	  regions.	  	  The	  number	  of	  reads	  used	  to	  identify	  these	  regions	  is	  
lower	  than	  the	  number	  identified	  in	  the	  Sertoli	  cell	  lists.	  	  This	  likely	  because	  many	  of	  
the	  5’	  flanking	  and	  Exon1	  regions	  were	  also	  identified	  in	  myoid	  cells	  thus	  removing	  
them	  from	  this	  list.	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Comparison	  of	  the	  two	  genome	  assemblies	  only	  identified	  four	  regions	  that	  
corresponded	  to	  both	  lists.	  	  Two	  of	  the	  regions	  were	  intergenic	  and	  two	  were	  within	  
gene	  introns.	  	  This	  is	  a	  smaller	  number	  of	  cross-­‐identified	  regions	  when	  compared	  
to	  the	  Sertoli	  and	  myoid	  cell	  lists.	  	  	  
Table	  3-­‐10	  identifies	  peaks	  located	  1000	  bp	  upstream	  of	  known	  TSS	  and	  only	  
two	  of	  these	  regions	  (Fshr	  and	  Tinagl1)	  were	  also	  found	  in	  the	  masked	  genome	  
assembly	  top	  40	  list.	  	  Gene	  expression	  was	  determined	  by	  searching	  the	  GEO	  
expression	  database	  identifying	  genes	  expressed	  in	  E13	  Sertoli	  cells	  (indicated	  by	  *	  
within	  the	  table)	  or	  by	  general	  testis	  expression.	  	  All	  genes	  analyzed	  except	  one	  
(RT1-­‐M3-­‐1)	  were	  expressed	  in	  E15	  mouse	  Sertoli	  cells.	  	  This	  indicates	  that	  H3K4me3	  
enrichment	  within	  the	  upstream	  promoter	  region	  can	  be	  associated	  with	  gene	  
expression	  in	  Sertoli	  cells.	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Discussion	  
The	  mapping	  of	  post-­‐translationally	  modified	  histone	  tails	  has	  become	  a	  vast	  
field	  of	  study	  and	  has	  led	  to	  the	  identification	  of	  specific	  histone	  modifications	  that	  
are	  correlated	  with	  various	  states	  of	  sequence	  activity.	  	  Some	  histone	  marks	  like	  
Histone	  4	  acetylation	  tend	  to	  mark	  larger	  regions	  of	  active	  chromatin	  while	  others	  
like	  Histone	  2	  lysine	  27	  tri-­‐methylation	  and	  H3K4me3	  correspond	  to	  a	  more	  specific	  
function	  and	  localize	  to	  smaller	  genomic	  regions	  like	  promoters	  and	  enhancers.	  	  For	  
our	  studies,	  we	  took	  advantage	  of	  the	  latter	  and	  used	  H3K4me3	  as	  a	  marker	  to	  
identify	  locally	  active	  regions	  within	  P15	  Sertoli	  cells.	  	  	  Six	  databases	  were	  
generated	  using	  this	  mark,	  three	  corresponding	  to	  Sertoli	  cells	  and	  three	  
corresponding	  to	  Sertoli	  cell	  specific	  enrichment	  using	  myoid	  cells	  to	  filter	  out	  any	  
cross	  identified	  regions.	  	  Each	  database	  was	  generated	  using	  three	  genome	  builds:	  
unmasked,	  masked	  and	  a	  build	  containing	  only	  the	  upstream	  promoter	  region	  of	  
known	  genes.	  
We	  included	  the	  three	  different	  genome	  assemblies	  in	  our	  analysis.	  	  The	  
unmasked	  and	  masked	  genomes	  were	  each	  used	  to	  identify	  genome	  wide	  
association	  patterns	  associated	  with	  H3K4me3.	  	  The	  unmasked	  assembly	  contains	  
repetitive	  DNA	  sequence	  and	  was	  included	  because	  these	  regions	  are	  relevant	  to	  
genome	  function	  and	  transcriptional	  regulation	  (Kidwell	  and	  Lisch	  2000;	  
Waterston,	  Lindblad-­‐Toh	  et	  al.	  2002;	  Feschotte	  2008).	  	  Although	  relevant,	  repetitive	  
regions	  are	  often	  difficult	  to	  map	  as	  a	  single	  read	  may	  align	  to	  numerous	  repetitive	  
sites	  within	  the	  genome	  and	  alignment	  programs	  are	  only	  capable	  of	  aligning	  a	  
single	  read	  to	  a	  single	  location.	  	  This	  can	  cause	  over/under	  representation	  of	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enrichment	  at	  various	  locations.	  	  The	  inclusion	  of	  repetitive	  sequences	  in	  alignments	  
can	  also	  mask	  significant	  enrichment	  in	  non-­‐repetitive	  sequences	  when	  enrichment	  
levels	  are	  evaluated	  based	  on	  fold	  change	  between	  and	  input	  sample.	  	  For	  this	  
reason,	  we	  also	  included	  a	  masked	  genome	  assembly	  that	  did	  not	  contain	  repetitive	  
sequences.	  	  The	  third	  genome	  assembly	  that	  was	  included	  contained	  only	  genomic	  
sequence	  corresponding	  to	  1000	  bp	  upstream	  of	  transcriptional	  start	  sites.	  	  We	  
included	  this	  genome	  assembly	  to	  generate	  a	  list	  of	  enriched	  regions	  pertaining	  to	  
the	  5’	  flanking	  sequences	  of	  all	  known	  genes	  (~13,450).	  
For	  our	  analysis,	  we	  analyzed	  the	  H3K4me3	  enrichment	  patterns	  of	  two	  cell	  
types-­‐	  Sertoli	  and	  peritubular	  myoid	  cells.	  	  Both	  cell	  types	  are	  found	  within	  the	  
testis,	  but	  each	  play	  a	  very	  different	  role	  in	  testis	  function.	  	  Sertoli	  cells	  are	  found	  
within	  the	  tubules	  and	  foster	  the	  environment	  throughout	  spermatogenesis.	  	  
Around	  P15	  the	  Sertoli	  cells	  have	  ceased	  dividing	  and	  are	  terminally	  differentiating,	  
preparing	  for	  the	  initiation	  of	  spermatogenesis.	  	  Peritubular	  myoid	  cells	  are	  found	  
on	  the	  outside	  of	  the	  tubule.	  	  The	  role	  of	  the	  myoid	  cell	  is	  largely	  to	  assist	  in	  the	  
movement	  of	  fluid	  through	  the	  tubules.	  	  Myoid	  cells	  were	  included	  in	  this	  study	  as	  a	  
control	  to	  allow	  for	  the	  identification	  of	  Sertoli	  cell	  specific	  enriched	  H3K4me3.	  
Initial	  Sertoli	  cell	  analysis	  identified	  37,	  371,	  26,	  804	  and	  2,372	  enriched	  
regions	  in	  the	  unmasked,	  masked	  and	  1000	  bp	  upstream	  genome	  assemblies	  
respectively;	  and	  Myoid	  cell	  analysis	  identified	  59,441,	  27,509	  and	  2,015	  enriched	  
regions	  respectively.	  	  With	  respect	  to	  the	  unmasked	  genome,	  the	  myoid	  cell	  genome	  
contained	  31,932	  more	  enriched	  regions	  than	  the	  Sertoli	  cell	  genome.	  	  This	  is	  likely	  
explained	  by	  the	  differential	  differentiation	  states	  between	  the	  two	  cells.	  	  At	  P15	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Sertoli	  cells	  have	  undergone	  differentiation	  and	  are	  no	  longer	  actively	  dividing.	  	  As	  
such,	  they	  contain	  more	  heterochromatin	  that	  the	  actively	  dividing	  myoid	  cells.	  	  
Previous	  studies	  have	  indicated	  that	  H3K4me3	  enrichment	  is	  higher	  in	  euchromatic	  
vs.	  heterochromatic	  regions	  (Li,	  Wang	  et	  al.	  2008;	  Radman-­‐Livaja,	  Liu	  et	  al.	  2010;	  
Yin,	  Sweeney	  et	  al.	  2011).	  	  	  
Analysis	  of	  the	  1000	  bp	  5’	  flanking	  regions	  identified	  2,372	  enriched	  regions	  
in	  the	  Sertoli	  cells	  and	  2,015	  enriched	  regions	  in	  the	  myoid	  cells.	  	  Numerous	  studies	  
have	  indicated	  that	  enrichment	  of	  H3K4me3	  at	  promoters	  and	  across	  
transcriptional	  start	  sites	  denotes	  transcriptional	  activation.	  	  Published	  expression	  
data	  from	  the	  Griswold	  lab	  indicates	  that	  there	  are	  ~2,800	  expressed	  genes	  in	  P20	  
rat	  Sertoli	  cells	  indicating	  that	  there	  may	  be	  a	  correlation	  between	  expressed	  genes	  
and	  5’	  enrichment	  of	  H3K4me3	  within	  Sertoli	  and	  myoid	  cells	  as	  in	  other	  studies	  cell	  
types	  (McLean,	  Friel	  et	  al.	  2002).	  	  	  
To	  identify	  Sertoli	  cell	  specific	  H3K4me3	  enrichment,	  the	  Sertoli	  cell	  and	  
myoid	  cell	  datasets	  were	  compared	  and	  subtractive	  analysis	  identified	  22,914,	  9,777	  
and	  944	  enriched	  regions	  for	  the	  unmasked,	  masked	  and	  1000	  bp	  upstream	  genome	  
assemblies	  respectively.	  	  Previous	  studies	  have	  identified	  roughly	  700	  Sertoli	  cell	  
specific	  genes	  expressed	  at	  P22	  implying	  that	  a	  majority	  of	  the	  regions	  identified	  in	  
the	  unmasked	  and	  masked	  genome	  are	  likely	  intergenic	  (Ryser,	  Glauser	  et	  al.	  2011).	  	  
This	  also	  implies	  that	  some	  of	  the	  regions	  identified	  in	  the	  upstream	  promoter	  
region	  as	  Sertoli	  cell	  specific	  must	  be	  associated	  with	  silent	  or	  weakly	  expressed	  
genes.	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For	  analysis	  of	  specific	  regions	  within	  our	  databases,	  the	  top	  40	  regions	  were	  
selected	  based	  on	  the	  number	  of	  reads	  within	  the	  sample	  compared	  to	  a	  control	  
sample.	  	  Within	  the	  Sertoli	  cell	  unmasked	  and	  masked	  genome	  assembly	  datasets,	  
seven	  genes	  were	  cross-­‐identified	  (Mfsd8,	  Hn1l,	  Ptar1,	  Rad51c,	  Zfp40,	  Nup205	  and	  
RGD1303003)	  only	  three	  have	  been	  studied	  in	  reproductive	  tissues.	  	  Hn1l	  abundant	  
in	  testis	  and	  skeletal	  muscle	  during	  embryo	  development	  (Zhou,	  Wang	  et	  al.	  2004),	  
however	  its	  role	  within	  the	  testis	  has	  not	  been	  further	  explored.	  	  Zfp40	  transcripts	  
were	  identified	  in	  spermatogonia,	  spermatocytes,	  and	  in	  testis	  cords	  in	  the	  genital	  
ridge	  as	  well	  as	  in	  oocytes	  and	  follicle	  cells	  in	  the	  ovary(Noce,	  Fujiwara	  et	  al.	  1993),	  
however	  the	  role	  of	  Zfp40	  in	  Sertoli	  cells	  has	  not	  been	  studied.	  	  Rad51c	  is	  implicated	  
in	  breast	  and	  ovarian	  cancer	  and	  is	  involved	  in	  homologous	  recombination(Smeenk,	  
de	  Groot	  et	  al.	  2010;	  Zheng,	  Zhang	  et	  al.	  2010;	  Monsees,	  Kraft	  et	  al.	  2011),	  but	  its	  
role	  within	  Sertoli	  cells	  has	  not	  been	  explored.	  	  	  
Within	  the	  Sertoli	  cell	  specific	  database,	  the	  top	  candidate	  identified	  in	  both	  
the	  masked	  and	  unmasked	  genomes	  corresponds	  to	  a	  region	  that	  lies	  ~98kb	  from	  
the	  5’	  end	  of	  Lhcgr	  and	  ~140kb	  from	  the	  3’	  end	  of	  Fshr.	  	  Expression	  of	  both	  of	  these	  
genes	  is	  known	  for	  Sertoli	  cells	  and	  only	  Fshr	  is	  expressed	  within	  this	  cell	  type.	  	  The	  
upstream	  promoter	  region	  of	  Fshr	  was	  also	  identified	  within	  the	  Sertoli	  cell	  specific	  
database	  as	  the	  second	  most	  enriched	  region	  when	  compared	  to	  myoid	  cells.	  	  
Research	  indicates	  that	  the	  Fshr	  gene	  is	  likely	  regulated	  by	  an	  unidentified	  distal	  
regulatory	  element(Hermann,	  Hornbaker	  et	  al.	  2007),	  and	  the	  role	  of	  this	  region	  will	  
be	  further	  explored	  in	  Chapter	  4	  of	  this	  text.	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Expression	  data	  is	  not	  available	  at	  this	  time	  for	  P15	  Sertoli	  cells	  so	  GEO	  
expression	  databases	  were	  searched	  for	  gene	  expression	  profiles.	  	  Analysis	  of	  the	  
top	  40	  Sertoli	  cell	  specific	  genes	  identified	  by	  H3K4me3	  enrichment	  within	  the	  5’	  
flanking	  region	  indicates	  that	  all	  of	  the	  identified	  genes	  are	  expressed	  in	  E13	  Sertoli	  
cells.	  	  This	  implies	  that	  again	  that	  H3K4me3	  enrichment	  within	  upstream	  promoter	  
regions	  may	  correlate	  with	  gene	  expression	  in	  Sertoli	  cells.	  	  	  
It	  is	  important	  to	  note	  that	  while	  we	  often	  think	  of	  genomes	  as	  being	  
completely	  sequenced	  this	  is	  often	  on	  the	  case.	  	  While	  this	  data	  provides	  important	  
information	  regarding	  H3K4me3	  enrichment	  across	  the	  Rattus	  norvegicus	  genome,	  
the	  current	  rn5	  genome	  build	  is	  only	  ~90%	  complete.	  	  Currently	  there	  is	  no	  
sequence	  data	  for	  the	  Y	  chromosome	  in	  the	  current	  build	  and	  there	  are	  numerous	  
regions	  across	  other	  chromosomes	  that	  haven’t	  been	  fully	  sequenced.	  	  Thus,	  ChIP-­‐
Seq	  data	  will	  need	  to	  be	  realigned	  and	  reanalyzed	  with	  each	  new	  release	  of	  the	  
Rattus	  norvegicus	  genome.	  
Taken	  together	  these	  datasets	  provide	  a	  snapshot	  of	  H3K4me3	  within	  P15	  
Sertoli	  cells	  and	  support	  the	  idea	  that	  functional	  roles	  of	  H3K4me3	  identified	  in	  
other	  cell	  types	  may	  apply	  to	  Sertoli	  cells.	  	  These	  databases	  also	  highlight	  numerous	  
intergenic	  regions	  enriched	  with	  H3K4me3	  that	  may	  lead	  to	  the	  identification	  of	  
new	  regulatory	  regions	  important	  in	  Sertoli	  cell	  function.	  	  Future	  work	  combining	  
the	  H3K4me3	  enrichment	  profiles	  with	  a	  database	  highlighting	  gene	  expression	  will	  
also	  provide	  a	  powerful	  tool	  useful	  in	  the	  identification	  of	  genes	  and	  regulatory	  
regions	  important	  in	  Sertoli	  cell	  function	  and	  differentiation.	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Abstract	  
The	  follicle	  stimulating	  hormone	  receptor	  (FSHR)	  is	  a	  G-­‐protein	  coupled	  
receptor,	  which	  is	  responsible	  for	  conveying	  signals	  form	  the	  pituitary	  glycoprotein	  
FSH.	  	  its	  regulation	  is	  critical	  to	  physiologic	  response	  to	  FSH,	  and	  thus	  to	  gonad	  
development	  and	  regulation	  of	  fertility.	  	  To	  date,	  transcriptional	  mechanisms	  
responsible	  for	  its	  exquisite	  cell-­‐specificity	  remain	  poorly	  understood.	  	  Prior	  studies	  
have	  identified	  regulatory	  elements	  and	  their	  proteins	  that	  function	  through	  the	  
promoter	  region,	  but	  have	  provided	  few	  clues	  as	  to	  the	  mechanism	  of	  cell-­‐specific	  
expression.	  	  Previous	  studies	  have	  identified	  that	  regions	  outside	  the	  Fshr	  promoter	  
are	  responsible	  for	  driving	  cell-­‐specific	  expression	  of	  Fshr.	  	  As	  knowledge	  of	  gene	  
regulation	  progresses,	  key	  regulatory	  domains	  have	  been	  identified	  that	  lie	  outside	  
the	  proximal	  promoter,	  sometimes	  hundreds	  of	  kilobases	  away.	  	  Only	  recently	  have	  
technological	  advances	  provided	  sufficient	  tools	  to	  uncover	  these	  distal	  regulatory	  
elements.	  	  To	  help	  uncover	  distal	  regulatory	  elements	  that	  direct	  expression	  of	  Fshr,	  
we	  used	  a	  combination	  of	  bioinformatic	  and	  molecular	  assays.	  	  Comparative	  
genomics	  identified	  thirty-­‐one	  ECRs	  surrounding	  Fshr	  and	  histone	  modification	  
analysis	  identified	  a	  single	  site,	  ECR	  1f,	  indicative	  of	  Sertoli	  cell	  specific	  activity.	  	  
Transient	  transfection	  analysis	  of	  ECR	  1f	  in	  rat	  Sertoli	  and	  myoid	  cells	  demonstrate	  
that	  this	  region	  represses	  the	  Fshr	  promoter	  in	  vitro.	  Block	  deletion	  studies	  of	  ECR1f	  
identified	  a	  specific	  region	  of	  that,	  when	  deleted,	  eliminated	  the	  repressive	  action	  of	  
ECR1f	  on	  the	  Fshr	  promoter	  in	  vitro.	  	  EMSA	  analysis	  of	  this	  region	  identified	  two	  
protein-­‐binding	  sites,	  one	  site	  bound	  Gata4	  and	  another	  bound	  an	  unidentified	  
protein	  in	  vitro.	  	  Collectively,	  these	  studies	  have	  identified	  a	  potential	  cis-­‐regulatory	  
	   137	  
element	  capable	  of	  repressing	  the	  Fshr	  promoter	  in	  vitro.	  	  Future	  studies	  will	  
investigate	  the	  role	  these	  proteins	  play	  in	  transcriptional	  regulation	  of	  Fshr	  in	  vivo.	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Introduction	  
	  
	   Accurate	  signaling	  between	  the	  pituitary	  and	  the	  gonads	  is	  critical	  for	  
reproductive	  function	  and	  requires	  timely	  release	  of	  signaling	  molecules	  from	  the	  
pituitary	  and	  proper	  spatio-­‐temporal	  expression	  of	  their	  receptors	  on	  the	  target	  
cells.	  	  Within	  the	  hypothalamic–pituitary–gonadal	  axis,	  FSH	  is	  an	  important	  
glycoprotein	  hormone	  produced	  by	  the	  pituitary	  that	  specifically	  targets	  the	  gonads	  
by	  binding	  its	  receptor,	  follicle	  stimulating	  hormone	  receptor	  (FSHR),	  which	  is	  
expressed	  only	  on	  testicular	  Sertoli	  cells	  and	  ovarian	  granulosa	  cells.	  	  FSHR	  is	  a	  G	  
protein-­‐coupled	  receptor	  and	  the	  binding	  of	  FSH	  induces	  signaling	  cascades	  that	  
affect	  many	  cellular	  and	  physiological	  processes	  including	  cell	  division,	  
differentiation,	  follicle	  development,	  hormone	  secretion	  and	  fertility	  (Tindall,	  
Schrader	  et	  al.	  1974;	  Steinberger,	  Heindel	  et	  al.	  1975;	  Chemes,	  Dym	  et	  al.	  1979;	  
Handel	  and	  Eppig	  1979).	  	  Thus,	  proper	  reproductive	  function	  requires	  accurate	  
expression	  of	  Fshr.	  
	   In	  males,	  the	  physiologic	  role	  of	  FSHR	  and	  FSH	  differs	  with	  the	  
developmental	  sage	  of	  the	  testis.	  	  During	  early	  testis	  development	  (E13-­‐P15),	  FSH	  
induces	  proliferation	  of	  immature	  Sertoli	  cells,	  while	  later,	  around	  P15,	  the	  action	  of	  
FSHR	  action	  on	  Sertoli	  cells	  changes	  from	  supporting	  Sertoli	  cell	  proliferation	  to	  
supporting	  their	  differentiation	  (Murphy	  1965;	  Dorrington,	  Roller	  et	  al.	  1974;	  
Means	  and	  Huckins	  1974;	  Orth	  1984;	  Chaudhary,	  Whaley	  et	  al.	  1996).	  	  The	  period	  of	  
growth	  and	  the	  timing	  of	  differentiation	  are	  critical	  as	  the	  Sertoli	  cells	  cease	  dividing	  
prior	  to	  puberty	  and	  the	  final	  number	  of	  Sertoli	  cells	  sets	  the	  upper	  limit	  of	  sperm	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production	  by	  the	  testes	  (Steinberger	  and	  Steinberger	  1971).	  	  As	  Sertoli	  cell	  
proliferation	  ceases,	  proper	  differentiation	  ensures	  development	  of	  mature	  Sertoli	  
cells,	  which	  are	  critical	  for	  supporting	  spermatogenesis	  (Orth,	  Gunsalus	  et	  al.	  1988).	  	  	  
In	  the	  female,	  the	  primary	  role	  of	  FSH	  is	  to	  support	  folliculogenesis.	  	  Similar	  
to	  the	  testis,	  FSH	  targets	  a	  specific	  cell	  type	  within	  the	  ovary,	  the	  granulosa	  cells,	  and	  
supports	  the	  proliferation	  of	  Granulosa	  cells,	  a	  critical	  step	  in	  folliculogenesis.	  	  FSH	  
also	  plays	  a	  role	  in	  regulating	  the	  synthesis	  of	  aromatase,	  the	  key	  enzyme	  involved	  
in	  the	  conversion	  of	  testosterone	  to	  estradiol	  (Gore-­‐Langton	  and	  Dorrington	  1981).	  	  
Estradiol	  is	  the	  bioactive	  form	  of	  estrogen	  responsible	  for	  stimulating	  endometrial	  
growth	  prior	  to	  ovulation,	  a	  critical	  event	  for	  successful	  embryo	  implantation.	  	  
Defects	  in	  FSH	  signaling,	  either	  due	  to	  a	  pituitary	  or	  receptor	  issue,	  result	  in	  
complete	  infertility	  in	  the	  female,	  again	  highlighting	  the	  importance	  of	  this	  signaling	  
pathway	  and	  the	  proper	  expression	  of	  Fshr.	  
The	  goal	  of	  this	  project	  is	  to	  elucidate	  the	  transcriptional	  mechanisms	  
involved	  in	  cell	  specific	  activation	  of	  the	  follicle	  stimulating	  hormone	  receptor	  
(FSHR)	  gene.	  	  As	  discussed	  above,	  regulation	  of	  FSHR	  at	  a	  cellular	  level	  plays	  a	  
critical	  role	  in	  mediating	  the	  physiologic	  responses	  to	  FSH	  and	  thus	  correct	  spatio-­‐
temporal	  expression	  of	  Fshr,	  which	  requires	  specific	  regulatory	  elements	  within	  the	  
Fshr	  locus,	  is	  critical	  for	  proper	  cellular	  function.	  	  We	  are	  focusing	  our	  studies	  on	  
Fshr	  regulation	  in	  P15	  Sertoli	  cells,	  and	  we	  specifically	  want	  to	  identify	  the	  distal	  
regulatory	  region	  involved	  in	  correct	  spatio-­‐temporal	  expression	  of	  Fshr.	  	  	  
	   Since	  1992,	  when	  Fshr	  was	  first	  cloned,	  numerous	  studies	  have	  sought	  to	  
determine	  the	  transcriptional	  mechanisms	  behind	  its	  exquisite	  cell-­‐specificity	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(Heckert	  and	  Griswold	  1991;	  Heckert,	  Daley	  et	  al.	  1992;	  Gromoll,	  Dankbar	  et	  al.	  
1994;	  Linder,	  Heckert	  et	  al.	  1994;	  Findlay	  and	  Drummond	  1999;	  Heckert,	  Sawadogo	  
et	  al.	  2000;	  Heckert	  2001;	  Xing	  and	  Sairam	  2001;	  Xing	  and	  Sairam	  2002;	  Hermann	  
and	  Heckert	  2005;	  Wunsch,	  Ahda	  et	  al.	  2005;	  Hermann	  and	  Heckert	  2007;	  Zaidi,	  Zhu	  
et	  al.	  2007;	  Lu,	  Yang	  et	  al.	  2009;	  Perez-­‐Solis,	  Macias	  et	  al.	  2009).	  	  To	  date,	  studies	  
have	  identified	  several	  regulatory	  elements,	  and	  their	  cognate	  binding	  factors,	  
within	  the	  Fshr	  promoter	  region,	  but	  have	  yielded	  few	  clues	  about	  how	  cell-­‐specific	  
expression	  is	  achieved	  (Heckert,	  Sawadogo	  et	  al.	  2000;	  Heckert	  2001;	  Kim	  and	  
Griswold	  2001;	  Levallet,	  Koskimies	  et	  al.	  2001).	  	  Research	  has	  shown	  that	  the	  
elements	  identified	  within	  the	  promoter	  (-­‐5000	  bp)	  control	  basal	  transcription	  but	  
cannot	  direct	  correct	  spatio-­‐temporal	  expression	  of	  Fshr	  (Linder,	  Heckert	  et	  al.	  
1994).	  	  Transgenic	  animals	  carrying	  a	  5000	  bp	  promoter/reporter	  construct	  or	  a	  
413	  kb	  yeast	  artificial	  chromosome	  (YAC)	  containing	  the	  entire	  rat	  Fshr	  gene	  also	  
failed	  to	  restrict	  gene	  expression	  to	  Sertoli	  cells	  (Hermann,	  Hornbaker	  et	  al.	  2007).	  	  
Thus,	  our	  knowledge	  of	  Fshr	  transcription	  combined	  with	  more	  recent	  insight	  on	  
the	  role	  of	  distal	  elements	  suggests	  correct	  spatio-­‐temporal	  expression	  is	  controlled	  
by	  distal	  elements.	  	  	  
Current	  knowledge	  of	  cis-­‐acting	  regulatory	  elements	  shows	  they	  can	  lie	  
anywhere	  from	  a	  few	  hundred	  base	  pairs	  to	  1	  Mb	  away	  from	  the	  transcriptional	  
start	  site	  and	  function	  as	  enhancers,	  silencers	  and	  locus	  control	  regions	  (Amouyal	  
1991;	  Ruh,	  Dunn	  et	  al.	  1996;	  Ringrose,	  Chabanis	  et	  al.	  1999;	  Engel	  and	  Tanimoto	  
2000;	  Liu	  and	  Garrard	  2005;	  Wicks	  and	  Knight	  2011;	  Guo,	  Monahan	  et	  al.	  2012).	   
Physical	  interaction	  between	  the	  promoter	  and	  the	  cis-­‐regulatory	  regions	  are	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observed,	  indicating	  that	  chromatin	  looping	  occurs.	  	  Activation	  by	  cis-­‐regulatory	  
elements	  can	  occur	  by	  several	  mechanisms.	  	  Androgen	  receptor	  (AR)	  activation	  of	  
the	  Prostate	  specific	  antigen	  (PSA)	  enhancer	  element	  increases	  transcription	  by	  
recruiting	  RNA	  Polymerase	  II	  (RNA	  PolII)	  to	  the	  cis-­‐element,	  which	  then	  scans	  along	  
the	  DNA	  until	  the	  promoter	  region	  is	  reached	  and	  activated	  (Wang,	  Carroll	  et	  al.	  
2005).	  	  Within	  the	  beta-­‐globin	  locus,	  interactions	  between	  GATA-­‐1	  and	  FOG-­‐1	  
mediate	  the	  interaction	  between	  the	  locus	  control	  region	  (cis-­‐regulatory	  region)	  and	  
the	  beta-­‐globin	  promoter	  (Vakoc,	  Letting	  et	  al.	  2005).	  	  In	  all,	  there	  are	  growing	  list	  of	  
genes	  regulated	  by	  cis-­‐elements,	  and	  the	  mechanisms	  that	  regulate	  the	  long-­‐range	  
interactions	  are	  now	  being	  identified.	  
To	  identify	  potential	  cis-­‐regulatory	  elements	  important	  for	  cellular	  
specificity,	  the	  present	  study	  evaluated	  Fshr	  and	  its	  intergenic	  sequences	  for	  regions	  
of	  conservation	  and	  the	  presence	  of	  H3K4me3	  unique	  to	  Sertoli	  cells,	  using	  myoid	  
cells	  for	  comparison.	  	  These	  two	  techniques	  led	  to	  the	  identification	  of	  one	  
conserved	  region	  that	  was	  tested	  for	  function	  using	  in	  vitro	  transcription	  and	  DNA	  
binding	  assays.	  	  In	  vitro	  analysis	  identified	  a	  region	  repressive	  region	  within	  this	  cis-­‐
element	  that	  was	  capable	  of	  binding	  GATA-­‐4	  in	  vitro.	  	  Data	  derived	  from	  the	  current	  
studies	  adds	  to	  our	  understanding	  of	  the	  transcriptional	  mechanisms	  required	  for	  
Fshr	  expression,	  and	  how	  the	  receptor	  functions	  on	  a	  cellular	  level	  to	  regulate	  
gamete	  development	  and	  maintain	  fertility.	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Materials	  and	  Methods	  
Experimental	  Animals.	  	  All	  experiments	  using	  animals	  were	  approved	  by	  the	  
Institutional	  Animal	  Care	  and	  Use	  Committee	  of	  the	  University	  of	  Kansas	  Medical	  
Center	  (Protocol	  2009-­‐1850),	  and	  performed	  in	  accordance	  with	  the	  National	  
Institutes	  of	  Health	  Guide	  for	  the	  Care	  and	  Use	  of	  Laboratory	  Animals.	  
	  
Sertoli	  Cell	  and	  Myoid	  Cell	  Preparations.	  	  Sertoli	  and	  myoid	  cells	  were	  prepared	  
as	  previously	  described	  with	  slight	  modification	  (Steinberger,	  Heindel	  et	  al.	  1975;	  
Karl	  and	  Griswold	  1990).	  	  Tubules	  were	  isolated	  from	  P15	  Sprague	  Dawley	  rats	  and	  
processed	  through	  a	  series	  of	  digestions	  releasing	  the	  myoid	  cells	  which,	  following	  
centrifugation,	  remain	  in	  the	  supernatant	  while	  Sertoli	  cells	  and	  germ	  cells	  are	  
collected	  in	  the	  pellet.	  	  During	  the	  isolation,	  myoid	  cells	  were	  removed	  from	  the	  
tubules	  prior	  to	  complete	  digestion	  and	  subsequent	  release	  of	  the	  Sertoli	  and	  germ	  
cells.	  	  The	  majority	  of	  germ	  cells	  remaining	  in	  the	  culture	  after	  digestion	  are	  
spermatogonia	  as	  more	  advanced	  stages	  of	  germ	  cells	  are	  removed	  during	  tubule	  
digestion.	  	  Freshly	  isolated	  Sertoli	  cells	  were	  used	  fresh	  for	  ChIP	  assays	  and	  contain	  
a	  subpopulation	  of	  spermatogonia.	  	  For	  transfection	  analysis,	  Sertoli	  cells	  were	  and	  
cultured	  for	  two	  days,	  shocked	  with	  10	  mM	  Tris	  pH	  7.4	  for	  2-­‐4	  minutes	  to	  remove	  
germ	  cells,	  and	  transfected.	  	  Myoid	  cells	  were	  cultured	  and	  passaged	  once	  prior	  to	  
transfection.	  	  All	  cell	  cultures	  were	  incubated	  at	  37°C	  in	  5%	  CO2.	  	  	  
	  
ChIP.	  	  Chromatin	  was	  prepared	  as	  previously	  described	  with	  slight	  modifications	  
(Aparicio,	  Geisberg	  et	  al.	  2005).	  	  Prior	  to	  cross	  linking,	  Sertoli	  and	  myoid	  cells	  were	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counted	  to	  establish	  cell	  numbers	  for	  micrococcal	  nuclease	  digestion.	  	  To	  cross-­‐link	  
chromatin,	  primary	  rat	  Sertoli	  and	  myoid	  cells	  were	  and	  incubated	  in	  30	  mL	  cell	  
media	  containing	  1%	  Formaldehyde	  for	  10	  minutes	  at	  room	  temperature.	  	  Cross-­‐
linking	  was	  stopped	  by	  the	  addition	  of	  2.5	  M	  glycine	  to	  a	  final	  concentration	  of	  
125mM.	  	  Cells	  were	  pelleted	  and	  washed	  two	  times	  in	  10	  mL	  ice-­‐cold	  PBS	  containing	  
freshly	  prepared	  Protease	  Inhibitors	  (Roche,	  South	  San	  Francisco,	  CA).	  	  Cell	  pellets	  
were	  then	  washed	  three	  times	  in	  20	  mL	  ice-­‐cold	  MC	  lysis	  buffer	  (10mM	  Tris-­‐HCl	  pH	  
7.5,	  10mM	  NaCl,	  3mM	  MgCl2,	  0.5%	  NP-­‐40)	  and	  incubated	  on	  ice	  for	  10	  minutes	  
during	  the	  third	  wash.	  	  After	  the	  final	  wash	  was	  complete	  the	  cell	  pellets	  were	  
vortexed	  (setting	  3)	  for	  three	  minutes.	  	  The	  cells	  were	  pelleted,	  the	  supernatant	  
removed	  and	  the	  pellet	  frozen	  by	  immersion	  in	  liquid	  nitrogen.	  	  The	  pellets	  were	  
then	  thawed	  in	  an	  ice-­‐water	  bath,	  resuspended	  to	  4	  x	  107	  cells/mL	  in	  MNase	  buffer	  
(10mM	  Tris-­‐HCl	  pH	  7.5,	  10mM	  NaCl,	  3mM	  MgCl2,	  1mM	  CaCl2,	  4%	  NP-­‐40)	  and	  
disrupted	  using	  10	  strokes	  with	  a	  Type	  B	  pestle	  in	  an	  ice-­‐cold	  Dounce	  homogenizer	  
to	  release	  chromatin.	  	  Chromatin	  suspensions	  were	  diluted	  with	  cold	  MNase	  buffer	  
to	  a	  final	  concentration	  of	  2	  x	  107	  cells/mL,	  Micrococcal	  nuclease	  (New	  England	  
BioLabs	  M0247S)	  was	  added	  (120U	  per	  2	  x	  106	  cells)	  and	  extracts	  were	  incubated	  
for	  30	  minutes	  at	  37°C.	  	  Nuclease	  digestion	  was	  stopped	  by	  the	  addition	  of	  (final	  
concentration):	  	  6mM	  EGTA,	  1x	  protease	  inhibitors	  (Roche,	  South	  San	  Francisco,	  
CA),	  10%	  SDS	  and	  200mM	  NaCl.	  	  Chromatin	  samples	  were	  aliquoted	  to	  1	  x	  107	  cells	  
(~500	  µl)	  and	  stored	  at	  -­‐80°C.	  	  Rat	  Sertoli	  and	  myoid	  chromatin	  was	  used	  for	  ChIP	  
at	  an	  equivalent	  of	  1	  x	  107	  cells	  per	  immunoprecipitation	  sample.	  	  	  Chromatin	  
samples	  were	  thawed	  and	  cleared	  with	  75	  µl	  of	  a	  50%	  slurry	  of	  Salmon	  sperm-­‐
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blocked	  protein	  A-­‐agarose	  beads	  (Millipore	  16-­‐157)	  for	  one	  hour	  at	  4°C	  with	  
rotation.	  	  Agarose	  beads	  were	  then	  pelleted	  by	  centrifugation	  for	  one	  minute	  at	  
3900	  x	  g	  at	  4°C	  and	  the	  supernatants	  transferred	  to	  new	  tubes.	  	  The	  following	  
antibodies	  were	  purchased	  and	  used	  for	  immunoprecipitation:	  	  Anti-­‐acetyl-­‐Histone	  
H4	  (Lys5,	  8,	  12,	  16)	  (Millipore	  06-­‐866);	  Anti-­‐trimethyl-­‐Histone	  H3	  (Lys4)	  (Millipore	  
07-­‐473);	  Anti-­‐trimethyl-­‐Histone	  H3	  (Lys27)	  (Millipore	  07-­‐449),	  IgG	  (Santa	  Cruz	  SC-­‐
2027),	  Anti-­‐dimethyl-­‐Histone	  H3	  (Lys9)	  (Millipore	  07-­‐441)	  and	  Anti-­‐acetyl-­‐Histone	  
H3	  (Millipore	  06-­‐599).	  	  Five	  micrograms	  of	  primary	  antibody	  was	  added	  to	  the	  
supernatants	  and	  the	  samples	  incubated	  at	  4°C	  for	  18	  hours.	  	  Complex	  were	  
precipitated	  with	  100	  µl	  of	  protein	  A-­‐agarose	  slurry	  and	  incubated	  for	  one	  hour	  at	  
4°C	  with	  rotation.	  	  Chromatin	  and	  agarose	  beads	  were	  then	  transferred	  to	  Spin-­‐X	  
tubes	  (Corning,	  Tewksbury	  MA-­‐#8160)	  for	  washing.	  	  Each	  wash	  (600	  µl)	  was	  
preformed	  for	  five	  minutes	  at	  RT	  on	  a	  rotator,	  followed	  by	  a	  one-­‐minute	  spin	  at	  300	  
x	  g.	  	  Wash	  conditions	  were	  as	  follows:	  1	  x	  Low	  Salt	  Wash	  (20mM	  Tris	  pH	  8.1,	  
150mM	  NaCl,	  2mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%	  SDS,	  protease	  inhibitors),	  1	  x	  High	  
Salt	  Wash	  (20mM	  Tris	  pH	  8.1,	  500mM	  NaCl,	  2mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%	  
SDS,	  protease	  inhibitors),	  1	  x	  LiCl	  Wash	  (10mM	  Tris	  pH	  8.1,	  250mM	  LiCl,	  1%	  NP-­‐40,	  
1%	  Na	  Deoxycholate,	  1mM	  EDTA,	  protease	  inhibitor),	  2	  x	  TE	  wash	  (10mM	  Tris	  pH	  
8.0,	  1mM	  EDTA,	  protease	  inhibitor).	  	  Chromatin	  elution	  was	  achieved	  by	  incubating	  
the	  agarose	  beads	  in	  200	  µl	  Elution	  buffer	  (100mM	  NaHCO3,	  1%	  SDS)	  for	  15	  
minutes	  at	  RT	  with	  rotation.	  	  Supernatant	  was	  collected	  and	  NaCl	  added	  to	  a	  final	  
concentration	  of	  200mM.	  	  Samples	  were	  then	  incubated	  at	  65°C	  for	  four	  hours	  to	  
reverse	  the	  cross-­‐links.	  	  Twenty	  micrograms	  of	  Proteinase-­‐K	  was	  added	  and	  the	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buffer	  concentration	  increased	  to	  50mM	  Tris	  and	  10mM	  EDTA.	  	  Samples	  were	  
incubated	  for	  one	  hour	  at	  45°C.	  	  DNA	  was	  isolated	  using	  the	  ChIP	  DNA	  Clean	  and	  
Concentrator	  Kit	  (Zymo	  Research	  D5205)	  and	  eluted	  in	  50	  µl	  TE.	  	  Prior	  to	  Illumina	  
sequencing,	  each	  ChIP-­‐DNA	  sample	  was	  first	  analyzed	  to	  assess	  quality	  via	  qPCR	  
using	  an	  Applied	  Biosystems	  7900HT	  Fast	  Real-­‐Time	  PCR	  System.	  	  Each	  reaction	  
was	  preformed	  in	  triplicate	  and	  contained	  one	  microliter	  ChIP	  DNA,	  five	  microliters	  
SyberGreen	  Master	  Mix	  (Applied	  Biosystems),	  and	  300	  nM	  forward	  and	  reverse	  
primer.	  	  Primers	  for	  the	  Fshr	  promoter	  are	  FHSR	  Prom	  F	  5’-­‐
TTTACTTGCCTGGAAGCGACTAA-­‐3’	  AND	  FSHR	  Prom	  R	  5’-­‐GCTTGGAGAACGGGCAAA-­‐
3’	  and	  for	  the	  Nrxn1	  promoter	  are	  Nrxn1	  Prom	  F	  5’-­‐
GGGAGGAATCTGATCACTGTACTGT-­‐3’	  AND	  Nrnx1	  Prom	  R	  5’-­‐
CATGATCTTCCCAATTGTCCAA-­‐3’.	  	  The	  standard	  cycle	  was	  used,	  without	  any	  
changes	  to	  the	  default	  parameters.	  	  A	  dissociation	  curve	  was	  run	  following	  the	  final	  
cycle	  to	  determine	  if	  contamination	  was	  present.	  	  	  The	  SDS	  Software	  package	  2.4	  
(Applied	  Biosystems)	  was	  used	  to	  calculate	  the	  cycle	  threshold	  (Ct)	  value	  for	  each	  
primer	  set,	  which	  were	  adjusted	  such	  that	  the	  threshold	  was	  set	  at	  the	  initial	  phase	  
of	  linear	  PCR	  amplification.	  	  Data	  was	  exported	  to	  a	  Microsoft	  Excel	  spreadsheet	  and	  
analyzed	  as	  a	  percent	  of	  the	  input	  sample	  [100*2^(Adjusted	  input	  -­‐	  Ct	  sample)].	  	  
Adjusted	  input	  was	  calculated	  based	  on	  the	  Ct	  value	  of	  the	  1%	  input	  sample.	  	  qPCR	  
was	  also	  used	  to	  verify	  regions	  identified	  by	  next	  generation	  sequencing	  as	  listed	  
above.	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ChIP-­‐DNA	  Sequencing.	  	  ChIP	  DNA	  samples	  from	  two	  independent	  samples	  were	  
pooled,	  analyzed	  via	  qPCR,	  dried	  and	  shipped	  to	  Cofactor	  Genomics	  LLC	  (St.	  Louis,	  
MO)	  for	  library	  preparation	  and	  sequencing.	  	  Samples	  were	  prepared	  following	  
Illumina	  library	  preparation	  protocols	  by	  Cofactor	  and	  sequenced	  on	  the	  Illumina	  
GAIIx.	  	  The	  NEBNext®	  ChIP-­‐Seq	  Library	  Prep	  Reagent	  Set	  for	  Illumina®	  (New	  
England	  Biolabs),	  was	  used	  by	  Cofactor	  to	  prepare	  all	  samples	  for	  sequencing.	  	  	  	  
Briefly,	  10	  ng	  ChIP	  DNA	  was	  treated	  with	  klenow	  and	  T4	  DNA	  Polymerase	  to	  repair	  
fragmented	  ends,	  cleaned	  and	  ligated	  to	  the	  NEBNext	  Adaptor	  sequence.	  	  The	  DNA	  
was	  then	  cleaned	  and	  PCR	  amplified	  for	  15	  cycles	  using	  the	  NEBNext	  High-­‐Fidelity	  
2X	  PCR	  Master	  Mix	  and	  Universal	  PCR	  Primers	  per	  the	  manufacturers	  protocol.	  	  The	  
resultant	  library	  was	  cleaned	  using	  AMPure	  XP	  Beads,	  diluted	  and	  analyzed	  on	  the	  
Agilent	  Bioanalyzer.	  	  Twenty	  picomoles	  of	  Library	  DNA	  were	  prepared	  for	  
sequencing	  using	  the	  Illumina	  Cluster	  station.	  	  This	  ligated	  a	  llumina-­‐supplied	  
adapter	  sequence	  to	  one	  end	  of	  the	  DNA	  fragment,	  amplified	  the	  DNA	  clusters	  and	  
hybridized	  the	  DNA	  to	  the	  flow-­‐cell.	  	  The	  flow-­‐cell	  was	  then	  loaded	  onto	  the	  Genome	  
Analyzer	  IIx.	  	  Sequencing	  data	  output	  was	  in	  FASTQ	  files.	  	  
	  	  
Processing	  and	  Analysis	  of	  Sequencing	  Data.	  	  ChIP-­‐Seq	  data	  was	  analyzed	  
through	  the	  K-­‐INBRE	  Bioinformatics	  Core,	  University	  of	  Kansas,	  by	  Aaron	  Smalter	  
Hall,	  Ph.D.	  	  FASTQ	  files	  representing	  eight	  lanes	  of	  single-­‐end	  Illumina	  ChIP-­‐Seq	  
sequence	  tags	  produced	  by	  Cofactor	  Genomics	  were	  analyzed.	  	  	  FastQC	  (Babraham	  
Bioinformatics-­‐http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)	  was	  
used	  to	  test	  the	  quality	  of	  the	  sequence	  data	  for	  each	  sample	  prior	  to	  alignment.	  	  
	   147	  
FastQC	  is	  a	  quality	  control	  application	  for	  high	  throughput	  sequence	  data	  that	  
provides	  an	  interactive	  application	  to	  review	  the	  results	  of	  several	  different	  QC	  
checks	  relating	  to	  the	  quality	  of	  sequence	  tags.	  	  The	  Trim	  Galore!	  (Babraham	  
Bioinformatics	  -­‐http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/)	  
tool	  was	  used	  to	  trim	  low-­‐quality	  base	  pairs,	  the	  Illumina	  primer	  and	  known	  
adapter	  sequences	  using	  the	  following	  parameters:	  	  Quality	  Phred	  score	  cutoff:	  51,	  
Quality	  encoding	  type	  selected:	  ASCII+64,	  Adapter	  sequence:	  
'GATCGGAAGAGCGGTTCAGCAGGAATGCCG',	  Maximum	  trimming	  error	  rate:	  0.1	  
(default),	  Minimum	  required	  adapter	  overlap	  (stringency):	  1	  bp	  and	  Minimum	  
required	  sequence	  length	  before	  a	  sequence	  gets	  removed:	  20	  bp.	  	  The	  following	  
command	  line	  was	  used:	  -­‐f	  fastq	  -­‐e	  0.1	  -­‐q	  51	  -­‐O	  1	  -­‐a	  
GATCGGAAGAGCGGTTCAGCAGGAATGCCG	  ‘file	  name’.fq.	  	  Removal	  of	  duplicate	  
sequence	  tag	  was	  performed	  using	  the	  "rmdup"	  module	  in	  the	  Samtools	  package	  
(Sourceforge.net-­‐	  http://samtools.sourceforge.net/).	  	  The	  BWA	  alignment	  tool	  
(Sourceforge.net-­‐	  http://bio-­‐bwa.sourceforge.net/)	  was	  used	  to	  align	  the	  resulting	  
files	  to	  the	  latest	  build	  of	  the	  Rattus	  norvegicus	  genome	  (rn5,	  May	  2012)	  using	  the	  
default	  parameters.	  	  Alignment	  was	  performed	  against	  two	  base	  library	  builds	  –	  a	  
‘Soft	  Masked’	  and	  a	  ‘Hard	  Masked’.	  The	  soft	  masked	  file	  contains	  the	  entire	  rn5	  
genome	  with	  repeat	  region	  denoted	  by	  lower	  case	  font	  while	  the	  hard	  masked	  
genome	  masks	  all	  repeat	  regions	  to	  N’s.	  	  These	  will	  be	  referred	  to	  as	  Unmasked	  and	  
Masked	  respectively.	  	  Visualization	  of	  the	  mapped	  sequence	  tags	  was	  achieved	  using	  
the	  UCSC	  Genome	  Browser	  using	  the	  BED,	  BEDGraph	  and	  BigWig	  file	  formats.	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UCSC	  Genome	  Browser	  Custom	  Track	  Settings.	  	  	  To	  visualize	  the	  aligned	  
sequence	  tags,	  bigwig	  files	  were	  imported	  into	  the	  UCSC	  Genome	  Browser	  using	  the	  
‘add	  custom	  track’	  feature.	  	  The	  bigWig	  format	  is	  for	  display	  of	  dense,	  continuous	  
data	  that	  will	  be	  displayed	  in	  the	  Genome	  Browser	  as	  a	  graph.	  	  Each	  track	  was	  
imported	  based	  on	  the	  alignment	  of	  the	  sequence	  tag,	  i.e.	  positive	  or	  negative	  strand	  
alignment.	  	  The	  following	  import	  command	  was	  used:	  track	  type=bigWig	  name="file	  
name"	  description=""	  bigDataUrl=http://[ftp	  location	  of	  file].	  	  Visualization	  settings	  
were	  set	  as	  follows-­‐	  Display	  mode:	  Full,	  Type	  of	  graph:	  bar,	  Track	  height:	  40	  pixels,	  
Vertical	  viewing	  range:	  min-­‐1	  max-­‐30,	  Data	  view	  scaling:	  use	  vertical	  viewing	  range	  
setting,	  Always	  include	  zero:	  off,	  Transform	  function:	  Transform	  data	  point	  by:	  
None,	  Window	  function:	  maximum,	  Smoothing	  window:	  off,	  Dray	  y	  indicator	  lines:	  
at	  y=0.0:	  off	  at	  y=0	  off.	  	  
	  
Transfection	  Vectors.	  	  Vector	  inserts	  for	  ECR	  1f,	  ECR	  1f-­‐a	  and	  1f-­‐b	  and	  ECR	  1f	  
Block	  Deletions	  were	  PCR	  amplified	  (primers	  listed	  in	  Table	  4-­‐1)	  from	  rat	  genomic	  
DNA	  using	  iProof	  polymerase	  and	  PCR	  (98	  C	  denaturing	  temperature,	  annealing	  66	  
C,	  30’	  x	  35	  cycles,	  and	  72	  C	  extension).	  	  The	  ECR	  1f	  a/b	  clone	  was	  generated	  by	  
restriction	  digest	  and	  ligation	  of	  the	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  fragments	  using	  a	  
BamHI.	  	  Vectors	  for	  the	  Footprint	  mutations	  were	  amplified	  via	  Fusion	  PCR.	  	  Briefly,	  
5’	  and	  3’	  PCR	  fragments	  were	  fused	  by	  PCR	  (98	  C	  denature,	  60	  C	  anneal	  for	  1	  minute,	  
72	  C	  extension	  for	  3	  minutes	  –	  for	  3	  cycles),	  ECR	  1f-­‐SacI	  F	  and	  ECR	  1f-­‐SacI	  R	  primers	  
were	  added	  and	  the	  templates	  amplified	  (98	  C	  denaturing	  temperature,	  annealing	  
66	  C,	  30’	  x	  35	  cycles,	  and	  72	  C	  extension).	  	  All	  digests	  used	  Fermentas	  Fast	  Digest	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restriction	  enzymes	  (SacI,	  KpnI,	  BamHI	  and	  NdeI)	  and	  cloned	  into	  a	  pGL3-­‐Basic	  
vector,	  a	  3:1	  insert	  to	  vector	  ratio,	  containing	  either	  a	  -­‐220/+123	  or	  -­‐2700/+123	  bp	  
fragment	  of	  the	  FSHR	  promoter	  in	  both	  5’	  (SacI	  and	  KpnI)	  and	  3’	  orientation	  
(BamHI)	  (Figure	  4-­‐1)	  (Heckert,	  Daggett	  et	  al.	  1998).	  	  400,000	  units	  of	  T4	  DNA	  ligase	  
(New	  England	  Biological)	  were	  used	  to	  ligate	  the	  insert	  and	  vector.	  	  Constructs	  were	  
transformed	  to	  DH5	  alpha	  competent	  cells,	  spread	  on	  LB+Ampicillin	  culture	  plates	  
and	  allowed	  to	  grow	  overnight	  at	  37°C.	  Plasmids	  used	  for	  transient	  transfections	  
were	  prepared	  using	  the	  GeneJET	  Plasmid	  Miniprep	  kit	  (Fermentas,	  Maryland,	  MD),	  
and	  confirmed	  by	  restriction	  nuclease	  digestion	  and	  DNA	  sequencing.	  	  
	  
Statistical	  Analysis.	  	  Statistical	  analysis	  was	  performed	  using	  GraphPad	  Prism	  6.0.	  	  
For	  transient	  transfection	  analysis,	  ANOVA	  was	  used	  to	  determine	  statistical	  
significance	  using	  the	  base	  vector	  (-­‐220/+123	  or	  -­‐2700/+123)	  as	  the	  control.	  	  
Sertoli	  and	  Myoid	  cell	  transfections	  were	  analyzed	  using	  two-­‐way	  ANOVA	  and	  MSC1	  
cell	  transfections	  were	  analyzed	  using	  one-­‐way	  ANOVA.	  	  ChIP-­‐qPCR	  data	  was	  
analyzed	  using	  one-­‐way	  ANOVA,	  statistical	  significance	  was	  determined	  using	  the	  
IgG	  sample	  as	  the	  control.	  	  For	  all	  analyses,	  statistical	  significance	  is	  marked	  on	  the	  
graphs	  using	  asterisks	  as	  follows,	  	  *	  =	  p-­‐value≤0.05,	  	  **	  =	  p-­‐value≤0.01,	  ***	  =	  p-­‐
value≤0.001	  and	  ****	  =	  p-­‐value≤0.0001	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Sertoli	  and	  Myoid	  cell	  Transfections.	  	  Sertoli	  and	  myoid	  cells	  were	  transfected	  as	  
previously	  described	  (Karl	  and	  Griswold	  1990;	  Heckert,	  Daggett	  et	  al.	  1998;	  Chen	  
and	  Heckert	  2001;	  Lei	  and	  Heckert	  2002).	  	  Sertoli	  cells	  were	  plated	  directly	  into	  24	  
well	  plates	  at	  a	  density	  of	  ~	  1.6	  mg	  testes	  (based	  on	  the	  starting	  testes	  weight)	  per	  
well.	  	  Forty-­‐eight	  hours	  after	  plating,	  the	  cells	  were	  shocked	  with	  10	  mM	  Tris	  (pH	  
7.4)	  for	  two	  minutes	  to	  remove	  germ	  cells,	  and	  allowed	  to	  recover	  for	  at	  least	  2	  
hours	  in	  fresh	  culture	  media.	  	  Immediately	  prior	  to	  transfection,	  the	  culture	  media	  
was	  removed	  and	  400	  µl	  Dulbecco's	  Modified	  Eagle	  Medium	  (Sigma-­‐Aldrich,	  St.	  
Louis,	  MO),	  without	  added	  supplements,	  was	  added	  to	  each	  well.	  	  For	  each	  well,	  300	  
ng	  plasmid	  DNA	  and	  10	  ng	  Renilla	  (pHRL-­‐TK)	  was	  incubated	  with	  1.5	  µl	  
Lipofectamine	  and	  2ul	  Plus	  Reagent	  three	  hours	  at	  37°C.	  	  Cells	  were	  fed	  3	  hours	  
later	  with	  300	  µl	  straight	  DMEM.	  	  Prior	  to	  transfection,	  myoid	  cells	  were	  passaged	  
twice	  and	  then	  plated	  in	  24	  well	  plates	  at	  a	  density	  of	  52,000	  cells	  per	  well.	  	  
Eighteen	  hours	  after	  plating	  the	  cell	  media	  was	  changed	  to	  straight	  DMEM	  and	  cells	  
were	  transfected	  using	  100	  ng	  plasmid	  DNA,	  10	  ng	  Renilla	  (pHRL-­‐TK),	  1ul	  
Lipofectamine	  and	  1ul	  Plus	  per	  well	  and	  incubated	  overnight	  37°C,	  18	  hours	  later	  
the	  transfection	  media	  was	  removed	  and	  the	  cells	  were	  fed	  with	  1	  ml	  complete	  
media.	  	  	  Seventy-­‐two	  hours	  after	  transfection,	  cells	  were	  lysed	  and	  assayed	  using	  the	  
Dual-­‐Luciferase®	  Reporter	  Assay	  System	  (Promega,	  Madison)	  for	  both	  firefly	  and	  
Renilla	  following	  the	  manufactures	  instructions.	  	  	  
	  
Nuclear	  Extract	  Preparation.	  	  Rat	  Sertoli	  cell	  nuclear	  extracts	  were	  prepared	  from	  
rat	  Sertoli	  cells	  isolated	  as	  described	  in	  Chapter	  2.	  Cells	  were	  washed	  with	  ice-­‐cold	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PBS,	  followed	  by	  a	  wash	  with	  five	  milliters	  of	  HEGD	  (25	  mM	  HEPES	  pH	  7.4,	  1	  mM	  
DTT,	  1.5mM	  EDTA	  pH	  8.0,	  10	  %	  glycerol,	  0.5	  mM	  PMSF).	  	  Pellet	  resuspension	  was	  in	  
in	  10	  mL	  HEDG	  for	  Sertoli	  cells	  and	  6	  mL	  HEDG	  for	  myoid	  cells.	  	  Cell	  lysis	  was	  
achieved	  using	  an	  ice-­‐cold	  Dounce	  homogenizer-­‐	  30	  strokes	  with	  a	  type	  B	  pestle.	  	  
Cellular	  suspensions	  were	  transferred	  to	  cold	  1.5	  mL	  microcentrifuge	  tubes	  and	  
nuclei	  pelleted	  via	  centrifugation	  at	  16,000	  x	  g	  for	  one	  minute	  at	  4°C.	  	  Supernatants	  
were	  removed	  and	  nuclear	  pellets	  were	  resuspended	  in	  ice-­‐cold	  HEGDK	  (25	  mM	  
HEPES	  pH	  7.9,	  1	  mM	  DTT,	  1.5mM	  EDTA	  pH	  8.0,	  10	  %	  glycerol,	  0.5M	  KCl,	  0.5	  mM	  
PMSF)	  at	  a	  1:1	  ratio.	  	  Suspensions	  were	  mixed	  with	  a	  pipette	  tip,	  vortexed,	  and	  
incubated	  on	  ice	  for	  one	  hour.	  	  Nuclear	  debris	  was	  removed	  by	  centrifugation	  at	  
100,000	  x	  g	  for	  six	  minutes	  at	  4°C.	  	  Supernatants	  were	  aliquoted	  and	  stored	  at	  -­‐80°C.	  	  
Protein	  concentration	  was	  determined	  by	  Bradford	  assays	  (BIO-­‐RAD,	  Hercules,	  CA)	  
following	  the	  manufacturers	  protocol.	  	  	  
	  
DNase	  I	  Footprinting	  Analysis.	  
Probe	  preparation	  
	   DNase	  I	  footprinting	  was	  performed	  on	  a	  5′-­‐32P-­‐labeled	  PCR	  amplicon	  
(Figure	  4-­‐2).	  	  Adenosine	  5’-­‐triphosphate	  [γ-­‐32P]	  label	  was	  added	  to	  PCR	  primers	  
(Table	  4-­‐2)	  using	  T4	  polynucleotide	  kinase	  (Thermo	  EK0031)	  as	  per	  manufacturers	  
instructions.	  	  40	  pmol	  forward	  primer	  was	  incubated	  in	  10	  µl	  PNK	  buffer	  (500	  mM	  
Tris-­‐HCl	  (pH	  7.6	  at	  25°C),	  100	  mM	  MgCl2,	  50	  mM	  DTT,	  1	  mM	  spermidine)	  containing	  
50	  µCi	  adenosine	  5’-­‐triphosphate	  [γ-­‐32P]	  and	  10	  U	  Polynucleotide	  kinase	  for	  30	  
minutes	  at	  37°C	  followed	  by	  a	  five	  minute	  incubation	  at	  95°C.	  PCR	  amplification	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with	  a	  5’	  radiolabelled	  and	  an	  unlabeled	  3’	  primer	  generated	  probes	  for	  
Footprinting.	  	  PCR	  reactions	  (50µl)	  contained:	  1x	  OptiBuffer	  (Bioline,	  Taunton,	  MA),	  
four	  picomoles	  of	  radiolabelled	  forward	  primer,	  12.5	  pmol	  reverse	  primer,	  50mM	  
MgCl2,	  25mM	  dNTP’s,	  50	  ng	  plasmid	  DNA	  and	  four	  units	  BIO-­‐X-­‐ACT	  Long	  DNA	  
Polymerase	  (Bioline,	  Taunton,	  MA-­‐#BIO-­‐21049).	  	  Reactions	  were	  denatured	  for	  five	  
minutes	  at	  95°C	  followed	  by	  35	  amplification	  cycles	  of	  95°C,	  30	  s;	  56°C,	  30	  s;	  72°C	  
30	  s.	  	  A	  PCR	  cleanup	  kit	  (Qiagen,	  Germantown,	  MD	  -­‐#	  28104)	  purified	  radiolabelled	  
PCR	  products.	  	  Specific	  activity	  was	  measured	  using	  a	  scintillation	  counter	  and	  
probes	  were	  diluted	  to	  a	  final	  ‘concentration’	  of	  ~50,000	  cpm/µl.	  	  
Ladder	  preparation	  
	   The	  Sequenase	  Version	  2.0	  DNA	  Sequencing	  Kit	  (Affymetrix,	  Santa	  Clara,	  CA	  -­‐
#	  70770)	  was	  used	  to	  prepare	  DNA	  sequencing	  ladders	  as	  per	  manufacturers	  
instructions.	  	  0.5	  pmol	  plasmid	  DNA	  containing	  the	  rat	  ECR	  1f	  sequence	  was	  
denatured	  and	  incubated	  with	  0.5	  pmol	  forward	  primer	  in	  10µl	  (fv)	  Sequenase	  
reaction	  buffer	  (200mM	  Tris-­‐HCl	  pH.7.5,	  100mM	  MgCl2,	  250mM	  NaCl).	  	  Primer	  
annealing	  was	  achieved	  by	  heating	  DNA/primer	  mix	  to	  95°C	  for	  five	  minutes	  
followed	  by	  five	  minutes	  at	  56°C	  in	  a	  PCR	  machine.	  	  Annealed	  template	  was	  placed	  
directly	  on	  ice	  and	  used	  immediately	  for	  ladder	  generation.	  	  0.1	  M	  DTT,	  labeling	  mix,	  
5	  µCi	  [α-­‐32P]dATP	  and	  Sequenase	  Polymerase	  were	  incubated	  for	  two	  minutes	  at	  
room	  temperature.	  	  3.5	  µl	  was	  transferred	  to	  new	  tubes	  containing	  termination	  mix	  
(dideoxy	  nucleotide)	  and	  incubated	  for	  five	  minutes	  at	  37°C.	  Four	  microliters	  of	  stop	  
solution	  was	  added	  immediately	  to	  terminate	  the	  reaction	  and	  the	  samples	  were	  
frozen	  at	  -­‐20°C	  until	  needed.	  The	  Sequenase	  kit	  (Affymetrix,	  Santa	  Clara,	  CA)	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contained	  all	  necessary	  buffers	  and	  enzymes.	  	  For	  electrophoresis,	  ladder	  preps	  
were	  heated	  to	  75°C	  for	  five	  minutes	  prior	  to	  loading.	  
DNaseI	  Digestion	  -­‐	  Footprinting	  
	   Eighty	  microliters	  of	  reaction	  buffer	  (10mM	  HEPES	  pH	  7.9,	  40	  mM	  KCl,	  2	  mM	  
MgCl2,	  5%	  glycerol)	  containing	  20mM	  DTT,	  1	  µg	  poly(dI:dC),	  labeled	  probe	  
(~50,000	  CPM),	  nuclear	  extract	  and	  DNaseI	  (Worthington,	  Lakewood,	  NJ	  -­‐
#LS006333)	  was	  used	  for	  each	  footprinting	  reaction.	  	  DNase	  concentration,	  nuclear	  
extract	  concentration	  and	  digest	  time	  varied,	  see	  Table	  4-­‐3.	  	  Samples	  were	  
incubated	  at	  room	  temperature	  for	  the	  allotted	  time	  and	  digests	  were	  stopped	  by	  
the	  addition	  of	  200	  µl	  Tris-­‐saturated	  Phenol	  and	  vortexed	  on	  max	  setting	  for	  10	  
seconds.	  	  120µl	  water	  was	  added,	  vortexed	  and	  samples	  were	  centrifuged	  for	  10	  
minutes	  at	  16,000	  x	  g.	  	  The	  aqueous	  phase	  was	  transferred	  to	  a	  clean	  tube	  and	  re-­‐
extracted	  with	  a	  1:1	  mixture	  of	  phenol:chloroform,	  twice.	  	  A	  final	  chloroform	  
extraction	  of	  the	  aqueous	  phase	  was	  preformed.	  	  The	  final	  DNA	  supernatant	  was	  
removed	  and	  transferred	  to	  a	  clean	  tube.	  	  300mM	  Sodium	  acetate	  (pH	  5.2)	  was	  
added	  and	  the	  samples	  were	  vortexed.	  	  One	  milliliter	  of	  ice-­‐cold	  100%	  Ethanol	  was	  
added	  to	  each	  sample,	  thoroughly	  mixed	  and	  incubated	  at	  -­‐80°C	  for	  15	  minutes.	  	  
DNA	  was	  pelleted	  by	  centrifugation	  at	  16,000	  x	  g	  for	  20	  minutes	  at	  4°C,	  washed	  with	  
60%	  Ethanol,	  air-­‐dried	  and	  resuspended	  in	  5	  µl	  1x	  stop	  solution	  (Sequenase	  Kit).	  	  
Samples	  were	  heated	  to	  95°C	  for	  5	  minutes	  prior	  to	  loading	  on	  the	  sequencing	  gel.	  
Sequencing	  Gel	  and	  Electrophoresis	  
	   The	  DNA	  samples	  were	  resolved	  by	  denaturing	  PAGE	  and	  visualized	  by	  
autoradiography.	  	  A	  denaturing	  8%	  polyacrylamide	  (7M	  Urea)	  gel	  was	  cast	  and	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allowed	  to	  polymerize	  overnight	  at	  room	  temperature.	  	  The	  gel	  was	  pre-­‐ran	  in	  1x	  
TBE	  until	  the	  gel	  temperature	  reached	  45°C.	  	  Resolution	  of	  the	  digested	  DNA	  
samples	  was	  achieved	  by	  electrophoresis	  for	  2.5	  hours	  at	  70	  watts.	  	  Gel	  temperature	  
remained	  around	  45°C	  the	  entire	  run.	  	  The	  gel	  was	  transferred	  to	  filter	  paper	  and	  
vacuum	  dried	  for	  two	  hours	  at	  50°C.	  	  The	  dried	  gel	  was	  exposed	  to	  autoradiography	  
film	  at	  room	  temperature.	   	  





Table	  4-­‐2.	  PCR	  primers	  used	  for	  footprinting	  probe	  generation.	  
	  
	  
Primer	   Sequence	  
1fa1	  F	   GGCCATGCGGAGCTCGAGCCTGTTTCTTGGATGCC	  
1fa1	  R	   CTCATCACAGGAATGCCTTCTG	  
1fa2	  F	   GATACTCCATTCTTCCTGCAAAGG	  
1fa2	  R	   AGGCGTGAGGATAGGCTTTTAA	  
1b	  F	   TCTTGGGGCTCAGTGTGGAGT	  






















Sertoli	   30	   0.2	   2:30	  
Myoid	   30	   0.1	   1:15	  
TM4	   30	   0.1	   1:10	  
MSC1	   30	   0.1	   1:10	  
Probe	  
only	   	  	   	  	   	  	  
1f1	   -­‐	   0.05	   22s	  
1f2	   -­‐	   0.05	   22s	  
1b	   -­‐	   0.05	   22s	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Electric	  Mobility	  Shift	  Assays.	  	  EMSA	  assay	  were	  preformed	  as	  previously	  
described	  with	  slight	  modifications	  (Daggett,	  Rice	  et	  al.	  2000;	  Lei	  and	  Heckert	  
2002).	  	  The	  LUEGO	  (Labeled	  Universal	  Electrophoretic	  Gel	  shift	  Oligonucleotide	  
method	  was	  used	  to	  add	  a	  5’	  fluorescent	  label	  on	  all	  EMSA	  probes	  (Jullien	  and	  
Herman	  2011).	  	  Nuclear	  extract,	  competitors	  and	  antibodies	  were	  incubated	  for	  20	  
minutes	  on	  ice	  in	  EMSA	  buffer	  (20	  mM	  HEPES	  pH	  7.9,	  80	  mM	  KCl,	  4	  mM	  MgCl2,	  10%	  
glycerol,	  250	  µM	  ZnCl2,	  0.5	  mM	  DTT,	  200	  ng	  ssDNA,	  500	  ng	  poly(dI-­‐dC)).	  	  Cold	  
competitors	  (100	  fold	  molar	  excess)	  and	  antibody	  (2	  µg)	  were	  included	  prior	  to	  
addition	  of	  nuclear	  extracts	  (Table	  4-­‐4).	  	  The	  following	  antibodies	  were	  purchased	  
from	  Santa	  Cruz	  Biotechnology,	  Inc	  (Santa	  Cruz,	  CA):	  	  Goat	  polyclonal	  anti-­‐GATA-­‐
1(M-­‐20)	  IgG,	  mouse	  monoclonal	  anti-­‐GATA-­‐2	  (CG2-­‐96)	  IgG,	  mouse	  monoclonal	  anti-­‐
GATA-­‐3	  (HG3-­‐31)	  IgG,	  rabbit	  polyclonal	  anti-­‐GATA-­‐4	  (H-­‐112)	  IgG,	  rabbit	  polyclonal	  
anti-­‐GATA-­‐6	  (H-­‐92)	  IgG.	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Table	  4-­‐4.	  	  Oligonucleotides	  used	  for	  EMSA	  probes	  and	  competitors.	  
Probe	   Sequence	  5'	  to	  3'	  
LUEGO	  5'	  IR-­‐800	   /5IRD800/GTGCCCTGGTCTGG	  
ECR	  1f	  3.2-­‐1	  S	   TGATAGGAGAAACCACAATCCAAAACTATGTTCCT	  
ECR	  1f	  3.2-­‐1	  AS	   AGGAACATAGTTTTGGATTGTGGTTTCTCCTATCACCAAGACCAGGGCAC	  
ECR	  1f	  3.2-­‐2	  S	   AACTATGTTCCTTTTTCAGAAGCAAAACCACAGAA	  
ECR	  1f	  3.2-­‐2	  AS	   TTCTGTGGTTTTGCTTCTGAAAAAGGAACATAGTTCCAAGACCAGGGCAC	  
ECR	  1f	  3.3-­‐1	  S	   GCAAAACCACAGAAGGCATTCCTGTGATGAGTTCA	  
ECR	  1f	  3.3-­‐1	  AS	   TGAACTCATCACAGGAATGCCTTCTGTGGTTTTGCCCAAGACCAGGGCAC	  
ECR	  1f	  3.3-­‐2	  S	   CCTGTGATGAGTTCAGACATTATTCATAAGGCGTT	  
ECR	  1f	  3.3-­‐2	  AS	   AACGCCTTATGAATAATGTCTGAACTCATCACAGGCCAAGACCAGGGCAC	  
Competitor	   Sequence	  5'	  to	  3'	  
ECR	  1f	  3.2-­‐1	  mut1	  S	   TGAGAGGAGAAACCACAATCCAAAACTATGTTCCT	  
ECR	  1f	  3.2-­‐1	  mut1	  AS	   AGGAACATAGTTTTGGATTGTGGTTTCTCCTCTCA	  
ECR	  1f	  3.2-­‐1	  mut2	  S	   ACGCCTGAGAAACCACAATCCAAAACTATGTTCCT	  
ECR	  1f	  3.2-­‐1	  mut2	  AS	   AGGAACATAGTTTTGGATTGTGGTTTCTCAGGCGT	  
ECR	  1f	  3.2-­‐1	  mut3	  S	   TGATAGGAGAAACGTAGCAACGAAACTATGTTCCT	  
ECR	  1f	  3.2-­‐1	  mut3	  AS	   AGGAACATAGTTTCGTTGCTACGTTTCTCCTATCA	  
ECR	  1f	  3.2-­‐1	  mut4	  S	   TGATAGGAGAAACCACAATCCAAAACCGGATTCCT	  
ECR	  1f	  3.2-­‐1	  mut4	  AS	   AGGAATCCGGTTTTGGATTGTGGTTTCTCCTATCA	  
ECR	  1f	  3.3-­‐2	  mut	  1	  S	   AGACCTATGAGTTCAGACATTATTCATAAGGCGTT	  
ECR	  1f	  3.3-­‐2	  mut	  1	  AS	   AACGCCTTATGAATAATGTCTGAACTCATAGGTCT	  
ECR	  1f	  3.3-­‐2	  mut	  2	  S	   CCTGTGGCAGTGTCAGACATTATTCATAAGGCGTT	  
ECR	  1f	  3.3-­‐2	  mut	  2	  AS	   AACGCCTTATGAATAATGTCTGACACTGCCACAGG	  
ECR	  1f	  3.3-­‐2	  mut	  3	  S	   CCTGTGATGAGTGGCTAGATTATTCATAAGGCGTT	  
ECR	  1f	  3.3-­‐2	  mut	  3	  AS	   AACGCCTTATGAATAATCTAGCCACTCATCACAGG	  
ECR	  1f	  3.3-­‐2	  mut	  4	  S	   CCTGTGATGAGTTCAGACCGTATCCATAAGGCGTT	  
ECR	  1f	  3.3-­‐2	  mut	  4	  AS	   AACGCCTTATGGATACGGTCTGAACTCATCACAGG	  
ECR	  1f	  3.3-­‐2	  mut	  5	  S	   CCTGTGATGAGTTCAGACATTATTTGAACTGCGTT	  
ECR	  1f	  3.3-­‐2	  mut	  5	  AS	   AACGCAGTTCAAATAATGTCTGAACTCATCACAGG	  
ECR	  1f	  3.3-­‐2	  mut	  6	  S	   CCTGTGATGAGTTCAGACATTATTCATAAGCTAGG	  
ECR	  1f	  3.3-­‐2	  mut	  6	  AS	   CCTAGCTTATGAATAATGTCTGAACTCATCACAGG	  
GATA	  consensus	  oligo	  S	   CACTTGATAACAGAAAGTGATAACTCT	  
GATA	  consensus	  oligo	  AS	   AGAGTTATCACTTTCTGTTATCAAGTG	  
	  	  	  	  	  	  	  	  Bold	  font	  indicates	  mutated	  sequence	  and	  underlined	  text	  indicates	  consensus	  sequence	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Results	  
	  
Conservation	  profile	  of	  the	  Fshr	  locus.	  	  To	  identify	  candidate	  distal	  regulatory	  
elements,	  a	  1.4	  Mb	  region	  of	  genomic	  DNA	  that	  included	  Fshr	  and	  its	  intergenic	  
sequences	  was	  analyzed	  for	  sequence	  conservation	  and	  7x	  regulatory	  potential,	  
using	  the	  UCSC	  genome	  browser	  (http://genome.ucsc.edu/cgi-­‐bin/hgGateway)	  and	  
associated	  software(Kolbe,	  Taylor	  et	  al.	  2004;	  King,	  Taylor	  et	  al.	  2005;	  Taylor,	  
Tyekucheva	  et	  al.	  2006).	  	  	  Evolutionarily	  conserved	  sequences	  were	  identified	  by	  
comparing	  the	  sequence	  of	  several	  species	  of	  divergent	  evolutionary	  origins,	  using	  
Homo	  sapiens	  as	  the	  base	  genome	  and	  Gallus	  gallus	  (chicken)	  as	  the	  most	  distant.	  	  To	  
identify	  DNA	  sequences	  with	  a	  high	  probability	  of	  regulatory	  potential,	  only	  
conserved	  regions	  with	  an	  increased	  7x	  regulatory	  score	  were	  selected.	  	  The	  7X	  
regulatory	  potential	  scores	  were	  computed	  from	  human,	  chimpanzee,	  macaque,	  
mouse,	  rat,	  dog,	  and	  cow	  by	  comparing	  short	  alignment	  pattern	  frequencies	  
between	  known	  regulatory	  elements	  and	  neutral	  DNA	  (Waterston,	  Lindblad-­‐Toh	  et	  
al.	  2002;	  Consortium	  2004;	  Gibbs,	  Weinstock	  et	  al.	  2004;	  Havlak,	  Chen	  et	  al.	  2004;	  
Kolbe,	  Taylor	  et	  al.	  2004;	  King,	  Taylor	  et	  al.	  2007).	  	  This	  allows	  selection	  of	  regions	  
that	  not	  only	  are	  highly	  conserved,	  but	  also	  contain	  DNA	  sequences	  that	  have	  
demonstrated	  regulatory	  activity	  associated	  with	  other	  genes.	  	   	  
The	  analysis	  identified	  30	  evolutionarily	  conserved	  regions	  (ECR’s)	  that	  also	  
showed	  sequence	  similarity	  to	  known	  regulatory	  elements,	  which	  were	  further	  
considered	  as	  possible	  Fshr	  regulatory	  regions.	  	  The	  ECR’s	  were	  then	  annotated	  on	  
the	  Rattus	  norvegicus	  genome	  listed	  in	  Table	  4-­‐5	  and	  shown	  graphically	  in	  Figure	  4-­‐
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3.	  	  	  Seventeen	  ECR’s	  mapped	  to	  the	  5’	  region	  of	  Fshr,	  seven	  to	  the	  intergenic	  region,	  
and	  six	  were	  located	  3’	  of	  the	  gene.	  	  The	  rat	  genome	  was	  selected	  for	  further	  study,	  
as	  Sertoli	  cell	  isolation,	  transcriptional	  assays	  and	  promoter	  analysis	  methods	  are	  
firmly	  established	  for	  this	  species.	  	  Thirty	  ECRs	  were	  then	  evaluated	  to	  determine	  
their	  role	  in	  Fshr	  regulation.	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Table	  4-­‐5.	  	  Genomic	  location	  of	  ECR’s	  in	  the	  Rattus	  norvegicus	  genome.	  
	  
ECR	   Chromosome	  Location	   Size	  (bp)	  
ECR	  1	   Chr6:	  23036890-­‐23037477	   588	  
ECR	  1c	   Chr6:	  22585376-­‐22586088	   713	  
ECR	  1d	   Chr6:	  22597052-­‐22597262	   211	  
ECR	  1f	   Chr6:	  22614761-­‐22616669	   1909	  
ECR	  1g	   Chr6:	  22590321-­‐22590502	   182	  
ECR	  2	   Chr6:	  22626739-­‐22629962	   3224	  
ECR	  3	   Chr6:	  22596865-­‐22597324	   460	  
ECR	  4	   Chr6:	  23287153-­‐23287391	   239	  
ECR	  5	   Chr6:	  23423202-­‐23423600	   399	  
ECR	  6	   Chr6:	  23219667-­‐23220065	   399	  
ECR	  7	   Chr6:	  23437816-­‐23438244	   429	  
ECR	  8	   Chr6:	  22771058-­‐22771652	   595	  
ECR	  9	   Chr6:	  22776439-­‐22777106	   668	  
ECR	  9b	   Chr6:	  22785969-­‐22786300	   332	  
ECR	  10	   Chr6:	  22813283-­‐22813805	   523	  
ECR	  11	   Chr6:	  22826398-­‐22826718	   321	  
ECR	  12	   Chr6:	  22826285-­‐22826757	   473	  
ECR	  13	   Chr6:	  22845802-­‐22846436	   635	  
ECR	  14	   Chr6:	  23024900-­‐23025427	   528	  
ECR	  15	   Chr6:	  23048424-­‐23049218	   795	  
ECR	  16	   Chr6:	  23055601-­‐23056494	   894	  
ECR	  17	   Chr6:	  23148636-­‐23149418	   783	  
ECR	  18	   Chr6:	  23153766-­‐23154371	   606	  
ECR	  19	   Chr6:	  23167660-­‐23168222	   563	  
ECR	  20	   Chr6:	  23173974-­‐23174670	   697	  
ECR	  21	   Chr6:	  23180610-­‐23181272	   663	  
ECR	  22	   Chr6:	  23188053-­‐23188745	   693	  
ECR	  23	   Chr6:	  23195435-­‐23196040	   606	  
ECR	  24	   Chr6:	  23212514-­‐23213040	   527	  
ECR	  25	   Chr6:	  23259302-­‐23260347	   1046	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Figure	  4-­‐3.	  ECRs	  identified	  by	  sequence	  conservation	  and	  regulatory	  potential	  
annotated	  on	  the	  Rattus	  norvegicus	  genome.	  	  Sequence	  identified	  by	  comparative	  
genomics	  were	  identified	  within	  the	  human	  genome	  and	  transposed	  to	  the	  rat	  
genome	  using	  the	  liftover	  tool	  in	  the	  UCSC	  genome	  browser.	  	  The	  light	  blue	  line	  
denotes	  the	  Fshr	  gene	  and	  the	  black	  arrow	  indicates	  the	  direction	  of	  transcription.	  	  
Solid	  horizontal	  black	  lines	  within	  the	  gene	  identify	  Fshr	  introns	  and	  are	  numbered	  
in	  black	  just	  above.	  	  ECR’s	  are	  identified	  by	  the	  solid	  horizontal	  red	  bars	  above	  the	  
sequence	  and	  are	  labeled	  accordingly.	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H3K4me3	  is	  a	  highly	  enriched	  histone	  modification	  of	  ECR	  1f.	  	  To	  prioritize	  our	  
selection	  of	  ECR’s,	  Chromatin	  Immunoprecipitation	  (ChIP)	  was	  coupled	  with	  deep	  
sequencing	  to	  help	  identify	  regions	  enriched	  for	  Histone	  3	  lysine	  4	  tri-­‐methylation	  
(H3K4me3)	  modification	  in	  Sertoli	  and	  myoid	  cells.	  	  H3K4me3	  enrichment	  is	  
commonly	  associated	  with	  active	  promoter	  and	  enhancer	  elements;	  as	  such	  we	  used	  
Sertoli	  cells	  to	  identify	  active	  regions	  within	  the	  Fshr	  locus	  and	  myoid	  cells	  as	  a	  
representative	  inactive	  locus.	  	  Sequenced	  ChIP	  DNA	  was	  aligned	  to	  version	  5.0	  of	  the	  
Rattus	  norvegicus	  genome	  assembly.	  	  H3K4me3	  Enrichment	  is	  indicated	  by	  the	  peak	  
height,	  which	  is	  a	  direct	  reflection	  of	  the	  number	  of	  sequence	  tags	  identified.	  	  Peak	  
finding	  analysis	  also	  identified	  ECR	  1f	  as	  the	  most	  enriched	  site	  in	  the	  Sertoli	  cell	  
genome	  (Chapter	  3),	  which	  can	  be	  appreciated	  when	  viewing	  the	  enrichment	  
profiles	  in	  the	  UCSC	  Genome	  Browser	  across	  the	  Fshr	  locus	  (Figure	  4-­‐4).	  
Overall,	  ECR	  1f	  was	  the	  only	  ECR	  associated	  with	  a	  histone	  profile	  indicative	  
of	  activity	  in	  Sertoli	  cells.	  	  Enrichment	  of	  H3K4me3	  is	  higher	  in	  the	  Sertoli	  cell	  
fraction	  within	  ECR	  1f	  across	  the	  entire	  ECR.	  	  Notably,	  the	  enrichment	  was	  not	  
observed	  in	  myoid	  cells,	  suggesting	  the	  region’s	  cell-­‐specific	  activity	  within	  Sertoli	  
cells,	  the	  active	  cell	  type.	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ECR	  1f	  is	  associated	  with	  other	  histone	  modifications	  indicative	  of	  active	  
chromatin.	  	  To	  further	  understand	  the	  chromatin	  state	  within	  ECR	  1f,	  ChIP	  coupled	  
with	  qPCR	  was	  employed	  to	  determine	  other	  histone	  modifications	  and	  DNA	  
binding	  proteins	  present	  in	  freshly	  isolated	  P15	  Sertoli	  cells	  in	  vivo.	  	  As	  seen	  in	  the	  
ChIP-­‐Seq	  data,	  there	  was	  an	  abundance	  of	  H3K4me3	  associated	  with	  ECR	  1f	  (Figure	  
4-­‐5).	  	  In	  addition,	  histone	  4	  acetylation	  (H4ac),	  a	  mark	  of	  active	  chromatin,	  was	  
enriched	  in	  ECR	  1f,	  while	  Histone	  3	  lysine	  27	  tri-­‐methylation	  (H3K72me3)	  and	  
Histone	  3	  lysine	  9	  tri-­‐methylation	  (H3K9me3),	  markers	  of	  repressed	  chromatin,	  
were	  not.	  	  This	  data	  confirms	  our	  ChIP-­‐Seq	  results	  and	  shows	  that	  ECR	  1f	  is	  
associated	  with	  other	  active,	  but	  not	  repressive,	  chromatin	  modifications.	  	  	  
	  
	   	  

























Figure	  4-­‐5.	  	  ChIP-­‐qPCR	  verification	  of	  ChIP-­‐Seq	  and	  identification	  of	  other	  
associated	  histone	  modifications.	  	  ChIP	  in	  P15	  Sertoli	  cells	  identifying	  protein	  
enrichment	  at	  ECR	  1f.	  Histone	  modifications	  selected	  for	  are:	  H3ac,	  H4ac,	  H3K4me3,	  
H3K9me2,	  H3K27me3,	  IgG	  and	  a	  No	  Antibody	  (No	  Ab)	  control.	  	  Enrichment	  values	  
are	  expressed	  as	  a	  percent	  of	  the	  Input	  sample.	  	  Error	  bars	  reflect	  the	  standard	  
deviation.	  	  Statistically	  significant	  differences	  are	  indicated	  by	  *	  (p-­‐value≤0.05)	  as	  
determined	  by	  one-­‐way	  ANOVA.	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ECR	  1f	  regulates	  Fshr	  promoter	  activity.	  	  To	  determine	  if	  ECR	  1f	  regulates	  Fshr	  
promoter	  activity,	  it	  was	  cloned	  into	  a	  firefly	  luciferase	  reporter	  together	  with	  the	  -­‐
220/+123	  and	  -­‐2700/+123	  Fshr	  promoter	  sequences,	  and	  transiently	  transfected	  
into	  primary	  rat	  Sertoli	  and	  myoid	  cells.	  	  ECR	  1f	  was	  inserted	  into	  the	  reporter	  
vector	  both	  5’	  and	  3’	  to	  the	  promoters	  and	  in	  both	  forward	  and	  reverse	  orientations.	  	  
Firefly	  luciferase	  activity	  in	  the	  transfected	  cells	  was	  normalized	  to	  the	  activity	  of	  
Renilla	  luciferase	  generated	  by	  the	  co-­‐transfected	  tK-­‐REN	  vector	  included	  as	  a	  
control	  for	  transfection	  efficiency.	  	  The	  Firefly/Renilla	  values	  from	  cells	  transfected	  
with	  ECR	  1f	  reporters	  were	  then	  normalized	  to	  the	  values	  from	  cells	  transfected	  
with	  their	  respective	  promoter-­‐only	  vectors.	  	  This	  revealed	  an	  approximate	  four-­‐
fold	  reduction	  in	  promoter	  activity	  in	  the	  presence	  of	  ECR	  1f	  in	  both	  promoter	  
constructs	  tested	  (Figure	  4-­‐6).	  	  ECR	  1f	  activity	  was	  independent	  of	  orientation	  
(forward	  or	  reverse),	  position	  (5’	  or	  3’	  relative	  to	  luciferase),	  promoter	  size	  (-­‐
220/+123	  or	  -­‐2700/+123)	  or	  cell	  type.	  	  These	  results	  indicate	  that	  ECR	  1f	  contains	  
sequences	  that	  can	  regulate	  Fshr	  promoter	  activity	  in	  transfections	  in	  both	  Sertoli	  
and	  myoid	  cells	  and	  this	  activity	  is	  independent	  of	  promoter	  size	  and	  element	  
position.	  	  This	  observation	  conflicts	  with	  our	  ChIP-­‐Seq	  data	  that	  identified	  ECR	  1f	  as	  
a	  cell-­‐specific	  regulatory	  region.	  	  This	  could	  imply	  that	  the	  DNA	  binding	  proteins	  
responsible	  for	  ECR	  1f’s	  activity	  are	  not	  cell	  specific;	  as	  this	  is	  a	  transient	  assay	  no	  
chromatin	  modifications	  exist	  to	  limit	  the	  activity	  of	  ECR	  1f	  within	  our	  reporter	  in	  
myoid	  cells.	  	  All	  other	  ECRs	  identified	  by	  comparative	  genomics	  were	  also	  tested	  by	  
transient	  transfection	  analysis	  and	  were	  unable	  to	  alter	  Fshr	  promoter	  activity	  in	  
vitro	  (data	  not	  shown).	   	  















Figure	  4-­‐6.	  	  ECR	  1f	  represses	  Fshr	  promoter	  activity	  in	  transient	  transfections.	  	  
Plasmids	  containing	  ECR	  1f	  were	  inserted	  into	  the	  pGem	  vector	  containing	  the	  (A)	  -­‐
200/+123	  bp	  Fshr	  promoter	  and	  (B)	  -­‐2700	  /+123	  bp	  Fshr	  promoter	  were	  
transiently	  transfected	  into	  primary	  Sertoli	  (black	  bars)	  cells	  and	  myoid	  (white	  
bars)	  cells.	  	  A	  schematic	  of	  the	  transfection	  vector	  represents	  the	  plasmid	  construct	  
used	  for	  each	  transfection.	  	  The	  light	  grey	  box	  represents	  the	  Fshr	  promoter	  and	  the	  
arrow	  indicates	  transcriptional	  direction,	  the	  dark	  grey	  box	  represents	  the	  
Luciferase	  gene,	  the	  white	  box	  represents	  the	  polyA	  tail	  and	  the	  black	  box	  with	  an	  
arrow	  represents	  the	  inserted	  ECR	  and	  the	  direction	  of	  the	  inserted	  sequence.	  	  Error	  
bars	  reflect	  the	  standard	  deviation.	  	  Statistically	  significant	  differences	  are	  indicated	  
by	  ****	  (p-­‐value≤0.0001)	  as	  determined	  by	  two-­‐way	  ANOVA.	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Identification	  of	  two	  highly	  conserved	  regions	  within	  ECR	  1f.	  	  To	  better	  define	  
the	  active	  sequences	  within	  the	  2000	  bases	  of	  ECR	  1f,	  conservation	  was	  used	  to	  
guide	  the	  generation	  of	  reporter	  with	  small	  portions	  of	  ECR	  1f	  directing	  Fshr.	  	  
Detailed	  inspection	  of	  the	  sequence	  conservation	  in	  ECR	  1f	  revealed	  two	  distinct	  
regions	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  (Figure	  4-­‐7).	  	  	  The	  conservation	  within	  these	  two	  
regions	  exists	  in	  the	  chicken,	  but	  no	  conservation	  exists	  with	  Zebrafish	  or	  Xenopus	  
(data	  not	  shown).	  	  ECR	  1f-­‐a	  is	  located	  at	  the	  5’	  region	  of	  ECR	  1f	  and	  is	  roughly	  400	  
base	  pairs,	  while	  ECR	  1f-­‐b	  is	  in	  the	  3’	  region	  of	  ECR	  1f	  and	  is	  roughly	  370	  base	  pairs.	  	  
The	  two	  conserved	  regions	  are	  separated	  by	  about	  1000	  bp	  of	  less-­‐conserved	  
sequence.	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Both	  ECR	  1f-­‐a	  and	  1f-­‐b	  are	  required	  for	  full	  ECR	  1f	  activity.	  	  To	  determine	  the	  
effect	  of	  ECR	  1f-­‐a	  and	  1f-­‐b	  on	  Fshr	  promoter	  activity,	  the	  two	  were	  individually	  
cloned	  into	  the	  FSHR	  -­‐220/+123	  and	  FSHR	  -­‐2700/+123	  vectors	  and	  transiently	  
transfected	  into	  P15	  rat	  Sertoli	  and	  myoid	  cells	  (Figure	  4-­‐8).	  	  Two	  significant	  trends	  
were	  associated	  their	  promoter	  activity.	  	  First,	  ECR	  1f-­‐a	  enhanced	  transcription	  in	  
myoid	  cells,	  in	  a	  manner	  that	  depended	  on	  its	  orientation	  (forward)	  and	  position	  
(3’).	  	  Second,	  ECR	  1f-­‐b	  repressed	  transcription	  in	  both	  Sertoli	  and	  myoid	  cells;	  but	  
only	  when	  it	  was	  at	  the	  3’	  end	  in	  reverse	  orientation.	  	  Similar	  results	  were	  seen	  with	  
both	  the	  -­‐220	  and	  -­‐2700	  promoters.	  	  Since	  the	  enhancer	  activity	  is	  only	  found	  in	  
myoid	  cells,	  it	  is	  likely	  that	  the	  protein	  involved	  in	  this	  activation	  is	  only	  present	  in	  
myoid	  cells	  and	  is	  not	  likely	  to	  play	  a	  role	  in	  Fshr	  repression	  in	  vivo.	  	  The	  repressive	  
action	  associated	  with	  ECR	  1f-­‐b	  indicates	  function	  in	  both	  Sertoli	  and	  myoid	  cells,	  
but	  is	  only	  associated	  with	  activity	  in	  the	  reverse	  orientation	  when	  located	  3’	  of	  the	  
reporter	  gene.	  	  This	  position	  is	  consistent	  with	  ECR	  1f	  in	  vivo	  as	  ECR	  1f	  is	  
downstream	  of	  Fshr.	  	  Neither	  ECR	  1f-­‐a	  or	  1f-­‐b	  alone	  recapitulates	  the	  activity	  of	  the	  
full	  ECR	  1f.	  
	   As	  distal	  regulatory	  elements	  often	  work	  in	  concert	  with	  each	  other,	  ECR	  1f-­‐a	  
and	  1f-­‐b	  were	  joined	  and	  cloned	  into	  the	  FSHR	  -­‐220/+123	  vector	  in	  the	  5’	  forward	  
direction	  and	  transiently	  transfected	  into	  P15	  rat	  Sertoli	  and	  myoid	  cells.	  	  Together	  
these	  two	  segments	  are	  capable	  of	  repressing	  the	  Fshr	  promoter	  (Figure	  4-­‐9),	  
although	  not	  to	  the	  same	  level	  as	  the	  full	  length	  ECR.	  	  This	  observation	  indicates	  that	  
required	  functional	  elements	  are	  contained	  within	  each	  conserved	  region	  of	  ECR	  1f,	  
	   177	  
but	  that	  the	  non-­‐conserved,	  intervening	  sequence	  also	  plays	  a	  role	  in	  the	  function	  of	  
ECR	  1f.	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Figure	  4-­‐8.	  	  Transient	  transfection	  analysis	  of	  ECR	  1f-­‐a	  and	  1f-­‐b	  in	  Sertoli	  and	  myoid	  
cells.	  	  Plasmids	  containing	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  were	  cloned	  into	  the	  pGem	  vector	  
containing	  the	  (A)	  -­‐200/+123	  bp	  Fshr	  promoter	  and	  (B)	  -­‐2700	  /+123	  bp	  Fshr	  promoter.	  	  A	  
schematic	  of	  the	  transfection	  vector	  represents	  the	  plasmid	  construct	  used	  for	  each	  
transfection.	  	  The	  light	  grey	  box	  represents	  the	  Fshr	  promoter	  and	  the	  arrow	  indicates	  
transcriptional	  direction,	  the	  dark	  grey	  box	  represents	  the	  Luciferase	  gene,	  the	  white	  box	  
represents	  the	  polyA	  tail	  and	  the	  black	  box	  with	  an	  arrow	  represents	  the	  inserted	  ECR	  and	  
the	  direction	  of	  the	  inserted	  sequence.	  Error	  bars	  reflect	  the	  standard	  deviation.	  	  
Statistically	  significant	  differences	  are	  indicated	  by	  	  *	  p-­‐value≤0.05,	  **	  p-­‐value≤0.01,	  ****	  p-­‐
value≤0.0001	  as	  determined	  by	  two-­‐way	  ANOVA.	   	  
A	  
B	  

























Figure	  4-­‐9.	  	  Transient	  transfection	  analysis	  of	  ECR	  1f-­‐a/b	  in	  Sertoli	  and	  myoid	  cells.	  	  
Plasmids	  containing	  a	  fusion	  of	  ECR	  1f-­‐a/b	  was	  cloned	  into	  the	  pGem	  vector	  5’	  of	  the	  -­‐
220/+123	  bp	  Fshr	  promoter	  in	  the	  forward	  orientation.	  Black	  bars	  represent	  Sertoli	  cells	  
and	  the	  white	  bar	  represents	  the	  myoid	  cells.	  	  Error	  bars	  reflect	  the	  standard	  deviation.	  	  
Statistically	  significant	  differences	  are	  indicated	  by	  	  *	  p-­‐value≤0.05,	  **	  p-­‐value≤0.01,	  as	  
determined	  by	  two-­‐way	  ANOVA.	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In	  Vitro	  DNaseI	  Footprinting	  identified	  protein-­‐binding	  sites	  within	  ECR1f-­‐a	  
and	  1f-­‐b.	  To	  help	  reveal	  the	  active	  sequences	  in	  ECR	  1f,	  in	  vitro	  DNase	  I	  Footprint	  
analysis	  was	  used	  to	  identify	  sites	  of	  protein	  binding	  and/or	  hypersensitive	  regions	  
within	  the	  conserved	  regions	  of	  ECR	  1f.	  	  Three	  different	  probes	  (Figure	  4-­‐2)	  were	  
used	  to	  cover	  the	  sequences	  within	  ECR	  1f-­‐a	  (1a.1	  and	  1a.2)	  and	  ECR	  1f-­‐b	  (1b),	  
together	  with	  nuclear	  extracts	  from	  primary	  Sertoli	  and	  myoid	  cells	  as	  well	  as	  two	  
Sertoli	  cell	  lines-­‐TM4	  and	  MSC1.	  	  The	  analysis	  identified	  46	  sequences	  that	  were	  
protected	  by	  proteins	  present	  in	  the	  nuclear	  extracts	  (Table	  4-­‐6	  and	  Figure	  4-­‐10)	  
and	  their	  binding	  regions	  annotated	  across	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  (Figure	  4-­‐11	  A	  
and	  B,	  respectively).	  	  Only	  two	  footprints,	  footprint	  13	  and	  18b,	  were	  specific	  to	  
Sertoli	  cells	  and	  MSC1	  cells,	  while	  nine	  footprints/hypersensitive	  sites	  were	  
observed	  in	  both	  Sertoli	  and	  myoid	  cells	  that	  exhibited	  different	  banding	  patterns	  
between	  Sertoli	  and	  myoid	  cells	  (asterisks,	  Table	  4-­‐5	  and	  Figures	  4-­‐10	  and	  4-­‐11).	  	  	  
Overall,	  more	  myoid	  cell-­‐specific	  footprints	  were	  observed	  (13)	  and	  fifteen	  
footprints	  were	  similar	  between	  both	  cell	  types.	  	  More	  footprints	  were	  observed	  in	  
ECR	  1f-­‐a	  when	  compared	  to	  ECR	  1f-­‐b;	  likely	  because	  the	  probe	  for	  ECR	  1f-­‐b	  was	  too	  
large	  and	  did	  not	  resolve	  well	  towards	  the	  3’	  end	  of	  the	  probe.	  	  Although	  the	  
intergenic	  sequence	  was	  not	  analyzed,	  our	  transient	  transfection	  data	  indicates	  that	  
this	  region	  contains	  sequence	  required	  for	  full	  ECR	  1f	  activity.	  	  This	  region	  should	  be	  
analyzed	  in	  future	  experiments.	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Figure	  4-­‐10.	  	  46	  footprinted	  and	  hypersensitive	  regions	  within	  ECR	  1f-­‐a	  and	  
1f-­‐b.	  	  DNase	  I	  footprinting	  analysis	  of	  ECR1f-­‐a	  and	  1f-­‐b	  with	  Probe	  only,	  Sertoli	  (SC),	  
myoid	  (MC),	  TM4	  and	  MSC1	  nuclear	  extract.	  	  	  ECR	  1f-­‐a	  is	  covered	  by	  two	  probes-­‐	  
1a.1	  covers	  the	  5’	  region	  and	  probe	  1a.2	  covers	  the	  3’	  region.	  	  A	  single	  probe	  covers	  
ECR	  1f-­‐b.	  	  *	  Indicates	  different	  footprint	  pattern	  between	  cell	  types.	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Table	  4-­‐6.	  	  Chromosome	  positions	  of	  footprint	  and	  hypersensitive	  sites.	  
	  
FP	  Number	   Probe	   Chromosome	  Location	   DNA	  Sequence	   Cell	  Type	  
1	   1a1	   chr6:22614772-­‐22614775	   acca	   SC,	  MC	  
2	   1a1	   chr6:22614800-­‐22614804	   tctct	   All	  
3*	   1a1	   chr6:22614808-­‐22614812	   aagca	   SC,	  MC	  
4	   1a1	   chr6:22614816-­‐22614820	   gggag	   All	  
5	   1a1	   chr6:22614845-­‐22614849	   ggctc	   MC	  
6*	   1a1	   chr6:22614854-­‐22614857	   caaa	   MC	  	  
7	   1a1	   chr6:22614862-­‐22614866	   ctgtg	   MC	  
8*	   1a1	   chr6:22614874-­‐22614879	   tgaata	   MC	  
9	   1a1	   chr6:22614881-­‐22614885	   gcaac	   MC	  
10	   1a1	   chr6:22614908-­‐22614916	   ccctccca	   SC,	  MC	  
11	   1a1	   chr6:22614925-­‐22614931	   ttcttcc	   MC	  
12	   1a1	   chr6:22614935-­‐22614942	   aaaggct	   MC,	  MSC1	  
13*	   1a1	   chr6:22614947-­‐22614964	   ggaggctagataatatc	   SC,	  MC,	  MSC1	  
13a	   1a2	   chr6:22614959-­‐22614965	   agtatct	   All	  
14	   1a1	   chr6:22614968-­‐22614974	   gaggaaa	   All	  
14a	   1a2	   chr6:22614968-­‐22614971	   gagg	   SC,	  MC	  
15	   1a1	   chr6:22614981-­‐22614992	   cctaattagcaa	   SC,	  MC	  
16	   1a2	   chr6:22614997-­‐22615000	   atta	   SC,	  MC	  
17	   1a2	   chr6:22615002-­‐22615005	   atta	   SC,	  MC	  
18	   1a1	   chr6:22615006-­‐22615015	   cacacatcct	   SC,	  MC	  
18a	   1a2	   chr6:22615005-­‐22615009	   acaca	   SC,	  MC	  
18b*	   1a2	   chr6:22615008-­‐22615011	   caca	   SC,	  MC	  
19	   1a2	   chr6:22615016-­‐22615020	   gacaa	   SC,	  MC	  
20	   1a1	   chr6:22615024-­‐22615034	   ccatttttaat	   TM4,	  MSC1	  
20a*	   1a2	   chr6:22615023-­‐22615025	   tcc	   SC,	  MC	  
20b*	   1a2	   chr6:22615027-­‐22615031	   ttttt	   SC,	  MC	  
21*	   1a2	   chr6:22615045-­‐22615047	   act	   SC,	  MC	  
22	   1a2	   chr6:22615049-­‐22615052	   gttg	   MC	  
23*	   1a2	   chr6:22615054-­‐22615064	   ttaaatctga	   SC,	  MC	  
24	   1a1	   chr6:22615066-­‐22615092	   ggagaaaccacaaatcca
aaactatgtt	  
SC,	  MC	  
24a	   1a2	   chr6:22615068-­‐22615073	   gagaaa	   SC,	  MC	  
24b	   1a2	   chr6:22615075-­‐22615078	   caca	   SC,	  MC	  
24c	   1a2	   chr6:22615080-­‐22615085	   tccaaa	   SC,	  MC	  
25	   1a2	   chr6:22615089-­‐22615094	   atgttc	   SC,	  MC	  
26	   1a2	   chr6:22615110-­‐22615116	   aaccaca	   MC	  
27	   1a2	   chr6:22615130-­‐22615136	   gatgag	   MC	  
28	   1a2	   chr6:22615149-­‐22615155	   cataagg	   MC	  
29	   1a2	   chr6:22615170-­‐22615180	   agtggcagggt	   MC	  
30	   1b	   chr6:22616161-­‐22616166	   aggaca	   MC	  
31	   1b	   chr6:22616192-­‐22616197	   aggtaa	   SC,	  MC	  
32*	   1b	   chr6:22616210-­‐22616215	   tgggat	   SC,	  MC	  
33	   1b	   chr6:22616224-­‐22616229	   gatacg	   MC	  
34	   1b	   chr6:22616248-­‐22616256	   gtttctttt	   SC,	  MC	  
35	   1b	   chr6:22616311-­‐22616316	   gtggat	   SC,	  MC,	  TM4	  
36	   1b	   chr6:22616328-­‐22616340	   ttaattagtataa	   MC,	  TM4,	  MSC1	  
37	   1b	   chr6:22616360-­‐22616370	   gagtaca	   SC,	  MC	  
	   *	  Indicates	  different	  footprint	  pattern	  between	  cell	  types	  	   	  
	   183	  
	  
	  






















































































































































































































































	   184	  
ECR1f-­‐a	  and	  ECR1f-­‐b	  block	  deletions	  identify	  single	  region	  capable	  of	  relieving	  
promoter	  repression.	  	  To	  identify	  the	  regulatory	  sequences	  within	  ECR	  1f,	  various	  
regions	  within	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  were	  systematically	  deleted	  from	  the	  full-­‐
length	  ECR	  1f	  and	  assayed	  for	  activity	  by	  transient	  transfections	  in	  Sertoli	  and	  
myoid	  cells	  (Figure	  4-­‐12	  A).	  	  Myoid	  cell	  data	  is	  not	  shown,	  as	  the	  standard	  deviation	  
was	  too	  large	  to	  obtain	  meaningful	  data.	  	  Within	  Sertoli	  cells,	  deletions	  in	  regions	  1-­‐
4	  correspond	  to	  ECR	  1f-­‐a	  and	  deletions	  in	  regions	  5-­‐7	  correspond	  to	  ECR	  1f-­‐b.	  	  Each	  
deletion	  construct	  was	  cloned	  into	  the	  FSHR	  -­‐220/+123	  plasmid	  in	  a	  5’-­‐forward	  
orientation.	  	  	  
Transient	  transfection	  analysis	  demonstrates	  that	  deletion	  of	  regions	  1,	  2,	  5,	  
6	  and	  7	  cannot	  relieve	  the	  promoter	  repression	  induced	  by	  ECR	  1f	  (Figure	  4-­‐12	  B).	  	  
However,	  deletion	  of	  the	  entire	  1f-­‐a	  region	  (region	  4)	  or	  deletion	  of	  its	  
corresponding	  3’	  end	  (region	  3)	  not	  only	  relieved	  the	  repression	  generated	  by	  the	  
region,	  but	  moderately	  enhanced	  promoter	  activity.	  	  These	  results	  indicate	  that	  the	  
activity	  of	  ECR	  1f	  lies	  in	  region	  3	  at	  the	  3’	  end	  of	  ECR	  1f-­‐a.	  	  This	  data	  conflicts	  with	  
the	  transient	  transfection	  data	  obtained	  by	  cloning	  of	  1f-­‐a	  in	  isolation	  with	  the	  Fshr	  
promoter.	  	  This	  implies	  that	  other	  regions	  within	  ECR	  1f	  are	  required	  for	  full	  
regulation	  of	  the	  Fshr	  promoter.	  	   	  
	   	  
















Figure	  4-­‐12.	  	  Block	  deletion	  of	  ECR	  1f-­‐a	  region	  3	  and	  4	  relieves	  repression	  on	  
the	  Fshr	  promoter.	  	  (A)	  -­‐200/+123	  bp	  Fshr	  promoter	  with	  ECR	  1f	  identifying	  the	  
location	  of	  block	  deletions	  generated	  across	  ECR	  1f-­‐a	  and	  1f-­‐b.	  	  (B)	  Plasmids	  
containing	  block	  deletions	  across	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  within	  ECR	  1f	  were	  cloned	  
into	  the	  pGem	  vector	  containing	  the	  -­‐200/+123	  bp	  Fshr	  promoter	  and	  transiently	  
transfected	  into	  Sertoli	  cells	  in	  the	  5’	  forward	  direction.	  	  Error	  bars	  reflect	  the	  
standard	  deviation,	  and	  statistically	  significant	  differences	  are	  indicated	  by	  	  **	  p-­‐
value≤0.01	  and	  ****	  p-­‐value≤0.0001,	  as	  determined	  by	  one-­‐way	  ANOVA.	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Individual	  mutations	  of	  footprinted	  sequences	  failed	  to	  alter	  ECR	  1f	  activity.	  	  
As	  determined	  by	  the	  DNaseI	  footprinting	  experiments,	  nine	  sites	  (FP	  21-­‐29)	  lie	  
within	  ECR	  1f-­‐a	  region	  3	  (Figure	  4-­‐13,	  a).	  	  To	  determine	  if	  any	  of	  these	  regions	  are	  
associated	  with	  Fshr	  promoter	  function	  in	  vitro,	  we	  selectively	  mutated	  each	  
footprint	  region	  within	  ECR	  1f	  and	  tested	  each	  construct	  in	  transient	  transfections.	  	  
Bases	  within	  the	  footprinted	  regions	  were	  randomly	  changed	  for	  analysis.	  	  For	  these	  
transfections,	  MSC1	  cells	  (a	  mouse	  Sertoli	  cell	  line)	  were	  used	  instead	  of	  Sertoli	  cells	  
to	  increase	  the	  speed	  and	  efficiency	  of	  construct	  analysis.	  	  ECR	  1f	  represses	  the	  Fshr	  
promoter	  within	  this	  cell-­‐type	  ~2.5	  fold.	  	  Within	  this	  system,	  none	  of	  the	  mutations	  
generated	  relieved	  the	  repressive	  effects	  of	  ECR	  1f	  on	  the	  Fshr	  promoter	  (Figure	  4-­‐
13,	  b).	  	  Each	  mutation	  was	  made	  individually	  and	  combinations	  of	  the	  mutations	  
were	  not	  tested.	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Figure	  4-­‐13.	  	  Identified	  footprint	  regions	  do	  not	  individually	  affect	  Fshr	  
promoter	  function	  in	  vitro.	  	  (A)	  -­‐200/+123	  bp	  Fshr	  promoter	  with	  ECR	  1f	  
identifying	  the	  location	  footprint	  mutations	  generated	  across	  ECR	  1f-­‐a	  Region	  3.	  	  	  
(B)	  plasmids	  containing	  mutations	  across	  each	  specific	  footprint	  were	  cloned	  into	  
the	  pGem	  vector	  upstream	  of	  the	  	  	  -­‐200/+123	  bp	  Fshr	  promoter	  and	  transiently	  
transfected	  into	  MSC1	  cells.	  	  Error	  bars	  reflect	  the	  standard	  deviation,	  and	  
statistically	  significant	  differences	  are	  indicated	  by	  	  ***	  p-­‐value≤0.001	  and	  ****	  p-­‐
value≤0.0001,	  as	  determined	  by	  one-­‐way	  ANOVA.	  
	  
	   	  
	   188	  
Block	  deletions	  within	  ECR	  1f-­‐a	  region	  3	  refined	  regions	  of	  activity.	  	  Since	  
mutation	  of	  the	  footprinted	  sequences	  in	  ECR	  1f-­‐a	  Region	  3	  did	  not	  identify	  any	  
active	  sequences	  in	  this	  region,	  smaller	  40	  bp	  deletions	  were	  generated	  across	  
region	  3	  and	  assayed	  for	  activity	  in	  MSC1	  cells	  (Figure	  4-­‐14	  A).	  	  Similar	  to	  the	  
transfection	  in	  Sertoli	  cells,	  deletion	  of	  Region	  3	  relieved	  the	  repressive	  effect	  of	  ECR	  
1f	  on	  the	  Fshr	  promoter;	  however,	  the	  effect	  is	  not	  as	  strong	  as	  previously	  seen	  in	  
the	  primary	  Sertoli	  cell	  transfections.	  	  Block	  deletions	  across	  regions	  3.1,	  3.2,	  3.3	  
and	  3.4	  were	  not	  significantly	  different	  from	  ECR	  1f.	  	  A	  combination	  of	  block	  
deletions	  3.2	  and	  3.3	  (deletion	  3.8	  figure	  4-­‐14,	  b)	  was	  the	  smallest	  regions	  
associated	  with	  a	  relief	  of	  repression	  similar	  to	  that	  of	  Region	  3	  in	  the	  MSC1	  cells.	  	  
This	  indicates	  that	  the	  active	  sequences	  may	  reside	  in	  this	  region.	  	  	  
The	  promoter	  activity	  observed	  by	  deletion	  of	  ECR	  1f	  region	  3	  in	  the	  MSC1	  
cells	  does	  not	  match	  that	  of	  primary	  Sertoli	  cells	  indicating	  that	  the	  regulatory	  
mechanisms	  may	  differ	  between	  these	  two	  cell	  types.	  	  These	  deletions	  also	  need	  to	  
be	  analyzed	  in	  primary	  Sertoli	  cells	  to	  identify	  the	  activity	  of	  these	  constructs	  within	  
the	  primary	  cells.	  	  
	  
	   	  





















Figure	  4-­‐14.	  	  Block	  deletions	  across	  ECR	  1f-­‐a	  region	  3.	  	  (A)	  Annotation	  of	  block	  
deletions	  generated	  across	  ECR	  1f-­‐a	  region	  3	  and	  (B)	  plasmids	  containing	  block	  
deletions	  across	  ECR	  1f-­‐a	  region	  3	  were	  cloned	  into	  the	  pGem	  vector	  containing	  the	  
-­‐200/+123	  bp	  Fshr	  promoter	  and	  transiently	  transfected	  into	  MSC1	  cells.	  Error	  bars	  
reflect	  the	  standard	  deviation,	  and	  statistically	  significant	  differences	  are	  indicated	  
by	  	  **	  p-­‐value≤0.01,	  ***	  p-­‐value≤0.001	  and	  ****	  p-­‐value≤0.0001,	  as	  determined	  by	  
one-­‐way	  ANOVA.	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EMSA	  analysis	  of	  ECR	  1f-­‐a	  region	  3.8	  identified	  a	  GATA4	  binding	  site.	  	  Since	  ECR	  
1f	  contains	  a	  significant	  portion	  of	  the	  region	  3	  activity,	  Electric	  Mobility	  Shift	  
Assays	  (EMSA)	  were	  performed	  to	  characterize	  the	  protein	  binding	  regions.	  	  Four	  
probes	  spanning	  Region	  3.8,	  were	  used	  with	  Sertoli	  cell	  nuclear	  extract	  (Figure	  4-­‐
15).	  	  No	  specific	  complexes	  were	  observed	  on	  probes	  3.2-­‐2	  and	  3.3-­‐1;	  However,	  
complexes	  were	  observed	  on	  3.2-­‐1	  and	  3.3-­‐2	  (Figure	  4-­‐16).	  	  Probe	  3.2-­‐1	  contains	  
three	  possible	  GATA	  binding	  sites	  (Figure	  4-­‐17),	  GATA	  antibodies	  were	  added	  to	  
EMSA	  reactions	  to	  determine	  their	  ability	  to	  cross-­‐react	  with	  bound	  proteins.	  	  
Figure	  4-­‐18	  shows	  that	  only	  the	  GATA4	  antibody	  is	  capable	  of	  cross-­‐reacting	  with	  
the	  observed	  protein/DNA	  band.	  	  To	  identify	  the	  specific	  GATA	  binding	  site,	  
competitors	  with	  mutations	  in	  each	  GATA	  site	  were	  included	  in	  the	  EMSA	  reactions.	  
Competitors	  with	  mutations	  generated	  in	  the	  first	  (Mut1	  and	  Mut2)	  and	  third	  
(Mut4)	  GATA	  binding	  site	  competed	  off	  almost	  all	  the	  protein/probe	  interaction	  
indicating	  that	  these	  sites	  are	  not	  required	  for	  binding	  (Figure	  4-­‐19).	  	  Mutation	  of	  
the	  second	  GATA	  binding	  site	  (Mut3)	  could	  not	  compete	  off	  the	  protein/probe	  
interaction	  indicating	  that	  the	  second	  GATA	  site	  is	  responsible	  for	  the	  protein/DNA	  
interaction.	  	  Competition	  with	  a	  sequence	  containing	  two	  GATA	  consensus	  
sequences	  also	  fully	  competed	  all	  binding	  from	  the	  probe,	  further	  supporting	  the	  
identification	  of	  GATA	  as	  the	  binding	  protein.	  
	   To	  further	  characterize	  proteins	  binding	  to	  probe	  3.3-­‐2,	  six	  base	  pair	  
mutations	  were	  made	  across	  the	  length	  of	  the	  probe	  and	  used	  as	  competitors.	  	  Two	  
mutant	  competitors	  (Mut4	  and	  Mut5)	  did	  not	  compete	  the	  protein	  complexes	  bound	  
to	  the	  probe	  (Figure	  4-­‐20),	  identifying	  the	  sequence	  5’-­‐	  ATT	  ATT	  CAT	  AAG-­‐3’	  as	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critical	  for	  protein	  binding.	  	  Comparison	  of	  the	  sequence	  to	  a	  database	  of	  known	  
transcription	  factor	  binding	  sites	  identified	  several	  binding	  candidates,	  most	  of	  
which	  belong	  to	  the	  POU	  family	  of	  transcription	  factors.	  	  Specifically	  POU1F1a,	  a.k.a	  
pit-­‐1	  and	  GHF-­‐1,	  has	  a	  similar	  consensus	  sequence	  5’-­‐TATNCAT-­‐3’	  (Figure	  4-­‐21).	  
	   	  






















































































































Figure	  4-­‐16.	  	  Two	  regions	  are	  capable	  of	  binding	  Sertoli	  cell	  nuclear	  proteins	  
in	  vitro.	  	  EMSA	  binding	  assays	  of	  four	  probes	  spanning	  ECR	  1f	  Region	  3.8.	  	  Each	  
probe	  was	  incubated	  with	  Nuclear	  extract	  only	  (Lanes	  1,	  4,	  7	  and	  10),	  unlabeled	  
competitor	  +	  nuclear	  extract	  (Lanes	  2,	  5,	  8	  and	  11)	  and	  nonspecific	  competitor	  +	  
nuclear	  extract	  (Lanes	  3,	  6,	  9	  and	  12).	  	  Black	  arrows	  indicate	  shift	  location	  of	  specific	  
protein/DNA	  interactions.	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Figure	  4-­‐17.	  	  Footprints	  and	  potential	  GATA	  binding	  sites	  within	  EMSA	  probe	  
3.2-­‐1.	  	  EMSA	  probe	  3.2-­‐1	  identifying	  potential	  GATA	  binding	  sites	  (underlined	  
sequence).	  	  Footprints	  are	  labeled	  with	  above	  the	  probe	  sequence.	  
	  
	   	  




Figure	  4-­‐18.	  	  Identification	  of	  GATA-­‐4	  specific	  protein/DNA	  interaction.	  	  EMSA	  
binding	  assay	  of	  probe	  3.2-­‐1.	  	  Probe	  was	  incubated	  with	  Nuclear	  extract	  only	  (Lane	  
1),	  unlabeled	  competitor	  +	  nuclear	  extract	  (Lane	  2),	  nonspecific	  competitor	  +	  
nuclear	  extract	  (Lane	  3)	  and	  nuclear	  extract	  +	  GATA	  specific	  antibodies	  (Lanes	  4-­‐8)	  
and	  FOG2	  (Lane	  9).	  	  Only	  the	  GATA-­‐4	  Antibody	  was	  capable	  of	  shifting	  the	  
Probe/protein	  band	  (Lane	  7).	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Figure	  4-­‐19.	  	  Identification	  of	  GATA-­‐4	  specific	  DNA	  binding	  site.	  	  EMSA	  binding	  
assay	  of	  probe	  3.2-­‐1.	  	  Probe	  was	  incubated	  without	  Nuclear	  extract	  (Lane	  1),	  Probe	  
was	  incubated	  with	  Nuclear	  extract	  (Lane	  2),	  unlabeled	  competitor	  +	  nuclear	  extract	  
(Lane	  3),	  nonspecific	  competitor	  +	  nuclear	  extract	  (Lane	  4)	  and	  nuclear	  extract	  +	  
GATA	  site	  specific	  mutations	  (Lanes	  5-­‐8),	  GATA	  consensus	  sequence	  (Lane	  9)	  and	  
GATA-­‐4	  antibody	  (Lane	  10).	  	  	  
	  
	   	  
1	  	  	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  	  5	  	  	  	  	  	  	  	  	  	  	  6	  	  	  	  	  	  	  	  	  	  7	  	  	  	  	  	  	  	  	  	  	  8	  	  	  	  	  	  	  	  	  	  	  9	  	  	  	  	  	  	  	  	  10	  
	   197	  
	  	  
	  
Figure	  4-­‐20.	  Identification	  of	  12	  base	  pair	  binding	  sequence	  within	  EMSA	  
probe	  3.3-­‐2.	  	  EMSA	  binding	  assay	  of	  probe	  3.3-­‐2.	  	  Probe	  was	  incubated	  without	  
Nuclear	  extract	  (Lane	  1),	  nuclear	  extract	  (Lane	  2),	  unlabeled	  competitor	  +	  nuclear	  
extract	  (Lane	  3),	  nonspecific	  competitor	  +	  nuclear	  extract	  (Lane	  4)	  and	  competitors	  
containing	  6	  bp	  mutations	  across	  the	  entire	  probe	  (Lanes	  5-­‐10).	  	  Only	  mutant	  
competitors	  4	  and	  5	  are	  incapable	  of	  competing	  the	  probe/protein	  interaction.	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Figure	  4-­‐21.	  	  EMSA	  probe	  3.3-­‐2	  identifying	  potential	  POU1f1	  binding	  site.	  	  
EMSA	  probe	  3.3-­‐2	  identifying	  potential	  POU1fa1	  binding	  site	  (underlined	  sequence).	  	  
Bold	  font	  indicates	  sequence	  identified	  by	  mutated	  competitors	  4	  and	  5.	  	  Footprints	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Discussion	  
	   	  
To	  date,	  most	  research	  on	  the	  regulation	  of	  Fshr	  has	  focused	  on	  identifying	  
regulatory	  elements	  located	  in	  its	  5’	  flanking	  region,	  making	  this	  region	  the	  most	  
highly	  characterized	  of	  the	  locus.	  	  	  In	  vitro	  transient	  transfection	  assays	  of	  the	  wild	  
type	  and	  mutant	  promoters	  identified	  elements	  required	  for	  activity	  of	  the	  5’	  
flanking	  region	  including	  an	  E-­‐box,	  AP1,	  E2F,	  Inverted	  GATA	  and	  Inr	  regulatory	  sites	  
(Goetz,	  Lloyd	  et	  al.	  1996;	  Heckert,	  Daggett	  et	  al.	  1998;	  Heckert,	  Sawadogo	  et	  al.	  
2000;	  Kim	  and	  Griswold	  2001).	  	  This	  characterization	  identified	  an	  E-­‐box	  element	  
just	  upstream	  of	  the	  transcriptional	  start	  site,	  as	  the	  dominant	  regulatory	  element	  in	  
this	  region.	  	  In	  vitro	  and	  in	  vivo	  analysis	  identified	  the	  transcription	  factors	  
Upstream	  Regulatory	  Factor	  1	  and	  2	  (USF1	  and	  USF2)	  as	  the	  main	  E-­‐box	  bound	  
proteins	  (Goetz,	  Lloyd	  et	  al.	  1996;	  Heckert,	  Daggett	  et	  al.	  1998).	  	  In	  vivo	  footprinting	  
and	  ChIP	  analysis	  for	  USF1/2	  indicate	  that	  E-­‐box	  is	  only	  occupied	  in	  Fshr-­‐expressing	  
cells	  (Heckert,	  Sawadogo	  et	  al.	  2000;	  Hermann,	  Hornbaker	  et	  al.	  2008).	  	  Therefore,	  it	  
appears	  specificity	  is	  somehow	  linked	  to	  access	  of	  USF1/2	  to	  the	  promoter.	  	  USF1	  
and	  USF2	  proteins	  are	  ubiquitously	  expressed	  transcription	  factors	  and	  have	  been	  
associated	  with	  CBP/p300	  and	  recruitment	  of	  proteins	  associated	  with	  histone	  
modifications	  (Sirito,	  Lin	  et	  al.	  1994;	  Breen	  and	  Jordan	  2000).	  	  Although	  USF	  
proteins	  are	  required	  for	  Fshr	  transcriptional	  activity,	  their	  ubiquitous	  expression	  
makes	  them	  unlikely	  determinants	  of	  Fshr	  cell-­‐specificity,	  which	  is	  limited	  to	  Sertoli	  
and	  granulosa	  cells.	  	  Thus,	  other	  mechanisms	  or	  elements	  must	  be	  required	  to	  
enable	  USF	  proteins	  to	  have	  access	  to	  the	  promoter	  and	  initiate	  gene	  transcription.	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To	  elucidate	  which	  sequences	  required	  for	  correct	  spatio-­‐temporal	  
expression	  of	  Fshr,	  transgenic	  animals	  were	  created	  with	  various	  amounts	  of	  the	  
Fshr	  promoter	  directing	  a	  LacZ	  reporter	  (Linder,	  Heckert	  et	  al.	  1994;	  Heckert,	  
Sawadogo	  et	  al.	  2000;	  Hermann	  and	  Heckert	  2007).	  	  Analysis	  of	  the	  animals	  
confirmed	  the	  requirement	  for	  distal	  elements	  as	  none	  of	  the	  transgenes	  expressed	  
appropriately,	  even	  for	  YAC	  transgenes	  containing	  up	  to	  413	  kilobases	  of	  the	  entire	  
locus(Hermann,	  Hornbaker	  et	  al.	  2007).	  	  Taken	  together,	  this	  data	  suggests	  that	  
correct	  spatio-­‐temporal	  expression	  of	  Fshr	  requires	  regulatory	  elements	  that	  lie	  far	  
from	  the	  promoter.	  	  	  
Identification	  of	  distal	  regulatory	  elements	  has	  not	  only	  increased	  our	  
understanding	  of	  gene	  regulation,	  but	  has	  also	  led	  to	  the	  identification	  of	  numerous	  
distal	  elements	  important	  in	  development	  and	  disease	  (Koschmieder,	  Rosenbauer	  et	  
al.	  2005;	  Rijnkels,	  Kabotyanski	  et	  al.	  2010;	  Hardison	  2012;	  Peterson,	  Fedosyuk	  et	  al.	  
2012;	  Xu,	  Shao	  et	  al.	  2012).	  	  Identifying	  distal	  regulatory	  elements	  has	  become	  
easier	  due	  to	  the	  large	  amount	  of	  whole	  genome	  sequence	  data	  now	  available.	  	  
Considerable	  data	  from	  the	  literature	  indicate	  that	  sequence	  conservation	  is	  a	  
hallmark	  of	  functional	  importance	  and	  this	  is	  especially	  true	  for	  regulatory	  elements	  
(Dickmeis	  and	  Muller	  2005;	  Hawkins	  and	  Ren	  2006;	  Acevedo,	  Iniguez	  et	  al.	  2007;	  
Visel,	  Bristow	  et	  al.	  2007;	  Brown	  2008;	  Strahle	  and	  Rastegar	  2008;	  Fromm	  and	  
Bulger	  2009).	  	  As	  noted	  in	  the	  results,	  we	  mapped	  the	  conservation	  profile	  and	  7x	  
regulatory	  potential	  of	  the	  1.4	  Mb	  locus	  of	  the	  Fshr	  and	  identified	  31	  ECRs	  
associated	  with	  increased	  regulatory	  potential.	  	  While	  computational	  genomics	  has	  
helped	  identify	  new	  distal	  elements,	  false	  positives	  and	  undetected	  sequences	  limit	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the	  analysis	  (Birney,	  Stamatoyannopoulos	  et	  al.	  2007;	  Giresi,	  Kim	  et	  al.	  2007;	  
Margulies,	  Cooper	  et	  al.	  2007).	  	  	  
To	  overcome	  this	  limitation,	  our	  bioinformatic	  selection	  was	  further	  refined	  
using	  ChIP-­‐qPCR	  and	  ChIP-­‐Seq	  analysis	  of	  histone	  modifications	  across	  the	  Fshr	  
locus.	  	  Numerous	  reports	  now	  exist	  that	  use	  histone	  modifications	  to	  identify	  
important	  regulatory	  elements	  (Rye,	  Saetrom	  et	  al.	  2011;	  Shu,	  Chen	  et	  al.	  2011;	  
Choe,	  Hong	  et	  al.	  2012;	  Zentner	  and	  Scacheri	  2012).	  	  	  For	  our	  studies,	  a	  genome-­‐
wide	  map	  of	  H3K4me3,	  a	  chromatin	  modification	  known	  to	  associate	  with	  
regulatory	  elements,	  was	  generated	  for	  both	  Sertoli	  and	  myoid	  cells.	  	  These	  maps	  
identified	  a	  single	  conserved	  region	  associated	  with	  cell-­‐type	  specific	  H3K4me3	  
enrichment–	  ECR	  1f.	  	  	  
ChIP-­‐qPCR	  analysis	  was	  used	  to	  gain	  a	  more	  in-­‐depth	  understanding	  of	  the	  
chromatin	  environment	  encompassing	  ECR	  1f.	  	  The	  histone	  modifications	  enriched	  
within	  ECR	  1f	  include	  H4ac,	  H3K4me3	  and	  to	  a	  lesser	  extent	  H3ac.	  	  	  Each	  of	  these	  
marks	  is	  typically	  associated	  with	  active	  chromatin	  regions;	  further	  indicating	  that	  
ECR	  1f	  is	  actively	  involved	  in	  regulation	  within	  Sertoli	  cells.	  	  Enrichment	  of	  histones	  
corresponding	  to	  repressed	  regions,	  H3K27me3	  and	  H3K9me2	  was	  not	  detected.	  
These	  assays	  demonstrate	  that	  the	  chromatin	  surrounding	  ECR	  1f	  is	  permissive	  to	  
activity.	  	  	  
To	  identify	  the	  functional	  activity	  of	  ECR	  1f	  with	  the	  Fshr	  promoter,	  vector	  
constructs	  were	  transiently	  transfected	  into	  Sertoli	  cells.	  	  Transient	  transfection	  
analysis	  revealed	  that	  ECR	  1f	  could	  repress	  the	  Fshr	  promoter	  activity	  in	  vitro	  in	  
both	  primary	  Sertoli	  cell	  and	  myoid	  cultures.	  	  The	  repressive	  activity	  of	  ECR	  1f	  was	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not	  restricted	  by	  orientation	  within	  the	  plasmid	  and	  did	  not	  change	  when	  different	  
promoter	  sizes	  (-­‐220	  or	  -­‐2700	  bp)	  were	  used	  indicating	  that	  ECR	  1f	  is	  an	  insulator.	  	  	  
The	  repressive	  activity	  observed	  was	  also	  not	  restricted	  by	  cell	  type,	  indicating	  that	  
the	  transcription	  factors	  responsible	  for	  the	  repressive	  activity	  are	  present	  in	  both	  
Sertoli	  and	  myoid	  cells.	  
Perhaps	  the	  most	  surprising	  finding	  was	  that	  ECR	  1f	  repressed	  Fshr	  
promoter	  activity	  in	  vitro.	  	  Data	  obtained	  from	  our	  ChIP	  studies	  indicated	  that	  ECR	  
1f	  was	  enriched	  for	  histone	  modifications	  commonly	  associated	  with	  activity.	  	  The	  
most	  likely	  explanation	  for	  this	  is	  that	  not	  all	  distal	  regulatory	  elements	  function	  the	  
same	  in	  vitro	  as	  they	  do	  in	  vivo	  (Bulger	  and	  Groudine	  2010).	  	  When	  regulatory	  
elements	  are	  taken	  out	  of	  their	  native	  chromatin	  environment	  and	  placed	  in	  
reporter	  assays,	  several	  factors	  are	  altered	  including	  the	  lack	  of	  appropriate	  histone	  
association,	  limiting	  physical	  constraints	  and	  the	  possible	  removal	  of	  other	  key	  
regulatory	  sequences	  involved.	  	  Another	  possibility	  is	  that	  ECR	  1f	  is	  functioning	  to	  
actively	  repress	  the	  Fshr	  in	  vivo.	  	  However,	  a	  search	  of	  the	  literature	  did	  not	  identify	  
other	  distal	  regulatory	  elements	  associated	  with	  an	  active	  histone	  profile	  that	  in	  
turn	  repressed	  gene	  activity	  in	  vivo.	  	  	  	  	  	  
To	  further	  explore	  the	  regulatory	  sequence	  within	  ECR	  1f,	  in	  silico	  was	  used	  
to	  identify	  highly	  conserved	  regions	  within	  ECR	  1f.	  	  Two	  regions	  were	  identified,	  
ECR	  1F-­‐a	  and	  ECR	  1F-­‐b,	  and	  assayed	  for	  activity	  using	  Fshr	  promoter	  constructs.	  
Neither	  ECR	  1f-­‐a	  or	  1f-­‐b	  was	  capable	  of	  repressing	  Fshr	  promoter	  activity	  to	  the	  
same	  level	  as	  ECR	  1f.	  	  However,	  ECR	  1f-­‐b	  did	  repress	  promoter	  activity	  in	  a	  position	  
and	  orientation	  dependent	  manner	  and	  ECR	  1f-­‐a	  activated	  promoter	  activity	  in	  a	  
	   203	  
cell-­‐type,	  position	  and	  orientation	  specific	  manner.	  	  These	  results	  indicate	  that	  the	  
full	  length	  ECR	  is	  required	  for	  full	  activity.	  	  A	  fusion	  construct	  consisting	  of	  ECR	  1f-­‐a	  
and	  ECR	  1f-­‐b	  did	  repress	  Fshr	  promoter	  activity,	  although	  not	  to	  the	  same	  level	  as	  
the	  full	  length	  ECR	  1f	  implying	  that	  the	  less	  conserved	  sequence	  may	  play	  a	  role	  in	  
the	  activity	  of	  ECR	  1f,	  either	  by	  providing	  spatial	  distance	  between	  ECR	  1f-­‐a	  and	  1f-­‐b	  
or	  by	  the	  addition	  of	  other	  regulatory	  sequences.	  
Overall	  these	  results	  imply	  several	  possible	  regulatory	  actions	  for	  ECR	  1f.	  	  
First,	  it	  is	  likely	  that	  there	  are	  several	  regulatory	  elements	  residing	  in	  ECR	  1f	  as	  
indicated	  by	  the	  mixed	  results	  obtained	  using	  ECR	  1f-­‐a	  and	  1f-­‐b.	  	  Second,	  the	  lack	  of	  
activity	  associated	  with	  a	  majority	  of	  the	  ECR	  1f-­‐a	  and	  ECR	  1f-­‐b	  constructs	  tested	  
implies	  that	  multiple	  sites	  are	  required	  for	  full	  activity.	  	  Third,	  the	  less	  conserved	  
region	  residing	  in	  between	  ECR	  1f-­‐a	  and	  1f-­‐b	  likely	  plays	  a	  role	  in	  the	  regulatory	  
action	  of	  ECR	  1f.	  	  These	  results	  indicate	  that	  ECR	  1f	  is	  complex	  and	  that	  multiple	  
regions	  are	  required	  for	  proper	  function.	  
To	  assess	  the	  regulatory	  potential	  of	  individual	  regions	  of	  ECR	  1f	  within	  the	  
context	  of	  the	  full	  length	  ECR	  1f,	  small	  block	  deletions	  were	  made	  across	  ECR	  1f-­‐a	  
and	  ECR	  1f-­‐b.	  	  By	  only	  deleting	  a	  subset	  of	  each	  region	  and	  leaving	  the	  remaining	  
ECR	  intact,	  we	  were	  able	  to	  identify	  a	  small	  region	  (~150	  bp)	  within	  ECR	  1f-­‐a	  that,	  
when	  removed,	  relieved	  the	  repressive	  effects	  of	  ECR	  1f	  on	  the	  Fshr	  promoter	  in	  
Sertoli	  cells,	  identified	  as	  ECR	  1f-­‐a	  region	  3.	  	  To	  further	  refine	  this	  region,	  40	  base	  
pair	  block	  deletions	  were	  made	  across	  ECR	  1f-­‐a	  region	  3	  and	  analyzed	  for	  activity	  in	  
MSC1	  cells.	  	  This	  selection	  process	  narrowed	  down	  the	  repressive	  region	  to	  ~80	  
base	  pairs.	  	  In	  vitro	  footprinting	  identified	  5	  possible	  binding	  sites	  within	  this	  region,	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however	  individual	  mutation	  analysis	  of	  these	  5	  regions	  was	  unable	  to	  relieve	  the	  
repressive	  effect	  of	  ECR	  1f	  on	  the	  Fshr	  promoter.	  
In	  silico	  analysis	  of	  transcription	  factor-­‐binding	  sites	  within	  ECR	  1f-­‐a	  region	  3	  
identified	  two	  possible	  regulatory	  candidates-­‐	  GATA	  and	  POU.	  	  GATA-­‐4	  is	  a	  
transcription	  factor	  whose	  cell	  specific	  expression	  is	  limited	  to	  the	  heart,	  testis	  and	  
ovary.	  	  Within	  the	  testis,	  GATA-­‐4	  expression	  is	  restricted	  to	  Sertoli	  and	  Leydig	  cells.	  	  
Expression	  has	  been	  documented	  from	  embryonic	  day	  11.5	  and	  remains	  throughout	  
adulthood;	  however,	  the	  highest	  expression	  levels	  are	  found	  in	  Sertoli	  cells	  during	  
sex	  determination.	  	  EMSA	  analysis	  selectively	  identified	  GATA-­‐4	  as	  the	  GATA	  family	  
member	  bound	  to	  ECR	  1f-­‐a	  region	  3	  in	  vitro.	  	  	  
Previous	  studies	  from	  our	  laboratory	  identified	  a	  repressive	  site	  located	  
within	  the	  first	  intron	  of	  Fshr	  that	  also	  binds	  GATA-­‐4	  in	  vitro	  (Hermann	  and	  Heckert	  
2005).	  	  In	  the	  current	  study,	  we	  identified	  another	  distal	  region	  that	  is	  capable	  of	  
repressing	  Fshr	  promoter	  activity,	  in	  vitro,	  in	  Sertoli	  and	  myoid	  cells	  alike	  and	  found	  
that	  it	  is	  capable	  of	  binding	  GATA-­‐4	  in	  vitro.	  	  ECR	  1f	  lies	  ~400	  kb	  downstream	  of	  the	  
Fshr	  promoter,	  indicating	  that	  distal	  looping	  must	  occur	  to	  enable	  this	  region	  to	  
regulate	  the	  promoter.	  	  Studies	  have	  indicated	  that	  other	  members	  of	  the	  GATA	  
family	  are	  capable	  of	  achieving	  distal	  interactions	  and	  can	  act	  as	  either	  activators	  or	  
repressors	  depending	  on	  gene	  context	  (Fong	  and	  Emerson	  1992;	  Barton,	  Madani	  et	  
al.	  1997;	  Grass,	  Boyer	  et	  al.	  2003;	  Obara,	  Suzuki	  et	  al.	  2008;	  Yu,	  Riva	  et	  al.	  2009;	  
Chen,	  Bates	  et	  al.	  2012).	  	  It	  is	  possible	  that	  the	  two	  GATA	  sites	  identified	  work	  in	  
concert	  together	  to	  regulate	  the	  Fshr	  promoter	  in	  Sertoli	  cells.	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In	  silico	  analysis	  also	  identified	  a	  consensus	  sequence	  in	  ECR	  1f-­‐a	  region	  3	  
compatible	  with	  the	  POU	  family	  of	  transcription	  factors,	  specifically	  POU1f1,	  a.k.a.	  
pit-­‐1.	  	  The	  primary	  role	  of	  POU1f1	  is	  regulating	  pituitary	  development	  and	  hormone	  
secretion,	  however,	  a	  splice	  variant	  of	  pit-­‐1,	  pit-­‐1w	  was	  identified	  in	  the	  testis	  and	  
its	  role	  is	  currently	  under	  investigation	  (Taniuchi,	  Maeda	  et	  al.	  2011;	  Maeda,	  
Taniuchi	  et	  al.	  2012).	  	  The	  role	  of	  this	  protein	  was	  not	  explored	  in	  the	  current	  study,	  
as	  antibodies	  have	  not	  been	  identified	  to	  use	  in	  EMSA	  analysis.	  	  However,	  mutant	  
competitors	  did	  identify	  a	  12	  base	  pair	  sequence	  capable	  of	  binding	  protein	  from	  
Sertoli	  cell	  nuclear	  extract	  and	  this	  12	  base	  pair	  sequence	  matches	  the	  POU	  
consensus	  sequence.	  
The	  current	  study	  expands	  our	  knowledge	  of	  the	  regulatory	  landscape	  
surrounding	  Fshr	  in	  vivo	  and	  has	  identified	  two	  more	  sites	  capable	  of	  repressing	  the	  
Fshr	  promoter	  in	  vitro.	  	  Future	  studies	  will	  aim	  to	  decipher	  the	  role	  of	  this	  distal	  
element	  in	  vivo.	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ChIP-­‐Seq	  Analysis	  of	  Histone	  Modifications	  
Our	  initial	  objective	  was	  to	  map	  genome	  wide	  histone	  modifications	  in	  
P15Sprague	  Dawley	  Sertoli	  and	  peritubular	  myoid	  cells	  for	  the	  use	  of	  identifying	  
Sertoli	  cell	  specific	  distal	  regulatory	  elements.	  	  For	  both	  of	  these	  cell	  types,	  we	  
gathered	  enrichment	  data	  for	  H4ac,	  H3K4me3	  and	  H3K27me3.	  	  The	  raw	  sequence	  
tags	  were	  processed	  and	  aligned	  to	  the	  latest	  version	  of	  the	  Rattus	  norvegicus	  
genome	  (rn5,	  March	  2012).	  	  Each	  aligned	  sequence	  file	  was	  processed	  for	  viewing	  
on	  the	  UCSC	  genome	  browser.	  	  Unfortunately,	  the	  alignment	  quality	  for	  the	  Sertoli	  
cell	  samples	  H4ac	  and	  H3K27me3	  were	  poor	  and	  meaningful	  data	  could	  not	  be	  
extracted	  from	  the	  alignments.	  	  For	  complete	  analysis	  to	  be	  performed	  between	  the	  
two	  cell	  types,	  these	  two	  samples	  will	  need	  re-­‐sequenced.	  	  	  
	   The	  H3K4me3	  samples	  for	  both	  Sertoli	  and	  myoid	  cells	  did	  align	  well	  to	  the	  
reference	  genome	  and	  provided	  good	  quality	  data.	  	  For	  this	  dissertation,	  only	  the	  
top	  40	  enriched	  regions	  were	  considered	  for	  analysis.	  	  Although	  meaningful,	  this	  
analysis	  only	  contained	  a	  fraction	  of	  the	  enriched	  regions	  identified.	  	  Future	  work	  
with	  these	  datasets	  should	  include	  analysis	  across	  all	  of	  the	  identified	  regions,	  
which	  will	  lead	  to	  a	  complete	  picture	  of	  the	  H3K4me3	  landscape	  within	  Sertoli	  and	  
myoid	  cells.	  	  Future	  analysis	  should	  also	  include	  RNA-­‐Seq	  analysis	  identifying	  all	  the	  
transcribed	  sequences	  within	  Sertoli	  and	  myoid	  cells	  at	  P15.	  
	   Completion	  of	  this	  work	  will	  generate	  a	  complete	  picture	  of	  the	  histone	  
environment	  for	  H4ac,	  H3K4me3	  and	  H3K27me3.	  	  Combining	  this	  data	  with	  cell-­‐
specific	  expression	  analysis	  will	  greatly	  aid	  in	  the	  identification	  of	  cell-­‐specific	  
regulatory	  sequences.	  	  This	  dataset	  will	  be	  a	  great	  asset	  to	  the	  understanding	  of	  
	   208	  
transcriptional	  regulation	  in	  both	  Sertoli	  and	  myoid	  cells	  and	  will	  allow	  for	  the	  
identification	  of	  Sertoli	  cell	  specific	  modification	  patterns.	  	  This	  dataset	  will	  also	  
provide	  a	  comprehensive	  map	  that	  can	  be	  used	  in	  the	  identification	  of	  new	  
regulatory	  elements	  important	  in	  Sertoli	  cell	  transcriptional	  regulation.	  
Distal	  Regulation	  of	  Fshr	  
	   Using	  a	  combination	  of	  sequence	  conservation	  and	  H3K4me3	  profiles	  across	  
the	  Fshr	  locus	  we	  identified	  a	  putative	  cis-­‐regulatory	  element	  (ECR	  1f)	  at	  the	  3’	  end	  
of	  Fshr.	  	  Initial	  in	  vitro	  analysis	  indicates	  that	  ECR	  1f	  represses	  the	  Fshr	  promoter	  in	  
Sertoli	  cells	  and	  that	  GATA-­‐4	  may	  be	  responsible	  for	  this	  activity.	  	  In	  vitro	  
protein/DNA	  binding	  analysis	  also	  identified	  another	  site	  capable	  of	  binding	  a	  
Sertoli	  cell	  nuclear	  protein	  that	  may	  be	  involved	  and	  in	  silico	  analysis	  indicates	  the	  
likely	  candidate	  belongs	  to	  the	  POU	  family	  of	  transcription	  factors.	  	  Further	  EMSA	  
analysis	  with	  POU1f1	  specific	  antibodies	  could	  confirm	  this	  finding.	  
	   Aside	  from	  the	  in	  vitro	  binding	  studies,	  future	  studies	  will	  include	  in	  vivo	  
analysis	  of	  GATA-­‐4	  binding	  within	  ECR	  1f	  using	  chromatin	  immunoprecipitation.	  	  To	  
determine	  if	  ECR	  1f	  is	  in	  close	  physical	  contact	  with	  the	  Fshr	  promoter,	  Chromatin	  
conformation	  capture	  (3C)	  will	  be	  performed.	  	  This	  technique	  allows	  for	  the	  
identification	  of	  distal	  regulatory	  regions	  that	  are	  in	  close	  physical	  contact	  with	  
known	  promoter	  regions	  in	  vivo.	  	  Identification	  of	  the	  distal	  element	  regulating	  Fshr	  
will	  further	  our	  understanding	  of	  transcriptional	  regulation	  in	  Sertoli	  cells	  and	  
provide	  information	  regarding	  the	  regulation	  of	  Fshr.	  	  Identification	  of	  the	  
transcription	  factors	  involved	  in	  the	  regulation	  of	  Fshr	  will	  further	  our	  
understanding	  of	  transcriptional	  regulation	  in	  Sertoli	  cells.	  	  These	  results	  are	  not	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only	  relevant	  for	  Sertoli	  cells	  as	  Fshr	  is	  also	  expressed	  in	  ovarian	  granulosa	  cells.	  	  
Understanding	  the	  mechanisms	  and	  regulatory	  proteins	  involved	  in	  Fshr	  expression	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